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Abstract
C.T. Chang, Controlling infectious disease in laboratory zebrafish (Danio rerio). 202 pages, 8
tables, 22 figures, 2017. CSE style guide used.
Mycobacteriosis is a bacterial disease caused by Mycobacterium spp. that is common in 
captive, wild and research fish species. The overall goal of this thesis was to investigate 
mycobacteriosis in laboratory zebrafish in order to increase our understanding of this disease 
with the intention of influencing control and management practices. First, disease prevention 
through embryo disinfection was investigated. The effectiveness of several disinfectants were 
evaluated and povidone-iodine was identified as an effective disinfectant in vitro, it was then 
evaluated in vivo and showed minimal effects embryo health. Second, the potential of antibiotic 
treatment against mycobacteriosis in zebrafish was evaluated in vitro where tigecycline and 
clarithromycin were identified as key drug candidates. The tolerance and efficacy of both 
antibiotics were tested in vivo in adult zebrafish; where treatments were well tolerated and 
resulted in a decreased severity in establish mycobacterial infections. Last, natural modes of 
transmission were examined. Transmission between tank biofilms and zebrafish was 
demonstrated and the role mycobacterial biofilms play as both a reservoir for and source of 
Mycobacterium spp. in zebrafish tanks was identified. Finally, the role that live feeds play as a 
vector of mycobacterial transmission to zebrafish was tested and common zebrafish feeds are 
able to transmit Mycobacterium spp. to zebrafish. Altogether, these studies contribute to our 
current knowledge of mycobacterial infections in laboratory zebrafish and inform management. 
These results are also of use to other fish species as well.
Key Words: antibiotics; biofilm; disinfection; mycobacteria; Mycobacterium spp.; surveillance; 
zebrafish
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Chapter 1: Literature Review and Project Summary
1.1 The Zebrafish Model
The zebrafish (Danio rerio) is a freshwater minnow originating from the Indian 
subcontinent that was first introduced in pet stores in the 1970s (Schilling and Webb 2007). This 
fish gained attention from the research community as it is easy to house, can be bred year-round, 
produces large egg clutches, and its embryos are transparent and easily manipulated. Throughout 
1980-1990, the zebrafish gained popularity as an experimental model and tools were developed 
to perform large-scale genomic analyses (Schilling and Webb 2007). Since then the usage of the 
zebrafish model has increased and there are an estimated 2000 zebrafish facilities in the United 
States (Holland, Lawrence et al. 2013). Zebrafish are now considered the “rising stars” of model-
organism research, with an almost 60% increase in R01 awards from the National Institutes of 
Health for zebrafish studies between 2008 and 2015 (Gaind 2016).
Zebrafish are typically housed at high density in large rack systems of tanks where design 
incorporates principles of industrial aquaculture, laboratory rodent housing, and research 
genetics (Lawrence and Mason 2012). These systems are commercially available from several 
vendors and many research institutes are creating large centralized zebrafish facilities to be 
shared amongst researchers (Lawrence and Mason 2012). The sophistication of these systems 
and facilities ranges from simple recirculating systems to fully-automated systems that are 
accessed remotely (Lawrence and Mason 2012).
Despite the increased usage of zebrafish and their elaborate housing, an underlying 
understanding of the biology of the laboratory zebrafish remains to be fully elucidated. Peer-
reviewed publications examining the optimal and experimentally validated husbandry and 
environmental conditions for laboratory zebrafish are outnumbered by those that describe 
research discoveries using zebrafish (Kent, Feist et al. 2009). Studies of the former are only 
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recently being conducted enabling researchers to understand the importance of environmental 
factors such as lighting (Blaser and Penalosa 2011), tank complexity (Carfagnini, Rodd et al. 
2009), water quality (Ramsay, Feist et al. 2009), and zebrafish health on research results.
Currently, these studies are primarily focused on zebrafish reproductive maturity and fecundity,
as fast generation times and large clutches are required for the high-throughput experiments. An 
important aspect of zebrafish biology where our understanding has lagged behind the growth in 
zebrafish usage is the pathogens that affect laboratory zebrafish, especially those pathogens that 
result in subclinical infections that are more difficult to detect but may significantly alter 
research results (Kent, Feist et al. 2009). Additionally, since the current morbidity and mortality 
rates associated with the microorganisms causing disease in zebrafish have been considered 
“acceptably” low; researchers have become tolerant of their presence despite repercussions of 
infections (Kent, Feist et al. 2009).
This lag in pathogen discovery also occurred during the development of the laboratory 
mouse, which is now the most widely used and best understood animal model used (Care 1984).
The last 100 years of laboratory rodent usage has been previously described as three periods with 
regard to the struggle against pathogens infecting these animals (reviewed in (Weisbroth 1996)). 
The first period (1880-1950) was the period of domestication where the usage of rodents as 
research subjects increased, and many of these original stocks harbored a variety of indigenous 
pathogens. Throughout this period progress was made in preventing and controlling these 
infections through improvements to sanitation, nutrition, environmental control and other aspects 
of husbandry. The second period (1960-1985) included the derivation of gnotobiotic strains 
where cesarean re-derivation was used to replace infected stocks with uninfected offspring,
effectively eliminating pathogens not transmitted in utero. The final period (1980-1996) included 
3
 
the eradication of indigenous murine viruses and reduction of other pathogens through practices 
including serological testing of animals for pathogen-specific antibodies and cesarean re-
derivation of positive colonies. Through the progress made during these periods, as well as 
through ongoing studies on infectious diseases affecting laboratory rodents, there is a continued 
steady decline in microbial contamination in laboratory colonies. Routine prevention of infection 
in laboratory rodents requires: an understanding of susceptibility to disease and disease 
processes, timely testing, appropriate housing, rapid diagnosis and control of outbreaks (Jacoby 
and Lindsey 1998). Importantly, there is agreement throughout the scientific community that 
advances in laboratory animal health have improved the reliability of rodent-based research
(Jacoby and Lindsey 1998).
The zebrafish community can draw from the progress made by the laboratory rodent 
community and seek direction from the steps taken to minimize disease in these laboratory 
animals. Compared to what is now known regarding laboratory rodent pathogens, much less is 
known about diseases affecting captive zebrafish. This need for knowledge has recently been 
identified (Kent 2012, Whipps 2012) and emphasized, as it is prudent to conduct research on 
healthy, disease-free animals where possible.
1.2 Disease in Laboratory Zebrafish
Thus far, progress has been made to identify common zebrafish pathogens and implement 
basic control measures to prevent disease spread. Microsporidiosis and mycobacteriosis are the 
most common diseases observed in laboratory zebrafish (Kent 2012). Microsporidiosis is caused 
by Pseudoloma neurophilia and affects 74% of the facilities submitting cases to the Zebrafish 
International Resource Center (ZIRC) diagnostic service (Figure 1-1) (De Kinkelin 1980, 
Zebrafish International Resource Center (ZIRC) Health Services 2017)((Kent 2012).
Mycobacteriosis is caused by Mycobacterium spp. and affects approximately 40% of facilities 
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submitting cases to ZIRC diagnostic services (Figure 1-1) (Kent, Whipps et al. 2004, Kent 2012, 
Zebrafish International Resource Center (ZIRC) Health Services 2017). Less frequently than 
microsporidiosis or mycobacteriosis, laboratory zebrafish are affected by myxozoan and 
helminth parasites, fungal infections, and other non-acid fast bacterial species (Figure 1-1) (Kent 
2012, Collymore, Crim et al. 2016, Zebrafish International Resource Center (ZIRC) Health 
Services 2017). Basic disease control and management measures broadly recommended include: 
quarantine of fish from outside facilities, equipment disinfection, UV water sterilization, embryo 
disinfection, and sentinel programs. Still lacking, is a deeper understanding of the manifestation 
of these diseases (i.e., beyond overt clinical signs), the mode of transmission of these pathogens 
(between both the environment and facilities as well as between facilities in the zebrafish 
research community), and the optimal species-specific method to control and eradicate these 
pathogens.
5Figure 1-1. Pathogens present in laboratory zebrafish facilities based on a 2015 survey of cases 
submitted to the Zebrafish International Resource Center’s Diagnostic Services (Zebrafish 
International Resource Center (ZIRC) Health Services 2017).
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1.3 The genus Mycobacterium
The genus Mycobacterium includes many medically important species that have impacted 
human and animal health. This genus includes the well-known Mycobacterium tuberculosis, the 
cause of tuberculosis (TB) which the World Health Organization (WHO) estimates infects 
almost one third of the human population (1.8 billion people) (www.who.org). Other species of 
Mycobacterium that are recognized to impact human health are Mycobacterium leprae, the 
causative agent of leprosy. Additionally, non-tuberculosis mycobacteria (NTM) are recognized 
to be a health threat to the health of immunocompromised individuals such as those infected with 
the human immunodeficiency virus (HIV). More than 185 Mycobacterium species have been 
validly published to date, according to the List of Prokaryotic Names with Standing in 
Nomenclature (http://www.bacterio.net/mycobacterium.html). Mycobacteria are Gram-positive,
aerobic bacteria and the only member of the family Mycobacteriaceae in the order 
Actinomycetales. Mycobacterium species have high genomic GC content (62-70%) and a waxy, 
lipid-rich, cell wall that is regularly identified using acid-fast staining that allows for these acid-
alcohol-fast rods to be differentiated from other bacteria. 
Phylogenetically, based on 16S ribosomal gene sequences, mycobacteria are subdivided 
into fast/rapid and slow growing species (Saviola and Bishai 2006) . The rapid growing 
mycobacteria (RGM) form colonies on selective media in less than 7 days compared to the 
slower growing mycobacteria (SGM) that require longer than 7 days. Historically there have 
been multiple attempts to group mycobacteria based on their ecology, first through dividing 
species into pathogenic or saprophytic groups (Saviola and Bishai 2006). Later, divisions into 
anonymous, typical or atypical, opportunist, non-tuberculosis, and other groups were proposed
(Runyon 1959, Wolinsky 1979, Davidson 1981, Jenkins 1981, Grange 1991). While at first 
helpful, these groupings became confusing due to differences in interpretation of groups. Kazda
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(2009) proposes three epithets for dividing mycobacteria: obligate pathogenic mycobacteria, 
potentially pathogenic mycobacteria, and environmental saprophytic mycobacteria. 
Obligate pathogenic mycobacteria (OPM) are the most specialized species of 
Mycobacterium and cause disease in humans and can be transmitted to other animals (e.g., feral 
opossum and badger). These species exhibit a high virulence and are able to survive in a dormant 
form for extended periods of time; however, their survival in the environment is limited. 
The environment serves as a primary source for potentially pathogenic mycobacteria 
(PPM) where these species persist and grow, while also being found in living hosts occupying 
environmental niches like mucous membranes. The PPM are able to cause mycobacteriosis in 
susceptible hosts (e.g., immunocompromised individuals) and serve a transitional role between 
OPM and environmental saprophytic mycobacteria.
Environmental saprophytic mycobacteria (ESM) together are the largest group of 
mycobacteria and can be isolated from a range of environments including: sphagnum and moss 
vegetation, surface and drinking water, and soil. These species are often identified as a 
contaminant in clinical material and their presence has been demonstrated to enhance the 
pathogenicity of leprosy bacillus.
1.4 Mycobacteriosis in Fishes
The first documental case of fish mycobacteriosis was the identification of a tuberculous-like 
disease in carp (Cyprinus carpio) (Bataillon, Dubard et al. 1897). Mycobacteriosis is now 
recognized as one of the most common chronic diseases of freshwater and marine fishes in 
temperate and tropical climate with a worldwide distribution (Pavlik and Khol 2009).
Mycobacteriosis is thought to be the most common chronic disease affecting aquarium fish
(Noga 2010). Freshwater and marine aquarium fish are susceptible, particularly members of the 
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freshwater families Anabanitdae, Characidae, and Cyprinidae (Decostere, Hermans et al. 2004)
(Nigrelli and Vogel 1963) (Smith 1997, Zanoni, Florio et al. 2008). More recently 
mycobacteriosis has become a problem in laboratory research facilities that maintain medaka
(Oryzias latipes) (Teska, Twerdok et al. 1993) and zebrafish (Astrofsky, Schrenzel et al. 2000, 
Harriff, Bermudez et al. 2007). Mycobacteriosis in aquarium fish encompasses infections with 
several species of Mycobacterium including Mycobacterium marinum, Mycobacterium fortuitum, 
Mycobacterium chelonae, Mycobacterium gordonae, and Mycobacterium peregrinum (Noga 
2010).
Mycobacterial infections are also problematic in cultured food fish including European sea 
bass (Colorni, Ankaoua et al. 1993, Colorni, Avtalion et al. 1998), tilapia, and striped bass
(Hedrick, Mcdowell et al. 1987). Mycobacteriosis has historically also been an issue in salmonid 
culture when the use of raw fish offal was used as a feed (Ross and Brancato 1959). More 
recently, salmonid mycobacteriosis occurs less frequently; however, asymptomatic infections 
have been observed to affect certain populations (Arakawa and Fryer 1984). Mycobacteriosis is a 
known disease of striped bass in Chesapeake Bay, USA (Rhodes, Kator et al. 2004).
It has been proposed that fish shed mycobacteria from infected skin ulcers and the 
intestine, and that these are a major source of infection for other fish (Noga 2010). The intestinal 
epithelium has been demonstrated to be a route of entry (Harriff, Bermudez et al. 2007), and 
ingestion is suspected to be a major source of infection (e.g., fish that have consumed dead tank 
mates). The swim bladder is another possible route of initial infection as zebrafish are 
physostomus and hence this organ is connected to the intestinal tract via the pneumatic duct.
Often the swim bladder is the only organ infected, with colonization of the swim bladder 
epithelium and lumen (Whipps, Matthews et al. 2008). Mycobacteria have been shown to 
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survive in the environment for 2 years (Reichenbach-Klinke 1972). In the aquatic setting, 
mycobacteria persist in surface biofilms (Beran, Matlova et al. 2006, Whipps, Matthews et al. 
2008). Additionally, transovarian transmission of mycobacteria has been shown in bettas (B. 
splendens) (Chinabut, Kanayati et al. 1994) and guppies (Conroy 1966) but not in other species 
such as salmonids (Ross and Johnson 1962).
Generally, the fish-pathogenic mycobacteria are considered atypical mycobacteria, non-
tubercular mycobacteria, or environmental mycobacteria. However, some species of fish-
pathogenic mycobacteria can infect humans causing localized, non-healing ulcers (fish tank
granuloma/fish handler’s disease/swimming pool granuloma)(Kern, Vanek et al. 1989, Wu, Chiu 
et al. 2012). Some of these zoonotic infections can be difficult to treat due to the antimicrobial 
resistance of some isolates of mycobacteria. 
Mycobacteriosis in fishes was historically identified to be caused by mostly 
Mycobacterium chelonae, Mycobacterium fortuitum, and Mycobacterium marinum (Frerichs 
1993). Through increased study and also more molecular diagnostic methods, at least 16 
different species have been described from infections in fish (Whipps, Dougan et al. 2007, 
Gauthier and Rhodes 2009).
1.5 Mycobacteriosis in Zebrafish
There are 6 described species of Mycobacterium that have been implicated in zebrafish 
mycobacteriosis (Table 1-1). The first described cases of zebrafish mycobacteriosis were M. 
abscessus, M. chelonae, and M. fortuitum were isolated in zebrafish experiencing decreased 
survival and fecundity (Astrofsky, Schrenzel et al. 2000). Following this description, several 
more species were isolated from zebrafish facilities experiencing mortality events (Kent, Whipps 
et al. 2004, Kent, Whipps et al. 2004). For these cases, M. peregrinum, M. haemophilum were 
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found to be associated with severe outbreaks, while M. chelonae and M. chelonae-like bacterium 
were found in fish from facilities experiencing moderate to minimal outbreaks.
Table 1-1. Species of Mycobacterium identified to infect laboratory zebrafish (from Whipps et 
al. 2012).
Species Source
Mycobacterium abscessus Astrofsky et al. (2000); Watral and Kent (2007)
Mycobacterium chelonae Astrofsky et al. (2000); Watral and Kent (2004); Whipps et al. (2008)
Mycobacterium chelonae-like Kent et al. (2004); Whipps et al. (2007a)
Mycobacterium fortuitum Astrofsky et al. (2000)
Mycobacterium haemophilum Whipps et al. (2007b)
Mycobacterium marinum Watral and Kent (2007)
Mycobacterium peregrinum Kent et al. (2004)
The manifestation of zebrafish mycobacteriosis is variable and clinical signs are not 
pathognomonic (Astrofsky, Schrenzel et al. 2000, Kent, Spitsbergen et al. 2012). External signs 
include nonspecific dermal lesions, raised scales, swollen abdomens, and emaciation. Fish may 
show behavioral signs including erratic swimming or lethargy. Importantly, often fish display no 
signs of disease. Internal signs may include disseminated granulomas throughout, particularly on 
hematopoetic organs. Diffuse infections have been reported with an absence of granulomatous 
lesions for infections with M. haemophilum (Whipps, Dougan et al. 2007) and M. marinum
(Ramsay, Watral et al. 2009). Bacteria in the ovaries (Kent, Whipps et al. 2004) and swim 
bladder (Whipps, Matthews et al. 2008) have also been observed. Additionally, bacteria have
been observed in the intestinal epithelium within the luminal space indicating shedding across 
the intestinal surface and fecal excretion (Whipps, Butler et al. 2007).
Mycobacteriosis in zebrafish is thought to be transmitted through the ingestion of 
contaminated food or tissues (i.e., fish cannibalism) as this has been demonstrated in other fishes 
(Ross 1970). Invasion has been reported to occur through the intestine (Harriff, Bermudez et al. 
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2007), rather than through the skin or gills; however, further research is required before 
transmission routes are fully understood. Other potential modes of transmission are vertical 
transmission following reproduction (Kent, Whipps et al. 2004, Kent, Watral et al. 2016),
exposure to mycobacteria that form biofilms in tank systems, and transmission from fomites and 
handlers. 
In terms of controlling and managing this disease, disease prevention is paramount. 
Recent reviews of zebrafish diseases emphasize the importance of preventative measures (i.e.,
quarantine, disinfection, UV water sterilization, sentinel monitoring programs, regular health 
monitoring) (Kent et al., 2009; Whipps et al., 2012)(Collymore, Crim et al. 2016, Mason, Snell 
et al. 2016).  In the event that an outbreak of mycobacteriosis occurs, control measures become 
much more invasive and include depopulation, system sterilization, and rederivation of zebrafish 
stocks (Whipps et al., 2012). Although these invasive measures have been demonstrated to be 
effective at controlling mycobacteriosis (Whipps et al., 2012) they may not always be feasible 
due to ongoing experiments and a lack of means to preserve valuable mutant lines, 
demonstrating a need for alternative methods for treating/controlling this disease in laboratory 
zebrafish.
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1.6 Objectives
In this dissertation, I aim to increase our understanding of mycobacteriosis in laboratory 
zebrafish through investigation of the prevention, treatment, and transmission of Mycobacterium 
spp. in zebrafish colonies. 
1. Prevention: Chapters 2 and 3 describe the evaluation of common disinfectants for 
zebrafish embryo disinfection in vitro and in vivo, respectively. 
Hypothesis: I hypothesize that the species of Mycobacterium isolated from 
zebrafish will be differentially susceptible to disinfectant treatments due to
previous observation of differential disinfectant susceptibilities of Mycobacterium 
species and that disinfection treatments already used in aquaculture will not result 
in adverse health effects on zebrafish embryos. 
2. Treatment: Chapters 4 and 5 evaluate the potential for antibiotic treatment of zebrafish 
mycobacteriosis through both an evaluation of the antibiotic susceptibility of species of 
Mycobacterium isolated from zebrafish in Chapter 4 and through an evaluation of the 
tolerance and efficacy of antibiotics in adult zebrafish in Chapter 5. 
Hypothesis: I hypothesize that the different species of Mycobacterium isolated in 
zebrafish will be differentially susceptible to different antibiotic treatments in 
vitro as Mycobacterium spp. have previously been observed to be differentially 
susceptible to antibiotic treatments as well has previous identification of genetic 
resistance in mycobacteria. I also hypothesize, that Mycobaterium spp. in vivo
will be susceptible to antibiotic treatments observed to be effective in prior in 
vitro testing. 
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3. Transmission: Chapter 6 investigates the role biofilms play in zebrafish infections with 
mycobacteria. Finally, Chapter 7 investigates the effect live food vectors play in 
mycobacterial transmission. 
Hypothesis: I hypothesize that transmission of Mycobacterium spp. occurs 
between tank biofilms and zebrafish because the same strains of mycobacteria 
have previously been identified in both fish and biofilms. I also hypothesize that 
Mycobacterium spp. can be transmitted to zebrafish through live feed vectors, and 
that the degree of virulence is vector-dependent because passage through a cell is 
known to activate virulence mechanisms.
Significance: 
The overall goal of this research is to provide insight that will inform effective disease 
control and management practices for the research community and improve zebrafish as a model 
organism. 
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2.1 Abstract 
Mycobacteriosis is a bacterial disease that is common in captive, wild and research fish. 
There is no one causative agent of mycobacteriosis, as several strains and species of 
Mycobacterium have been identified in zebrafish. With increased usage and investment in wild-
type and mutant zebrafish strains, considerable value is placed on preserving zebrafish health. 
One control measure used to prevent mycobacterial spread within and between zebrafish 
facilities is egg disinfection. Here we investigate the effectiveness of three disinfectants [chlorine 
bleach, hydrogen peroxide, and povidone iodine (PVPI)] commonly included in egg disinfection 
protocols for laboratory fish as well as aquaculture fish and compare the knockdown effect of 
these treatments on Mycobacterium spp. in vitro. Despite current usage, comparison of these 
disinfection regimes’ abilities to prevent mycobacterial growth has not been tested. We found 
that the germicidal effect of different disinfectants varies by Mycobacterium spp.. Hydrogen 
peroxide was the least effective disinfectant, followed by unbuffered chlorine bleach, which is 
commonly used to disinfect embryos in zebrafish facilities. Disinfection with 25 ppm PVPI for 5 
min was very effective, and may be an improved alternative to chlorine bleach for embryo 
disinfection. Results from this study can be utilized by laboratory fish facilities in order to 
prevent the spread of mycobacteriosis in research fish. 
Key words: zebrafish, embryo disinfection, husbandry, iodine, chlorine bleach, hydrogen 
peroxide, mycobacteriosis, biosecurity. 
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2.2 Introduction 
 Mycobacteriosis is a chronic bacterial disease caused by Mycobacterium species and is 
common in laboratory zebrafish colonies (Astrofsky et al., 2000; Kent et al., 2004; Kent, 2012; 
Whipps et al., 2012). Mycobacteria are facultative pathogens that can persist both within the host 
and in the environment and are readily isolated from surface biofilms (Falkinham, 2009; 
Falkinham et al., 2001). There is no single etiological agent for zebrafish mycobacteriosis and 
several species, both rapid-growing and slow-growing, of Mycobacterium have been implicated 
in zebrafish infections (Astrofsky et al., 2000; Kent et al., 2004; Whipps et al., 2012; Whipps et 
al., 2008). The manifestation of mycobacterial infections is species-specific and variable ranging 
from acute, severe epizootic outbreaks with significant colony mortality to chronic, low-level 
infections presenting no clinical signs of disease (Watral and Kent, 2007; Whipps et al., 2007a; 
Whipps et al., 2007b; Whipps et al., 2012). Thus, mycobacterial infections are detrimental to 
research when severe outbreaks cause population loss, but they are also concerning as a source of 
uncontrolled experimental variance in the case of chronic, low-level, sub-clinical infections 
(Kent et al., 2004; Whipps et al., 2012).  
 Control recommendations for mycobacteriosis in zebrafish colonies emphasize the 
importance of disease prevention through quarantine, disinfection, UV sterilization, and sentinel 
programs for monitoring disease (Kent et al., 2009; Whipps et al., 2012). Included in these 
recommendations is the surface disinfection of eggs through bleaching (Westerfield, 2000; 
Lawrence, 2007; Kent et al., 2009). Also, investigations involving the generation of gnotobiotic 
zebrafish include surface disinfection of embryos using immersion in bleach followed by an 
iodine solution (Milligan-Myhre et al., 2011). However, the efficacy of these disinfection 
treatments against Mycobacterium spp. from zebrafish is unknown (Whipps et al., 2012). 
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 Disinfectant is a term that usually describes a chemical agent that prevents infection 
through the destruction of harmful microorganisms, but that may not eliminate bacterial spores 
(Block, 2001). The Centers for Disease Control and Prevention prescribes three main levels for 
disinfection: high-level disinfectants killing all microorganisms (including spores); intermediate-
level disinfectants that kill vegetative cells, most viruses and some spores; and low-level 
disinfectants that kill vegetative cells (not including spores) (Garner and Favero, 1986). Many 
disinfectants currently used in aquaculture provide an intermediate-level of disinfection (Noga, 
2010). Compared to sterilization, disinfection is a less lethal process as not all forms of life are 
destroyed (Block, 2001; Noga, 2010). The effectiveness of a disinfectant is specific to the 
infectious agent in question as their susceptibilities vary (Block, 2001). Therefore considerations 
should be given to the required application prior to the selection of a particular disinfectant 
(Block, 2001).  
 Mycobacteria are considered to be resistant to disinfection and they are considered to fall 
between vegetative bacteria and endospores in terms of their resistance to chemical disinfection 
and are generally susceptible to intermediate-to-high-level disinfectants (Block, 2001; Widmer 
and Frei, 2003). This degree of resistance can be attributed to the extremely resilient waxy 
mycobacterial cell wall that is highly hydrophobic (Russell, 1996). This hydrophobicity prevents 
hydrophilic antimicrobials and chemical disinfectants from penetrating the cell wall, protecting 
the mycobacteria from elimination (Russell, 1996; Block, 2001). In addition to this, biofilm 
formation has been shown to increase mycobacterial resistance to disinfection (Bardouniotis et 
al., 2003; Steed and Falkinham, 2006). Also, the susceptibility of mycobacteria in biofilms to 
disinfection is species specific (Russell, 1996; Block, 2001; Bardouniotis et al., 2003; Steed and 
Falkinham, 2006). 
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 Chlorine bleaching of zebrafish embryos is already an established and accepted practice 
(Westerfield, 2000). Most zebrafish laboratories use concentrations of 25-100 ppm chlorine and 
dose embryos for up to 10 minutes (Westerfield, 2007; Harper and Lawerence, 2011; Kent et al., 
2014). More recently, an increased chlorine concentration from 50 ppm to 100 ppm has been 
recommended to increase the killing of Pseudoloma neurophilia spores, another common 
zebrafish pathogen (Ferguson et al., 2007; Kent et al., 2014). Buffered bleach solutions have also 
been shown to be more effective at killing P. neurophilia (Ferguson et al., 2007); however, 
buffered bleach is more toxic to zebrafish embryos (Kent et al., 2014). It is not known if, like P.
neurophilia, buffering bleach results in decreased mycobacterial survival compared to the 
currently utilized unbuffered solutions.  In general, zebrafish embryo bleach disinfection 
involves the immersion of embryos in a 25-100 parts per million (ppm) chlorine bleach solution 
for up to 10 minutes followed by rinsing in either system water or embryo medium (Westerfield, 
2007), neutralization in sodium thiosulfate and rinsing in embryo medium (Detrich et al., 2011), 
or rinsing in sterile embryo media for the derivation of gnotobiotic fish (Milligan-Mhyre et al., 
2011). Hydrogen peroxide is another disinfectant that is often used for embryos of other fish 
species, particularly in catfish, at a concentration of 250-500 ppm in both bath and flow-through 
treatments (Small, 2003). For Mycobacterium spp., however, a higher concentration of hydrogen 
peroxide seems to be necessary as recommendations for using hydrogen peroxide to disinfect 
Mycobacterium tuberculosis include the usage of concentrations greater than 30,000 ppm (Noga, 
2010). Iodine disinfection of embryos is a widely used and accepted practice in salmonid 
fisheries with a recommended immersion in 100 ppm povidone-iodine (PVPI) for 10 minutes 
(Wood, 1979; Alaska Department of Fish and Game, 1983, 1988; United States Fish and 
Wildlife Service, 2004; Wagner et al., 2008). Immersion in PVPI is also used for generating 
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gnotobiotic zebrafish at 100 ppm for 2 minutes (Milligan-Mhyre et al. 2011). Despite the usage 
of these disinfectant regimes on fish embryos, much remains to be understood about the 
effectiveness of these treatments on preventing the spread of fish mycobacteriosis.  
Mycobacteria are documented to be susceptible to the following chemical disinfectants: 
alcohols, aldehydes, some alkalis, halogens (including chlorine and iodine compounds), some 
peroxygen compounds and some phenols (Block, 2001; Widmer and Frei, 2003;  Noga, 2010). 
Because most investigations into the effectiveness of chemical disinfectants on mycobacteria are 
clinically oriented, information specific to the Mycobacterium spp. found in zebrafish facilities is 
limited to studies investigating Mycobacterium marinum and Mycobacterium fortuitum 
(Bardouniotis et al., 2003). Therefore, more information is needed regarding the susceptibility of 
zebrafish mycobacteria to disinfection and the efficacy of currently utilized disinfection practices 
at preventing mycobacterial spread.  
The aim of this study was to investigate the susceptibility of several Mycobacterium spp. 
isolated from zebrafish research facilities in the United States to chemical disinfection in vitro. 
Chemical disinfection regimes were chosen with a focus on methods already utilized within the 
fish community for egg disinfection. We hypothesize that Mycobacterium spp. will show 
differential susceptibility to different disinfectants and there will be species-specific 
susceptibilities similar to what has been previously shown in literature for non-zebrafish 
mycobacteria. 
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2.3  Methods 
Bacterial culture and growth media 
Isolates of Mycobacterium abscessus, Mycobacterium chelonae, Mycobacterium 
gordonae, and Mycobacterium peregrinum maintained in our culture collection were used. All 
were isolated from zebrafish facilities in the United States and were previously identified based 
on hsp65 gene sequencing as previously described (Kent et al. 2004; Poort et al. 2006; Whipps et 
al. 2007a; Whipps et al. 2007b). All isolates were grown at 28-30°C for seven days on solid-
phase Middlebrook 7H10 (MB 7H10) agar (BD Biosciences 262710) supplemented with oleic 
albumin dextrose catalase (OADC, BD Biosciences 211886), prior to preparation for disinfection 
treatments. 
Disinfection treatment and analysis 
Chlorine Bleach (unbuffered) – We treated Mycobacterium spp. isolates with chlorine 
bleach at concentrations of 100 and 150 ppm chlorine bleach (Clorox®) for 10 minutes. Isolated 
M. abscessus, M. chelonae, M. gordonae, and M. peregrinum colonies were individually 
inoculated with a sterile loop into sterile culture tubes containing 3 ml of 100% Middlebrook 
7H9 broth and incubated for 7 days at 30°C and 300 rpm. Following incubation, broth culture 
was diluted in sterile water to reach a concentration of 105 colony forming units (CFU) per 
milliliter measured using a nephelometer (Sensititre). Chlorine bleach treatment solutions (100 
ppm, 150 ppm, control) were prepared by diluting Clorox® bleach in autoclaved Milli-Q® 
filtered water to a 1000 ppm concentration. Chlorine concentration was verified using a chlorine 
meter (Extech CL200). For each treatment, 1.0 mL of diluted broth culture was added to a sterile 
2 ml Eppendorf tube and 1000 ppm chlorine bleach in Milli-Q® was added to bring treatment 
solutions to a final concentration of 100 ppm, 150 ppm chlorine bleach. For the control, sterile 
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Milli-Q water was added to the broth culture. The pH of the treatment solution was measured 
before and after treatment. Tubes were incubated for 10 minutes at room temperature with gentle 
mixing. Following exposure time, an equal volume of 1% sodium thiosulfate (Na2HPO4, Fisher 
Scientific S-446) made in autoclaved Milli-Q® water was added to neutralize the chlorine with 
gentle mixing. Neutralizing activity of the sodium thiosulfate was confirmed using a chlorine 
meter. Following neutralization, serial dilutions of these solutions were prepared at 100, 10-1, 10-2 
for treatment tubes and 10-3, 10-4, and 10-5 for control tubes. Finally, 100 μl of each dilution was 
plated onto MB 7H10 agar plates in triplicate using a sterile spreader. Plates were then incubated 
at 28°C for 7 days and colonies were counted. This experiment was repeated two more times. 
 Chlorine Bleach (buffered) - In addition to the chlorine experiment described above, we 
conducted another trial of chlorine disinfection in order to compare disinfection with buffered 
and unbuffered bleach. Cultures were prepared to 105 CFU/ml as above. For each treatment, 1 ml 
of this diluted culture was added to a sterile 2.0 ml tube and centrifuged to form a pellet. 
Following centrifugation the supernatant was removed and was replaced with 1 mL of treatment 
solutions [100 ppm, 150 ppm, or 0 ppm chlorine bleach prepared in autoclaved chlorine demand 
free buffer (CDFB), prepared by mixing 42% 0.05M KH2PO4, and 58% 0.05M Na2HPO4, or in 
autoclaved Milli-Q®  water as a control for comparison]. The same inoculating cultures were 
used for both treatments. M. chelonae and M. peregrinum cultures were used for this second trial 
for 5 and 10 minute exposure times at 100 ppm or 150 ppm concentrations for both buffers. 
Following exposures, neutralization, serial dilution and plating were carried out as in the 
previously described trial. This experiment was then repeated two more times. 
Hydrogen peroxide – We treated Mycobacterium spp. isolates to 15,000 ppm and 
30,000 ppm hydrogen peroxide (H2O2, drugstore brand) for 5 minutes. Cultures were prepared to 
32 

105 CFU/ml as above. For each treatment, 1 ml of this diluted culture was added to a sterile 1.5 
ml tube and centrifuged to form a pellet. Following centrifugation the supernatant was removed 
and was replaced with 1 ml of freshly made hydrogen peroxide (H2O2, drugstore brand) 
treatment solution (15,000 ppm or 30,000 ppm) or an equal volume of sterile water for the 
control treatment. Hydrogen peroxide treatment solutions were undiluted (30,000 ppm) and 
diluted with sterile water (15,000 ppm). Treatment tubes were vortexed to break pellet apart and 
tubes with incubated for 5 minutes at room temperature in the dark. Following incubation tubes 
were centrifuged again to re-pellet cells and the treatment/control solutions were replaced with 1 
ml of sterile water. Tubes were vortexed to resuspend cells and serial dilutions of 10-7, 10-6, 10-5, 
10-4, and 10-3 were prepared and 100 μl of each dilution was plated onto MB 7H10 in triplicate. 
These plates were incubated at 28°C for 7 days and colonies were counted. This experiment was 
repeated two more times.  
Iodine –We treated Mycobacterium spp. isolates to 12.5-100 ppm PVPI for 5 minutes. 
Cultures were prepared to 105 CFU/ml. For each treatment, 1 ml of this diluted culture was 
pelleted in a sterile 1.5 ml tube. Following centrifugation the supernatant was removed and was 
replaced with 1 ml of freshly made iodine treatment solution made in sterile Milli-Q® water. 
Initially, M. chelonae was tested at four concentrations (12.5 ppm, 25 ppm, 50 ppm, or 100 ppm) 
of PVPI (10%, drugstore brand). Following this trial, 25 ppm PVPI was chosen as the optimal 
treatment to be tested on M. abscessus, M. gordonae, and M. peregrinum. Control treatments 
consisted of an equal volume of sterile water. All treatment solution concentrations were verified 
using iodine test paper (LaMotte). Treatment tubes were vortexed to break pellet apart and tubes 
with incubated for 5 minutes at room temperature in the dark. Following incubation tubes were 
centrifuged again to re-pellet cells and the treatment/control solutions were replaced with 1 ml of 
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sterile water. Tubes were vortexed to resuspend cells and serial dilutions of 10-7, 10-6, 10-5, 10-4, 
and 10-3 were prepared, and 100 μl of each dilution was plated onto MB 7H10 agar plates in 
triplicate. Plates were incubated at 28°C for 7 days and colony counts conducted. This 
experiment was repeated two more times. 
Statistics 
The following analysis was carried out to compare differences between species for the 
same disinfectant treatment and also to compare different disinfectant treatments for each species 
separately. The same statistical method was utilized for all analyses using R 3.1.0 (R Core Team, 
2013) and R Studio (R Studio, 2012). Colony count data were entered into a spread sheet where 
percent survival for each treatment was determined by comparing treatment counts (CFU/mL) to 
control counts (CFU/mL); Percent Survival = [(Treatment Count/Control Average Count )*100]. 
Data were then sorted by treatment or species and saved as individual text files for analysis. For 
each data file descriptive statistics were obtained using the “psych” package (Revelle, 2014). 
Data were also checked for normality equal variances using the “stats” package (R Core Team, 
2013) and “car” package (Fox and Weisberg, 2011) respectively. Since all data sets were found 
to have non-normal distributions (p<0.05) and unequal variances (p<0.05) the non-parametric
Kruskal-Wallis rank sum test was used to compare percent survival values using the “stats” 
package (R Core Team, 2013). In the case of a significant result, indicating differences between 
disinfection treatments, post-hoc tests for pairwise multiple comparisons of the ranked data were 
performed using the “PMCMR” package (Pohlert, 2015). Data were then visualized as a 
clustered bar graph using the “sciplot” package (Morales et al., 2012).  
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2.4 Results 
Chlorine bleach disinfection
Treatment of M. abscessus, M. chelonae, M. gordonae, and M. pergrinum with 100ppm 
Clorox® chlorine bleach diluted in Milli-Q® water resulted in a minimum average survival of 
2.94% for M. gordonae, followed by18.89% for M. peregrinum. Average survival of M.
abscessus and M. chelonae was 27-40% (Figs 1-4). There was no significant difference between 
species for this treatment (p>0.05). Treatment with 150 ppm Clorox® chlorine bleach diluted in 
Milli-Q® water resulted in a similar trend in survival with a minimum average survival of less 
than 1% for M. gordonae. Mycobacterium chelonae had an average survival of 14.59%, M.
abscessus had a 20.21% average survival, and M. peregrinum showed the greatest survival at 
32.47%. Unbuffered treatment solution pH values are as follows: 100 ppm solutions ranged from 
11.67-14.10, 150 ppm ranged from 7.98-9.81, and control solutions ranged from 9.0-10.60. The 
difference in average survival between species was significant (Kruskal-Wallis; Ȥ2(3)=35.5966, 
p<0.0001) with M. abscessus and M. peregrinum equivalent to each other, with M. peregrinum 
having significantly higher survival than M. chelonae and M. gordonae, but M. abscessus only 
having higher survival over M. chelonae. Mycobacterium gordonae was significantly different 
from M. chelonae as well as M. peregrinum (p<0.05). When comparing 100 ppm and 150 ppm 
chlorine bleach to one another by species, there was no significant difference between 
concentrations (p<0.05) (Figures 2-1 - 2-4).  
Additional Clorox® chlorine bleach treatment trials were completed using a CDFB as the 
diluent with M. chelonae and M. peregrinum, and compared to chlorine bleach diluted in Milli-
Q® water. For M. chelonae bleach disinfection, there were significant differences between 
treatments (Kruskal-Wallis; Ȥ2(7)=48.3911, p<0.0001), specifically, the 10 minute treatments in 
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Milli-Q® were different from all others (Figure 2-2, significantly different groupings are 
indicated by group labels, p<0.05). Trials with CDFB resulted in less than 1% average survival 
for all concentration and treatment durations (not shown); whereas, only 150 ppm Clorox® 
chlorine bleach diluted in Milli-Q® resulted in this degree of knock-down (Figure 2-2). Trials 
with M. peregrinum resulted in similar outcomes (Figure 2-4); with less than 1% average 
survival for CDFB trails (not shown). For comparison, less than 1% average survival of M.
peregrinum following unbuffered Clorox® chlorine bleach treatment was only observed for 5 
minute, 100 ppm treatments (Figure 2-4). Buffered treatment solution pH values are as follows: 
100 ppm solutions ranged from 507-5.1, 150 ppm ranged from 4.90-5.07, and control solutions 
ranged from 9.0-10.60. 
Hydrogen peroxide disinfection 
Treatment of M. abscessus, M. chelonae, M. gordonae, and M. peregrinum with 15,000 
ppm hydrogen peroxide resulted in a minimum average survival of 12.87% for M. abscessus, 
45.26% survival for M. chelonae and 100% or more survival for M. gordonae and M.
peregrinum (Figures 2-1 - 2-4). This treatment did differ significantly in its effectiveness as 
significant differences in mycobacterial survival are observed between species (Kruskal-Wallis; 
Ȥ2(3)=12.0656, p<0.05). Post-hoc comparisons revealed that M. abscessus and M. chelonae had a 
significantly lower survival than M. peregrinum (p<0.01).  Results for 30,000 ppm hydrogen 
peroxide were similar to the lower 15,000 ppm treatment (Figures 2-1 - 2-4). Mycobacterium 
abscessus had the lowest resulting average survival of 13.60%, followed by M. chelonae with 
19.28% resulting average survival. Average survival of M. gordonae was 47.41%, and M.
peregrinum had the highest resulting average survival of 76.01%. This treatment did differ 
significantly in its effectiveness between species (Kruskal-Wallis; Ȥ2(3)=10.2262, p<0.01). Post-
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hoc comparisons revealed that M. abscessus had a significantly lower survival than M.
peregrinum (p<0.01). When comparing these two treatment concentrations to one another by 
species, there was no significant difference between concentrations (p<0.05) (Figures 2-1 - 2-4). 
Iodine disinfection
Initial PVPI disinfection treatments were tested on M. chelonae at a range of 
concentrations (12.5 ppm, 25 ppm, 50 ppm, and 100 ppm) for 5 minutes. Percent survival for 
treatments were significantly different between treatment concentration (Kruskal-Wallis; 
Ȥ2(3)=32.5721, p<0.0001). Post-hoc comparisons revealed that there was no significant 
difference between the 25-100 ppm treatments (average survival less than 1% ); however, the 
12.5 ppm concentration resulted in a significantly higher percent survival (average survival of 
51.25%) of M. chelonae (p<0.05). Further PVPI testing was narrowed down to testing 25 ppm 
treatment as this was the lowest concentration found to be equally as effective as 50 and 100 
ppm. Treatment of M. abscessus, M. chelonae, M. gordonae, and M. peregrinum with 25 ppm 
PVPI resulted in all species having less than 10% (Figures 2-1 - 2-4), with M. chelonae having 
the most survival at an average of 5.53%±18.79%. There was no significant difference found 
between species (Kruskal-Wallis; Ȥ2(3)=8.25, p=0.05). Prepared iodine solutions were evaluated 
for iodine concentration using iodine test strips immediately after they were prepared and used in 
these trials, as well as 24 hours later. There was a noticeable decrease in concentration (Figure 2-
5).  
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Figure 2-1. Mycobacterium abscessus percent survival effect of disinfectant treatments
(Clorox® bleach in Milli-Q®, hydrogen peroxide, and PVP-I). Group labels (A or B) identify 
treatments that differ significantly [Ȥ2(4)=33.38, p < 0.05]. Treatments resulting in survival 
values less than 1% are indicated (<1). 
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Figure 2-2. Mycobacteirum chelonae percent survival effect of disinfectant treatments , 
(Clorox® bleach in Milli-Q®, hydrogen peroxide, and PVPI). Group labels (A or B) identify 
treatments that differ significantly [Ȥ2(13)=99.55, p < 0.05]. Treatments resulting in survival 
values less than 1% are indicated (<1). 
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Figure 2-3. Mycobacterium gordonae percent survival effect of disinfectant treatments (Clorox® 
bleach in Milli-Q®, hydrogen peroxide, and PVP-I). Group labels (A or B) identify treatments 
that differ significantly [Ȥ2(4)=17.71, p < 0.05]. Treatments resulting in survival values less than 
1% are indicated (<1).  
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Figure 2-4. Mycobacterium peregrinum percent survival effect of disinfectant treatments 
(Clorox® bleach in Milli-Q®, hydrogen peroxide, and PVP-I). Group labels (A, B, or C) identify 
treatments that differ significantly [Ȥ2(7)=67.23, p < 0.05]. Treatments resulting in survival 
values less than 1% are indicated (<1).  
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Figure 2-5. Iodine test strips verifying the concentration of (A) 0 ppm, (B) 12.5 ppm, (C) 25 
ppm, and (D) 50 ppm PVP-I solutions immediately following solution preparation. The 
concentration of the same solutions 24h later (A’, B’, C’, D’) has decreased and solutions are no 
longer usable.  
2.5 Discussion 
Our study has demonstrated that not all disinfectants are effective at preventing 
mycobacterial growth and that species-specific differences in susceptibility exist. The standard 
procedure for zebrafish embryo disinfection is currently bleaching in a 25-100 ppm bleach 
solution prepared in system water for a total of 10 minutes (Westerfield, 2000). We found that 
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this method (100 ppm bleach in Milli-Q®) results in a decrease in mycobacterial survival; 
however, an average survival of 2.94-28.36% was observed and this was significantly variable 
between Mycobacterium spp. tested. This mycobacterial persistence post-bleaching emphasized 
the need for alternative disinfectant treatments to be considered. Additionally, because 
effectiveness varied between species, control and management recommendations are 
complicated as generally diagnostics are not performed prior to preventative measures. We did 
test bleaching further, this time using a CDFB as a diluent. We found that using a demand-free 
buffer does increase the effectiveness of bleach disinfection significantly, resulting in less than 
1% mycobacterial survival. The difference between these two bleach treatments was not 
surprising as it has been previously shown that the germicidal properties of chlorine are reduced 
as pH increases above 7.5, and the toxicity of bleach to microorganisms doubles as pH changes 
from 9 to 7 (Clark et al. 1989; Health Canada 2004). A shift in pH from 7 to 9 results in a drastic 
decrease of the germicidal form of chlorine, hypochlorous acid (HOCl), as chlorine exists 
predominantly in the less-active hypochlorite (OCl-) form (Clark et al. 1989). Important 
considerations when assaying chlorine compounds is to make sure reaction buffers are rendered 
chlorine-demand free. Otherwise, HOCl can react with the buffer and subsequently decrease the 
amount available to reach with target molecules (Pizza, 2002). For our experimental trials, the 
pH of the bleaching solution made in Milli-Q® water ranged from 7.98 to 14.10 during the 
treatment; whereas, the bleach solution prepared in CDFB was 4.9-5.1. This difference in pH and 
subsequent effect on chlorine availability explains the difference in germicidal activity on the 
Mycobacterium spp. tested. Despite this increased effectiveness, recommendations for using this 
buffered bleach treatment for embryos may not be ideal. First, this protocol for preparing the 
CDFB bleach solution would not be practical with the large-scale and frequent treatments used in 
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many zebrafish facilities (Kent et al. 2014). Second, buffered chlorine bleach treatments on 
zebrafish embryos were previously shown to be more toxic to embryos corresponding to higher 
mortality and malformations than unbuffered (and currently utilized) protocols (Kent et al. 
2014). Finally, throughout this study we experienced preparation of the bleaching solutions to be 
quite involved, requiring a chlorine meter to determine chlorine concentrations as calculations 
based on the concentration of chlorine in Clorox® resulted in solutions with varying amounts of 
actual measured chlorine. Due to this variability a more reliable and straight-forward treatment 
should be considered.  
We then considered hydrogen peroxide disinfection as a candidate for preventing 
mycobacterial spread. This disinfectant is already used for controlling pathogens in other aquatic 
species (e.g., catfish) and is regularly used in bath and flow-through set-ups to treat eggs at a 
concentration of 250-500 ppm (Small and Wolters, 2003). Recommendations for Mycobacterium 
spp. include the usage of a much more concentrated solution of 30,000 ppm hydrogen peroxide 
(Noga, 2010). We tested hydrogen peroxide at both 15,000 ppm and 30,000 for 5 minute 
treatments and found both treatments resulted in very little bacterial killing for all species of 
Mycobacterium tested (Figures 2-1 – 2-4). A longer duration of treatment may result in an 
increased germicidal effect, as bath treatments used in other fisheries are longer than five 
minutes (Small and Wolters, 2003). However, germicidal effect was poor even at very high 
concentrations which are unlikely to be safe for fish, and we do not recommend hydrogen 
peroxide disinfection as an alternative to bleach. 
Finally, we considered iodophor disinfection using PVPI. Iodine is already an established 
embryo disinfectant in salmonid culture (Wood 1979, Game 1983, 1988, Service 2004, Wagner 
et al. 2008). We first tested PVPI disinfection on M. chelonae, a frequent zebrafish pathogen, at 
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multiple concentrations (12.5 ppm, 25 ppm, 50 ppm, and 100 ppm) for a 5 minute duration. We 
found 25-100 ppm treatments resulted in a significant decrease of M. chelonae survival as well 
as no significant difference between these treatment concentrations. We then choose 25 ppm as 
the concentration to test additional Mycobacterium spp. as it was the lowest concentration with a 
significant effect on bacterial survival. This treatment was also effective for M. abscessus, M. 
gordonae and M. peregrinum resulting in less than 1% average survival for all of these species. 
This treatment is comparable to the buffered chlorine bleach treatment, but requires much less 
preparation. During these trials we found that preparing PVPI disinfection solutions was straight-
forward and concentration calculated from the original solution consistently produced treatment 
solution concentrations, verified by iodine test strips. Importantly, we did find that these PVPI 
treatment solutions need to be prepared shortly before treatment, as the concentration of iodine in 
these solutions decreased over time (Figure 2-5). We recommend making stock solutions 
immediately prior to use and not to be stored longer than a day. Results from the PVPI 
disinfection experiments identify iodophor disinfection at 25 ppm for 5 minutes as an effetive 
alternative from chlorine bleach for killing mycobacteria from zebrafish. Toxicity of this 
disinfection treatment on zebrafish embryos is still unknown but is currently under investigation.  
 Additionally, many factors influence the effectiveness of disinfectants including 
temperature, time of contact, pH, concentration as well as the presence of organic matter 
(Mainous and Smith, 2005). It is important to consider these factors. For example, embryos 
should be rinsed well to remove excess organic matter prior to disinfection. Rinsing solutions 
should be free of pathogens as rinsing with a contaminated solution following embryo 
disinfection could negate the efforts of disinfection. Adequate storage and preparation of 
disinfectants is important in order to ensure germicidal activity. Depending on the environmental 
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conditions (e.g., temperature, lighting) within a zebrafish facility, storage long-term storage of 
disinfectants may not be appropriate and alternative storage is necessary (e.g., refrigeration) in 
order to ensure disinfectant integrity. Also, as previously discussed, working solutions of 
disinfectants should be prepared shortly prior to use and concentrations verified. As successful as 
these treatments are at preventing the spread of microorganisms, they will not inhibit intraovum 
pathogens (e.g., P. neurophilia) (Sanders and Kent, 2013). Additional disease prevention and 
monitoring meaures should be used in addition to regular embryo disinfection. 
 The usage of disinfectants in zebrafish facilties is an important disease control measure 
that all facilities should consider, especially when introducing embryos from an outside facility. 
Here we showed that the germicidal effect of different disinfectants on Mycobacterium spp. 
varies by species, and that the currently used unbuffered chlorine bleach does have a germicidal 
effect, but 25 ppm PVPI for 5 min may be an improved alternative, once in vivo testing 
determines it is safe for embryos.  
2.6 Acknowledgements
This research was funded in part by the Office of Research Infrastructure Programs of the 
National Institutes of Health (NIH) under a subcontract of the award number R24OD010998 to 
CMW. The content is solely the responsibility of the authors and does not necessarily represent 
the official views of the NIH. We thank members of the Whipps Fish and Wildlife Disease Lab 
for their ongoing support, especially undergraduate research students, Team Chen, Kristen Doerr 
and Elle Palmer. 
46 

2.7 References
Alaska Department of Fish and Game, 1983. Fish culture manual, Juneau, Alaska.
Alaska Department of Fish and Game, 1988. Safer chemical use in Alaskan Aquaculture, Juneau, 
Alaska. 
 
Astrofsky, K.M., Schrenzel, M.D., Bullis, R.A., Smolowitz, R.M., Fox, J.G., 2000. Diagnosis 
and management of atypical Mycobacterium spp. infections in established laboratory zebrafish 
(Brachydanio rerio) facilities. Comparative Medicine 50, 666-672. 
 
Bardouniotis, E., Ceri, H., Olson, M.E., 2003. Biofilm formation and biocide susceptibility 
testing of Mycobacterium fortuitum and Mycobacterium marinum. Current Microbiology 46, 28-
32. 
 
Block, S.S., 2001. Disinfection, Sterilization, and Preservation, 5th ed. Lippincott Williams & 
Wilkins, Philadelphia. 
 
Clark, R.M., Eleanor, R.J., Hoff, J., 1989. Analysis of inactivation of Giardia lamblia by 
chlorine. J Environ. Eng. 115:80-90. 
 
Detrich III, H.W., Westerfield, M., Zon, L.I., 2011. The zebrafish: genetics genomics and 
informatics 3rd Ed. Methods in Cell Biology 104, 471-473. 
 
47 

Falkinham, J.O., 3rd, 2009. Surrounded by mycobacteria: nontuberculous mycobacteria in the 
human environment. Journal of  Applied  Microbiology 107, 356-367. 
 
Falkinham, J.O., 3rd, Norton, C.D., LeChevallier, M.W., 2001. Factors influencing numbers of 
Mycobacterium avium, Mycobacterium intracellulare, and other mycobacteria in drinking water 
distribution systems. Applied Environmental Microbiology 67, 1225-1231. 
 
Ferguson, J.A., Watral, V., Schwindt, A.R., Kent, M.L., 2007. Spores of two fish microsporidia 
(Pseudoloma neurophilia and Glugea anomola) are highly resistant to chlorine. Diseases of 
Aquatic Organisms 76, 205-214. 
 
Fox, J., Weisberg, S., 2011. An {R} Companion to Applied Regression. Sage, Thousand Oaks, 
CA, USA. 
 
Garner, J.S., Favero, M.S., 1986. Cdc Guideline for Handwashing and Hospital Environmental-
Control, 1985. Infection Control and Hospital Epidemiology 7, 231-243. 
 
Harper, C., Lawerence, C., 2011. The laboratory zebrafish. CRC Press, Boca Raton, FL. 
 
Health Canada., 2004. Guidelines for Canadian drinking water quality: supporting 
documentation - Protozoa: Giardia and Cryptosporidium. Water Quality and Health Bureau, 
Healthy Environments and Consumer Safety Branch, Health Canada, Ottawa. 
 
48 

Kent, M.L., Feist, S.W., Harper, C., Hoogstraten-Miller, S., Law, J.M., Sanchez-Morgado, J.M., 
Tanguay, R.L., Sanders, G.E., Spitsbergen, J.M., Whipps, C.M., 2009. Recommendations for 
control of pathogens and infectious diseases in fish research facilities. Comparative Biochemistry 
and Physiology. Toxicology & Pharmacology : CBP 149, 240-248. 
 
Kent, M.L., Whipps, C.M., Matthews, J.L., Florio, D., Watral, V., Bishop-Stewart, J.K., Poort, 
M., Bermudez, L., 2004. Mycobacteriosis in zebrafish (Danio rerio) research facilities. 
Comparative Biochemistry and Physiology. Toxicology & Pharmacology : CBP 138, 383-390. 
 
Kent, M.L.S., J.M., Matthews, J.M., Fournie, J.W., Murray, K.N., Westerfield, M., 2012. 
Diseases of Zebrafish in Research Facilities, Zebrafish International Resource Center. 
 
Kent, M. L. S., Buchner, C., Barton, C., Tanguay, R. L., 2014. Toxicity of chlorine to zebrafish 
embryos. Diseases of Aquatic Organisms 107, 235-240. 
 
Lawrence, C., 2007. The husbandry of zebrafish (Danio rerio): A review. Aquaculture 269, 1-20. 
 
Mainous, M.E., Smith, S.A., 2005. Efficacy of Common Disinfectants against Mycobacterium 
marinum. Journal of Aquatic Animal Health 17: 284-288. 
 
Milligan-Myhre, K., Charette, J.R., Phennicie, R.T., Stephens, W.Z., Rawls, J.F., Guillemin, K., 
Kim, C.H., 2011. Study of Host-Microbe Interactions in Zebrafish. Methods  in Cell Biology 
105, 87-116. 
49 

 
Morales, M., with code developed by the R Development Core Team, with general advice from 
the R-help listserv community and especially Duncan Murdoch, 2012. sciplot: Scientific 
Graphing Functions for Factorial Designs., R package version 1.1-0. ed. 
 
Noga, E.J., 2010. Fish Disease: Diagnosis and Treatment, 2 ed. Wiley-Blackwell, Iowa, USA. 
 
Pizzi N. Water Treatment Operator Handbook 2nd ed. 2002 American Water Works Association.   
 
Pohlert, T., 2015. PMCMR: Calculate Pairwise Multiple Comparisons of Mean Rank Sums., 1.1 
ed. R package. 
 
Poort, M.J., Whipps, C.M., Watral, V. G., Font, W. F., Kent, M. L., 2006. Molecular 
characterization of Mycobacterium species in non-native poeciliids in Hawaii using DNA 
sequences. Journal of Fish Diseases 29, 3: 181-185. 
 
R Core Team, 2013. R: A language and environment for statistical computing. . R Foundation 
for Statistical Computing, Vienna, Austria. 
R Studio, 2012. R Studio: Integrated development environment for R., 0.96.122 ed. R Studio, 
Boston, MA, USA. 
 
Revelle, W., 2014. psych: Procedures for Personality and Psychological Research, Version = 
1.4.8 ed. Northwestern University, Evanston, Illinois, USA. 
50 

 
Russell, A.D., 1996. Activity of biocides against mycobacteria. Journal of Applied  Bacteriology 
81, S87-S101. 
 
Small, B.C., Wolters, W. R., 2003. Hydrogen peroxide treatment during egg incubation improves 
channel catfish hatching success. North American Journal of Aquaculture 65, 314-317. 
 
Steed, K.A., Falkinham, J.O., 3rd, 2006. Effect of growth in biofilms on chlorine susceptibility 
of Mycobacterium avium and Mycobacterium intracellulare. Applied Environmental 
Microbiology 72, 4007-4011. 
 
United States Fish and Wildlife Service, 2004. Iodophor Disinfection of Fish Eggs, Handbook of 
Aquatic Animal Health Procedures and Protocols. United States Fish and Wildlife Service, 1-7. 
 
Wagner, E.J., Arndt, R.E., Billman, E.J., Forest, A., Cavender, W., 2008. Comparison of the 
efficacy of iodine, formalin, salt, and hydrogen peroxide for control of external bacteria on 
rainbow trout eggs. North American Journal of Aquaculture 70, 118-127. 
 
Watral, V., Kent, M.L., 2007. Pathogenesis of Mycobacterium spp. in zebrafish (Danio rerio) 
from research facilities. Comparative Biochemistry and Physiology. Toxicology & 
Pharmacology : CBP 145, 55-60. 
 
51 

Westerfield, M., 2000. The Zebrafish Book. A Guide for the Laboratory Use of Zebrafish (Danio
rerio), 4th ed. University of Oregon Press, Eugene. 
 
Westerfield, M., 2007. The Zebrafish Book. A Guide for the Laboratory Use of Zebrafish (Danio
rerio), 5th ed. University of Oregon Press, Eugene. 
 
Whipps, C.M., Butler, W.R., Pourahmad, F., Watral, V.G., Kent, M.L., 2007a. Molecular 
systematics support the revival of Mycobacterium salmoniphilum (ex Ross 1960) sp nov., nom. 
rev., a species closely related to Mycobacterium chelonae. International Journal of Systematic 
and Evolutionary Microbiology 57, 2525-2531. 
 
Whipps, C.M., Dougan, S.T., Kent, M.L., 2007b. Mycobacterium haemophilum infections of 
zebrafish (Danio rerio) in research facilities. FEMS microbiology letters 270, 21-26. 
 
Whipps, C.M., Lieggi, C., Wagner, R., 2012. Mycobacteriosis in Zebrafish Colonies. Ilar J 53, 
95-105. 
 
Whipps, C.M., Matthews, J.L., Kent, M.L., 2008. Distribution and genetic characterization of 
Mycobacterium chelonae in laboratory zebrafish Danio rerio. Diseases of Aquatic Organisms 
82, 45-54. 
 
52 

Widmer, A.F., Frei, R., 2003. Decontamination, Disinfection, and Sterilization, in: P.R. Murray, 
E.J. Baron, J.H. Jorgensen, M.A. Pfaller, R.H. Yolken (Eds.), Manual of Clinical Microbiology, 
8th ed. ASM Press, Washington, DC, USA, 77-108. 
 
Wood, J.W., 1979. Diseases of Pacific Salmon: Their Prevention and Treatment, 3rd ed. State of 
Washington Department of Fisheries, Hatchery Division. 
 53
Chapter 3: Zebrafish embryo disinfection with povidone iodine: evaluating an alternative 
to chlorine bleach
Carolyn T. Chang1, Jeffrey D. Amack2, Christopher M. Whipps1
Published in Zebrafish 13(S1): S96-S101.
1Department of Environmental and Forest Biology, , State University of New York College of 
Environmental Science and Forestry, 1 Forestry Drive, Syracuse, NY 13210 USA
2Department of Cell and Developmental Biology, State University of New York, Upstate Medical 
University, 750 E. Adams St., Syracuse, NY 13210 USA
 54
3.1 Abstract
Mycobacteriosis is a common bacterial infection in laboratory zebrafish caused by 
several different species and strains of Mycobacterium including both rapid- and slow-growers. 
One control measure used to prevent mycobacterial spread within and between facilities is 
surface disinfection of eggs. Recent studies have highlighted the effectiveness of povidone-
iodine (PVPI) on preventing propagation of Mycobacterium spp. found in zebrafish colonies. We 
evaluated the effect of disinfection using 12.5-50 ppm PVPI (unbuffered and buffered) on 
zebrafish exposed at 6 or 24 h post-fertilization (hpf) to determine if this treatment is suitable for 
use in research zebrafish. Our results show that 6 hpf embryos are less sensitive to treatment as 
fewer effects on mortality, developmental delay and deformity were observed. We also found 
that buffered PVPI treatment results in a greater knockdown of Mycobacterium chelonae and 
Mycobacterium marinum, as well as results in decreased harmful effects on embryos. Treatments 
of shorter (2 min vs. 5 min) duration were also more effective at killing mycobacteria in addition 
to resulting in fewer effects on embryo health. Additionally we compared the efficacy of a 
rinsing regime to rinsing and disinfecting. Based on the findings of this study, we recommend 
disinfecting embryos for 2 min with buffered PVPI at 12.5-25 ppm.
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3.2 Introduction
Disease prevention in laboratory zebrafish and the maintenance of healthy stocks is a 
primary interest of the zebrafish research community. Diseases in laboratory zebrafish not only 
directly affect research due to the loss of valuable wild-type and mutant genetic lines, but can 
also have indirect effects as chronic subclinical infections are a potential confounding source of 
uncontrolled experimental variance (Kent, Whipps et al. 2004, Whipps 2012).
Mycobacteriosis is a common bacterial disease that affects zebrafish (Astrofsky, 
Schrenzel et al. 2000, Kent, Whipps et al. 2004, Kent 2012, Whipps 2012). The Zebrafish 
International Resource Center’s (ZIRC) Diagnostic Services report that over 40% of facilities 
submitting specimens between 2006-2010 had fish diagnosed with mycobacteriosis (Kent 2012).
Several species of Mycobacterium have been implicated in outbreaks in zebrafish (Astrofsky, 
Schrenzel et al. 2000, Kent, Whipps et al. 2004, Whipps, Matthews et al. 2008, Whipps 2012).
Manifestation of mycobacterial infections in zebrafish is species-specific (Watral and Kent 2007, 
Whipps, Butler et al. 2007, Whipps, Dougan et al. 2007, Whipps 2012). For example, infection 
with Mycobacterium chelonae, the most common species found in laboratory zebrafish, typically 
results in chronic and low-to-subclinical infections (Watral and Kent 2007). Alternatively, 
Mycobacterium marinum causes acute and severe outbreaks that often result in obvious 
mortalities (Whipps, Burton et al. 2006). Both of these manifestations have the potential to be
devastating to research. 
Recommendations for mycobacterial disease management in zebrafish highlight the 
importance of disease prevention, as established infections are difficult and time-consuming to 
eradicate (Whipps 2012). As a measure of biosecurity, facilities are encouraged to implement 
“eggs-only” policies, introducing only disinfected embryos from outside facilities. 
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Embryo surface disinfection is a common practice in fisheries and the standard 
disinfectant for zebrafish eggs is currently rinsing embryos with chlorine bleach. However, 
povidone iodine (PVPI) has been shown to be a promising alternative as in vitro studies show 
PVPI is effective at killing Mycobacterium spp. that commonly infect zebrafish (Chang, Colicino 
et al. 2015).
Before PVPI can be recommended for use in zebrafish an evaluation of the effect of 
disinfection on the health of zebrafish embryos is required. To accomplish this, we evaluated 
both unbuffered and buffered povidone iodine on wild-type zebrafish embryos at two 
developmental time-points [6 hours post-fertilization (hpf) and 24 hpf]. We also tested the effect 
of these treatments on the survival of planktonic Mycobacterium chelonae and Mycobacterium 
marinum cultures.
3.3 Methods
Fish
All embryos used in the exposure studies were bred using AB and AB/Tübingen
zebrafish obtained from both the zebrafish facility at the SUNY-ESF Center for Integrated 
Teaching and Research in Aquatic Sciences as well as from the Amack Lab at SUNY Upstate 
Medical University. Embryos were obtained from both paired and large group spawns and held 
in E2 Embryo Medium(Westerfield 2000) (pH 7.4-7.5) at 28.5°C while development was 
monitored and staged (Kimmel, Ballard et al. 1995).
Exposure
Ninety-six eggs per treatment (3 replicates of 32) were used for each concentration of 
PVPI [unbuffered(drugstore brand) or buffered Ovadine ®(Western Chemical)] and were 
designated to treatment groups randomly. For all treatment solutions, iodine concentration was 
57
verified using iodine test strips (LaMotte). The PVPI solutions were prepared fresh within 30 
min of each treatment in autoclaved Milli-Q® water. A method for disinfectant exposure similar 
to a previous study evaluating chlorine bleach disinfection was utilized 12. Embryos were 
exposed at either 6 hpf or 24 hpf as embryo disinfection usually occurs following egg collection 
and screening (6 hpf) or following shipment of embryos to another facility (24 hpf) (Kent, 
Buchner et al. 2014).
Figure 3-1. Schematic of the embryo disinfectant exposure experiment. 
Embryo exposures were carried out by placing 32 embryos at 6 hpf or 24 hpf in a 50 mL 
conical tube where the bottom was replaced with a 50 μm mesh screen held in E2 Medium. This 
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tube was transferred to treatment and rinse solutions as illustrated (Figure 3-1). For each 
treatment solution (unbuffered PVPI: 12.5 ppm, 25 ppm, and 50 ppm; buffered PVPI: 12.5 ppm, 
25 ppm, and 50ppm) three treatment groups were run concurrently with embryos from the same 
clutch: 2 minute exposure, 5 minute exposure and 5 minute control (no iodine) exposure. During 
each exposure the 32 embryos in the conical tube were transferred from the E2 medium, to a 
PVPI treatment solution for 2 or 5 minutes, to three separate sterile Milli-Q® water rinses
(conical tubes were fully lowered into beakers containing 35 mL of sterile Milli-Q® and lifted 
out of solution, total rinse time lasted approximately 5 seconds) and to fresh E2 Medium (pH 
7.4-7.5).
Toxicity Evaluation
Following exposures, embryos were individually loaded into wells containing 300 μl of 
E2 Medium (pH 7.4-7.5) in a sterile 96-well plate so that embryos from the three concurrent 
exposures were incubated in the same 96-well plate. Following exposures, 6 hpf embryos were 
monitored at 30 minutes post-exposure and daily up to 5 dpf. Twenty-four hpf embryos were 
monitored at 30 min and 5 hours post-exposure as well as daily up to 5 dpf. Monitoring included 
observation of mortality, developmental delay, and deformity as in previous studies (Kent, 
Buchner et al. 2014) (Truong, L et al. 2010). Once embryos reached 5 dpf they were euthanized 
in a solution of 300 mg/L MS222 buffered to a pH of 7.5.
Culture 
An in vitro exposure of M. chelonae and M. marinum to the PVPI treatment solutions 
used in this study was also carried out. These exposures were carried out in triplicate following a
previously described method (Chang, Colicino et al. 2015) for M. chelonae cultures and similarly 
for M. marinum; however, for M. marinum the initial suspension of cells was prepared by 
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inoculating sterile water with M. marinum freshly cultured on solid-phase Middlebrook 7H10 
(MB 7H10) agar supplemented with hemin. Also, following exposures, solid-phase MB 7H10
agar supplemented with hemin was used, and plates were incubated for 14 days prior to colony 
counts.
An additional evaluation of disinfection in vitro was carried out to simulate an actual 
zebrafish embryo disinfection event. For this, N=32 embryos at 6 hpf were placed in a sterile 30 
mL culture flask in E2 Medium (pH 7.4-7.5). This flask was then inoculated with enough broth 
culture to result in a final concentration of 1.0 x 106 colony forming units (CFU) /mL of M. 
chelonae. This was intended to simulate an embryo shipment to another facility, in spawn water 
containing bacteria. This flask was then incubated overnight at 28.5ºC at 50 rpm on a shaker 
incubator to emulate courier transport and bacterial incubation during this period. An additional,
un-inoculated, flask was prepared and incubated as a control. 
The following morning at 10:30 am (a time-point when an overnight express courier 
option would be received) the contents of the flask were emptied into a 50 mL conical tube with 
the bottom replaced with 50 μm mesh and were taken through the disinfection exposure similar 
to the embryos undergoing a five minute exposure to either 25 ppm unbuffered PVPI or a control 
of sterile water. Samples (1mL) from the original E2 Medium (pH 7.4-7.5) from the flask and 
final E2 Medium (pH 7.4-7.5) solutions were taken and prepared for plating. Samples were 
diluted to 10-1, 10-2, and 10-3. One hundred μl of each dilution was plated in triplicate on 
Middlebrook agar plates using a sterile spreader and incubated at 28.5ºC for 7 days. Following 
incubation, colony counts were performed. This experiment was performed in triplicate.
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Statistics
To determine the difference between disinfection treatments on embryo health at 
different developmental stages the following analysis was carried out using R 3.1.0 (R Core 
Team 2013) and R Studio (R Studio 2012). Embryo mortality, developmental delay and 
deformity up to 5 dpf following disinfection treatment was recorded and entered in a spread 
sheet and saved as text files for analysis. Descriptive statistics were obtained using the “psych” 
package (Revelle 2014) and data normality and equal variances were assessed using the “stats” 
package (R Core Team 2013) and “car” package (Fox and Weisberg 2011) respectively. 
In the case of data with a normal distribution and equal variances, an analysis of variance 
(ANOVA) was performed to separately compare mortality, developmental delay or deformity 
between disinfection treatments using the “stats” package (R Core Team 2013). In the scenario 
of a significant ANOVA results (p<0.05) Tukey comparison post-hoc testing was performed 
using the “agricolae” package (De Mendiburu 2009). If data was non-normally distributed or had 
unequal variance a Kruskal-Wallis rank sum test was used to compare mortality, developmental 
delay or deformity between disinfection treatments using the “stats” package (R Core Team 
2013). In the case of a significant result (p<0.05), post-hoc testing for pairwise multiple 
comparisons of the ranked data were performed using the “PMCMR” package (Pohlert 2015).
Visualization of data was then carried out as a clustered bar graph using the “sciplot” package 
(Morales, with code developed by the R Development Core Team et al. 2012).
Analyses of PVPI disinfection on M. chelonae and M. marinum were analyzed using R 
3.1.0 (R Core Team 2013) and R Studio (R Studio 2012). Descriptive statistics were obtained 
using the “psych” package (Revelle 2014) and data normality and equal variances were assessed 
using the “stats” package  (R Core Team 2013) and “car” package (Fox and Weisberg 2011)
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respectively. A one-way analysis of variance (ANOVA) was performed using the “stats” 
package and Tukey post-hoc comparisons were carried out using the “agricolae” package (De 
Mendiburu 2009). Data was visualized as a clustered bar chart using the “sciplot” package 
(Morales, with code developed by the R Development Core Team et al. 2012).
To compare the effect of PVPI disinfection to a rinsing regime, resulting colony counts 
on serial dilution plates were entered into a spreadsheet and the average colony count from the 
original flask as well as the final E2 solution were calculated for each replicate for both the 
disinfection treatment as well as the control treatment. A percent survival was calculated for each 
replicate as [(E2 average colony count/Flask average colony count)*100]. These survival values 
were then analyzed using R 3.1.0 (R Core Team 2013) and R Studio (R Studio 2012).
Descriptive statistics were obtained using the “psych” package (Revelle 2014) and data 
normality and equal variances were assessed using the “stats” package (R Core Team 2013) and 
“car” package (Fox and Weisberg 2011) respectively. An independent 2-group t-test was carried 
out to compare the survival between the disinfection treatment and control treatment using the 
“stats” package (R Core Team 2013).
3.4 Results
Effects of PVPI Disinfection on Embryo Health
Results from the disinfectant embryo exposures show that for 6 hpf embryos disinfected 
with unbuffered PVPI, a significant increase in embryo mortality was only observed for the 50 
ppm, 5 min PVPI treatment compared to the control (0 ppm) embryos [F(12,41) = 4.46, p<0.001]
(Figure 3-2). There was no significant effect of unbuffered PVPI treatment on developmental 
delay or deformity for any of the treatments at 6 hpf. 
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Disinfection treatments with buffered Ovadine® resulted in no significant difference in 
mortality, developmental delay or deformity for any of the treatments tested compared to 6 hpf 
control embryos (Figure 3-2). When comparing PVPI treatments of the same concentration and 
duration between unbuffered and buffered PVPI solutions for 6 hpf embryos, there was 
significant difference in embryo mortality for the 50 ppm-5 min treatment [F(12,41) = 4.46, 
p<0.001] (compare Figure 3-2A and 3-2C). 
Figure 3- 2. Results of the embryo disinfectant exposures displaying the percent deformity 
(white bars), developmental delay (grey bars) and mortality (black bars) for (A) 6 hpf embryos 
exposed to unbuffered PVPI, (B) 24 hpf embryos exposed to unbuffered PVPI, (C) 6 hpf 
embryos exposed to buffered PVPI and (D) 24 hpf embryos exposed to buffered PVPI. 
Significant  differences  between treatment concentration/durations are indicated by an asterisk 
(*). Significant differences between PVPI solutions for the same treatment are indicated by a 
plus-sign (+).
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For disinfection treatment of 24 hpf embryos, effects on embryo health were observed for 
25 and 50 ppm treatments relative to controls (Figure 3-2). Unbuffered PVPI treatments resulted 
in a significant increase in mortality for 25 ppm-5 min, 50 ppm-2 min, and 50 ppm-5 min 
treatments compared to control 24 hpf embryos >Ȥ2(12) = 34.24, p<0.001] (Figure 2). Also, there 
was significantly greater embryo deformity observed for the 25 ppm-2 min treatment compared 
to control 24 hpf embryos [F(12,47) = 2.148, p<0.05]. There was no significant effect on 
developmental delay observed for any of the unbuffered PVPI treatments compared to 24 hpf 
control embryos. Buffered PVPI treatments of 24 hpf embryos resulted in significantly greater 
mortality for both 50 ppm treatments (2 and 5 min) compared to control 24 hpf embryos >Ȥ2(12) 
= 34.24, p<0.001] (Figure 2). There were no significant developmental delay or deformity effects 
for buffered PVPI treatment of 24 hpf embryos. When comparing PVPI treatments of the same 
concentration and duration between unbuffered and buffered PVPI solutions for 24 hpf embryos,
there was significant difference in embryo health effects for 25 ppm treatments. Specifically, the 
unbuffered PVPI solution resulted in significantly higher embryo deformity for the 25 ppm-2
min treatments[F(12,47) = 2.148, p<0.05], as well as significantly higher embryo mortality for 
the 25 ppm-5 min treatment compared to the buffered treatments >Ȥ2(12) = 34.24, p<0.001] 
(compare Figure 2b and 2d). No other significant differences were observed when comparing the 
two PVPI solutions. 
Effect of PVPI Disinfection on Mycobacterium spp. 
All PVPI treatments of M. chelonae and M. marinum in culture resulted in lower survival 
than control treatments. Generally, knock-down of survival increased as PVPI concentration 
increased and knockdown of M. chelonae was more variable than M. marinum (Figure 3-3).
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Figure 3-3. Results from the in vitro PVPI disinfection displaying the percent knockdown of M. 
chelonae (white) and M. marinum (grey). Significant differences between treatments is indicated 
by an asterisk (*).
For M. chelonae exposures, unbuffered (drugstore brand) PVPI treatments were most 
effective for 2 min exposures compared to 5 min exposures. Based on average bacterial 
knockdown, the most effective treatments were 50 ppm-2 min, 25 ppm-2 min, and 12.5 ppm-2m 
min (less than 2% survival) which were more effective than 5 min at the same concentration. The 
next most effective treatments were 25 ppm-5 min and 50 ppm-5 min (less than 20% survival). 
The least effective treatment, resulting in the greatest bacterial survival, was the 12.5 ppm-5 min 
treatment which resulted in significantly more survival of M. chelonae than all the other 
unbuffered PVPI treatments [F(23,466) = 4.012, p< 0.05].
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All buffered (Ovadine®) treatments were equally effective (less than 0.1% survival for 
all treatments) as there was no significant difference between treatment concentrations or 
durations (p>0.05). All PVPI treatments of M. marinum resulted in less than 0.1% survival and 
there were no significant differences found between treatment concentrations or durations 
(p>0.05). 
When unbuffered and buffered (Ovadine®) PVPI solutions are compared, the only 
difference observed was for the  M. chelonae treatment of 12.5 ppm for 5 min (p<0.05), which 
was previously shown to be the least effective PVPI treatment of M. chelonae. This treatment 
was also the only treatment where, after comparing M. chelonae and M. marinum survival for the 
same PVPI treatment, differences were observed between species (p<0.05). 
Embryo Mock-Disinfection Results
For the embryo mock-disinfection, prior to disinfection, the flasks, both control and 
treatment, originally inoculated and incubated overnight with M. chelonae contained an average 
1.8 x 105 - 2.0 x 105 CFU/ml. Following treatments (rinsing and PVPI disinfection, or rinsing 
alone) the amount of M. chelonae remaining in the E2 medium containing embryos decreased.
For the control treatment, which underwent 3 rinses in sterile water, the resulting E2 medium 
contained 3.0 x 103 CFU/ml M. chelonae based on plate counts. The disinfection treatment, 
which consisted of a 25 ppm unbuffered PVPI for 5 min treatment, the resulting E2 medium 
contained 0 CFU/ml (SD= 0 CFU/ml) M. chelonae based on plate counts. 
3.5 Discussion
The results from this study show that zebrafish embryos can tolerate disinfection with 
PVPI at concentrations/durations that are effective at killing mycobacteria. We found that similar 
to our previous study (Chang, Colicino et al. 2015), PVPI is effective at killing mycobacteria at 
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12.5-50 ppm PVPI at both 2 and 5 min treatment durations. Generally results from our 
evaluation of PVPI disinfection on embryo health show that effects on embryo health occur at 
higher concentrations and/or treatment durations of PVPI for both 24 hpf embryos and 6 hpf 
embryos.
The use of a buffered PVPI solution (Ovadine®) resulted in more consistent knockdown 
of planktonic M. chelonae and M. marinum in medium, as well as less embryo mortality and 
deformity compared to unbuffered treatments. This result is intriguing as buffering of chlorine 
bleach solutions has also been shown to enhance disinfection; although, this buffering has been 
shown to have a negative effect on embryo health (Kent, Buchner et al. 2014).
The pH of both buffered and unbuffered 50 ppm PVPI solutions were subsequently 
measured. Unbuffered PVPI had a pH of 5.97, 5.78, and 5.60 for 12.5 ppm, 25 ppm, and 50 ppm 
solutions, respectively. Unbuffered PVPI was unstable requiring 3 repeats of measurements.
Buffered PVPI had a pH of 6.27, 6.01, and 5.70 for 12.5 ppm, 25 ppm, and 50 ppm solutions, 
respectively, and did not require multiple measurements. The stability of pH as well as acidity 
may have influenced the impact of PVPI solutions on zebrafish embryo health. The less variable 
knockdown of M. chelonae and M. marinum following buffered PVPI treatment was likely due 
to the different additives and composition of the PVPI solution and their iodine-complexing 
properties and the subsequent effect on the concentration of free molecular iodine available for 
binding (Paulson 2014).
Similar to our previous study (Chang, Colicino et al. 2015), we found that shorter 
durations of disinfection resulted in more consistent decrease in survival of M. chelonae. This 
could be attributed to the amount of available bactericidal iodine [e.g., hydrated iodine (I2), 
hypoiodous acid (HOI), and iodine cation (H2OI+)], as there are several potential reactions of 
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molecular iodine in water (e.g., hydrolysis, dissociation, protonation, complex formation, and 
disproportionation) that could limit availability over time as more reactions are able to occur
(Cooper 2007).
Shorter durations of PVPI exposures had less of an impact on embryo health as embryo 
mortality was increased significantly for 6 hpf embryo treatment with unbuffered 50 ppm-5 min 
compared to 50 ppm-2 min as well as 24 hpf embryo treatment of 25 ppm-2 min compared to 
25ppm-5 min. An exception to this pattern was with 24 hpf embryos treated with unbuffered 25 
ppm PVPI for 2 minutes. Here we observed an increase in embryo deformity compared to 
controls and this was not observed for 5 min treated embryos; although this may be due to more 
5 min embryos dying compared to 2 min.
While 6 hpf and 24 hpf embryos cannot be compared directly as they are undergoing 
different developmental processes and subsequent variable natural early morality, for 24 hpf 
embryos instances of significantly increased mortality compared to 24 hpf control embryos 
occurred at 25-50 ppm (unbuffered PVPI). For buffered PVPI at 24 hpf, 25 ppm treatments are 
an option as increased embryo mortality was only observed for 50 ppm treatments. Whereas for 
6 hpf embryos, instances of significantly higher mortality compared to control 6 hpf embryos 
occurred only at 50 ppm (unbuffered PVPI). This is similar to Kent et al. (2014), supporting the 
recommendation to, when possible, treat embryos at an earlier time-point. 
We also evaluated the role that rinsing embryos has in preventing mycobacterial spread 
through a “mock-disinfection” experiment. We found that rinsing embryos that were incubated 
with M. chelonae resulted in a decrease in planktonic bacteria; however an average 3.0 x 103
CFU/ml bacteria persisted in the embryo medium. Although rinsing reduced the amount of 
planktonic bacteria dramatically, they were not eliminated and could still pose an infection risk.
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The rinsing followed by disinfection resulted in no culturable mycobacteria in the embryo water. 
Thus, the diluting effect of rinsing coupled with disinfection with PVPI is very effective at 
reducing the risk of mycobacterial contamination in embryo cultures.
Generally we recommend disinfection with at least 12.5 ppm PVPI. Similar to Kent et al. 
(2014) we recommend disinfecting embryos from an outside facility or from a population with a 
known infection with higher (25-50 ppm) disinfectant concentration as potential biosecurity risk 
would outweigh the health effects on the first generation. Following generations could then be 
treated with a lower concentration. Although the potential effects of PVPI disinfection on fine 
developmental or physiological processes are not known, caution might be warranted in 
toxicological and behavioral studies until additional studies are conducted.
We only evaluated the effects of PVPI disinfection on wild-type and AB/Tübingen
embryos that were not dechorionated. Also, the regular practice of pronase-mediated chorion 
removal may also influence the effect of disinfection on embryo health. Other genetic lines of 
zebrafish may be more or less sensitive to disinfection with PVPI. These factors as well as 
facility water hardness, pH, and conductivity should all be considered when adopting a 
disinfection protocol.
Also, in order to be consistent with our previous culture studies(Chang, Colicino et al. 
2015), we utilized Milli-Q water for diluting our PVPI concentrates as well as for rinse solutions. 
The usage of alternative rinse solutions (i.e. E2 Medium, autoclaved system water, etc) may 
result in different embryo health effects and future studies should consider evaluating these 
solutions. Finally, as previously discussed (Kent et al., 2014; Chang et al., 2015) these method 
contribute to good biosecurity and, as such, are likely to reduce the spread of microorganisms.
However, they are less likely to prevent the spread of intra-ovum pathogens (e.g., Pseudoloma
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neurophilia)(Sanders, Watral et al. 2013) and a holistic approach including additional disease 
prevention and control measures should be taken in addition to embryo disinfection.
In conclusion, we have demonstrated that PVPI is effective for killing Mycobacterium
spp. in media and these same concentrations and durations that are not harmful to zebrafish 
embryo health. We also demonstrate that while the practice of rinsing embryos results in 
decreased bacteria counts but disinfection is much more effective. We also showed that treatment 
with buffered PVPI (Ovadine®) relative to unbuffered result in greater bacterial knockdown, as
well as increased embryo survival.
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4.1 Abstract
The zebrafish (Danio rerio) is a popular vertebrate model organism used in a wide range 
of research fields. Importance is placed on zebrafish health and the maintenance of disease-free
laboratory fish so that experimental studies are not inadvertently impacted. Mycobacteriosis is a
common infection of laboratory zebrafish that is caused by several Mycobacterium species. Little 
is known regarding the potential of antibiotic treatment for zebrafish mycobacteriosis; however, 
treatment of infected zebrafish may be appropriate to maintain valuable strains. Here, we
investigate the antibiotic susceptibility of both rapid and slow growing zebrafish Mycobacterium
spp. isolates in vitro. Antibiotic testing was carried out using a commercially available 96-well 
microtiter plate format. Results indicate that some but not all antibiotics tested are effective at 
inhibiting mycobacterial growth and that susceptibility varies among species and strains. 
Tigecycline, tobramycin, clarithromycin and amikacin were most effective at broad inhibition of 
rapid-growing mycobacteria; whereas, amikacin, clarithromycin, and rifampin were effective at 
inhibiting all slow-growing Mycobacterium marinum strains tested. Results support the potential 
for targeted antibiotic treatment of zebrafish infected with mycobacteria, but additional testing 
should be carried out in vivo.
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4.2 Introduction
The zebrafish (Danio rerio) has become one of the most prominently used vertebrate model 
organisms (Dahm and Geisler 2006; Phillps and Westerfield 2014). Initially, zebrafish research 
was conducted in the fields of genetics and development with embryo and larval end points
(Schilling and Webb 2007). More recently, adult zebrafish have become popular in the fields of 
oncology (Feitsma and Cuppen 2008), toxicology (Truong et al. 2011), aging (Gerhard 2003),
and behavior (Wong et al. 2010). Laboratory colonies of zebrafish typically consist of both 
specialized mutant strains and wild-type strains used for breeding (Westerfield 2007). Due to the 
increased usage of adult zebrafish in biological research and the value placed on maintaining 
healthy mutant and wild-type stocks, laboratory zebrafish health is of utmost concern. Incidences
of background infections are concerning for multiple reasons, for example: infections can result
in fish mortality or decreased reproductive output (Kent et al. 2012a). Additionally, research can 
also be indirectly affected, as subclinical infections may be a source of uncontrolled 
experimental variance (or non-protocol variation). As such where possible, measures are taken in 
order to prevent, control and manage these diseases.
A summary report of cases submitted to the Zebrafish International Resource Center’s
(ZIRC) Diagnostic Services from 2006-2010 indicates that over 40% of facilities submitting 
specimens had fish diagnosed with mycobacteriosis (Kent et al. 2012b). Mycobacteriosis is 
caused by Mycobacterium spp. and is frequently found in wild and captive fishes (Chinabut 
1999), including ornamental marine and freshwater fishes (Noga 2010). There is no single agent 
of zebrafish mycobacteriosis as at least six species as well as several strains of  Mycobacterium 
spp. have been identified (Astrofsky et al. 2000; Kent et al. 2004; Whipps et al. 2008). In
particular, Mycobacterium marinum, Mycobacterium chelonae, Mycobacterium abscessus,
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Mycobacterium peregrinum, Mycobacterium haemophilum and Mycobacterium fortuitum are 
frequently associated with zebrafish mycobacteriosis (Whipps et al. 2012). Severity of infection 
varies between species and strains of Mycobacterium spp. ranging from high levels of mortality 
with M. marinum and M. haemophilum, and little to no observed mortality with M. abscessus
and M. chelonae (Watral and Kent 2007; Whipps et al. 2007a; Whipps et al. 2007b; Whipps et 
al. 2012). Morbidity due to infection is also variable and includes external signs such as skin 
lesions, emaciation, raised scales, swollen abdomen, and irregular or lethargic swim behavior 
(Astrofsky et al. 2000; Kent et al. 2012b). Internally, infection can be observed as granulomas, 
particularly on the spleen, kidneys and liver (Whipps et al. 2012). Diagnosis may be further 
complicated because signs of disease are often not observed in subclinical infections (Kent et al.
2004; Whipps et al. 2012). 
Recent reviews of zebrafish diseases, including mycobacteriosis, highlight the importance of 
preventative measures such as quarantine, regular disinfection of eggs and surfaces, UV 
sterilization of water, and sentinel programs in zebrafish facilities (Kent et al. 2009; Whipps et 
al. 2012). Once mycobacteriosis is established in a facility control and management of the 
disease becomes a major challenge and involves invasive measures such as depopulation, facility 
sterilization and re-derivation of zebrafish populations. Although these measures have been 
demonstrated to be effective at controlling mycobacteriosis, such intensive measures may not 
always be feasible if this disease becomes established during an ongoing experiment or in a 
valuable zebrafish mutant line (Whipps et al. 2012). Alternative methods for controlling and 
treating zebrafish mycobacteriosis such as targeted use of antibiotics should be considered.
Antibiotic treatment of non-tuberculosis mycobacteriosis in humans is routine (Griffith et al.
2007; Wu et al. 2012), but similar treatments in fish have not been investigated thoroughly.
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Treatment of fish destined for human consumption with antibiotics is not generally considered
feasible as treatments are expensive, long in duration and there are concerns regarding the use of 
pharmaceuticals in fish for human consumption (Whipps et al. 2012). A limited number of 
studies investigating antibiotic treatment of fish infected with M. marinum have been previously 
conducted and include treatment of both food fish [yellowtail (Seriola quinqueradiata):
Kawakami and Kusuda 1990; striped bass (Morone saxatilis): Hedrick et al. 1987; sea bass
(Dicentrarchus labrax): Colorni et al. 1998] and hobby fish [gouramis (Trichogaster 
trichopterus): Santacana et al. 1982; firemouth cichlid (Cichlasoma meeki): Boos et al. 1995; 
Congo tetra (Phenacogrammus interuptus): Boos et al. 1995; guppies (Lebistes reticulatus):
Conroy & Conroy 1999]. The results from these studies are highly variable and range from an 
observed elimination of infection to no decrease in the disease; however, these studies all used 
different treatment methods (i.e., antibiotic added to food, in water bath, in intraperitoneal
injection), antibiotic doses, and different experimental end-points to determine the effectiveness 
of antibiotic treatment. In addition, the susceptibility of fish mycobacteria to antibiotics has not 
yet been evaluated in vitro. Thus, the efficacy of antibiotics as a potential treatment method for 
zebrafish mycobacteriosis cannot be extrapolated from these previous studies. An evaluation of 
antibiotic susceptibility of Mycobacterium spp. isolated from infected zebrafish is required in 
order to determine the potential for antibiotic treatment of mycobacteriosis in zebrafish.
Here we investigate the in vitro antibiotic susceptibility of rapid and slow growing 
Mycobacterium spp. isolated from infected fish from different zebrafish facilities in the United 
States. Antibiotic susceptibility will be evaluated through determination of the minimum 
inhibitory concentration (MIC) of antibiotic required to inhibit bacterial growth in culture. We 
utilized a commercially available microtiter panel system that is commonly used for drug 
79
susceptibility testing of clinical Mycobacterium spp. infections. We hypothesized that the 
Mycobacterium species and strains examined in this study display antibiotic MICs consistent 
with those already identified for human isolates.
4.3 Methods
Bacterial Strains
Isolates maintained in our culture collection are described in Table 1. All organisms have 
previously been identified based on hsp65 gene sequencing as described previously (Kent et al. 
2004; Poort et al. 2006; Whipps et al. 2007a; Whipps et al. 2007b). In addition to these isolates,
reference cultures of rapidly growing Mycobacterium salmoniphilum (ATCC13758) and slow 
growing M.  marinum (ATCC927) are also included in this study. All isolates were grown on
solid-phase Middlebrook 7H10 (MB 7H10) agar (BD Biosciences 262710) supplemented with 
oleic albumin dextrose catalase (OADC, BD Biosciences 211886) at 28-30°C for seven (rapid-
growing) or 14 (slow-growing) days prior to MIC testing.
TABLE 4-1. Isolate list for all cultures used for antibiotic susceptibility testing. 
Isolate ID Species Location Host Reference (source)
ESF35 M.chelonae Pennsylvania, USA Zebrafish This study
ZF-48 M.chelonae Oregon, USA Zebrafish Whipps et al. (2008)
ZF-55 M.chelonae Oregon, USA Zebrafish Whipps et al. (2008)
H11-27-1 M.chelonae New York, USA Zebrafish This study
H11-05 M.chelonae North Carolina, USA Zebrafish Whipps et al. (2014)
JAN1 Mycobacterium sp.a Oregon, USA Zebrafish Kent et al. (2004)
KC1 M. abscessus Pennsylvania, USA Zebrafish Kent et al. (2004)
ATCC13758 M. salmoniphilum Washington, USA Chinook salmon ATCC13758
ESF36 M. fortuitum Pennsylvania, USA Zebrafish This study
SM4 M. peregrinum Washington DC, USA Zebrafish Kent et al. (2004)
MA-1 M.marinum Massachusetts, USA Zebrafish This study
AR103K M.marinum Arkansas, USA Zebrafish This study
OR932 M.marinum Oregon, USA Zebrafish This study
ATCC927 M.marinum Pennsylvania, USA Salt water fishesb ATCC927
TG19 M.marinum Oregon, USA Zebrafish This study
OSU214 M.marinum Oregon, USA Zebrafish Ostland et al. (2007)
a Originally characterized as M. chelonae by Kent et al. (2004), subsequently recognized as a distinct 
entity, but member of the M. chelonae complex by Whipps et al. (2007a)
b First isolated and identified by Aronson (1926) from three saltwater fish species: sergeant major 
(Abudufduf mauritii); croakers (Micropogon undulates); sea bass (Centropristes striatus).
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MIC Testing
MIC testing was performed using the commercially available Sensititre rapid- and slow-
growing Mycobacterium MIC panels (TREK Diagnostics). For rapid-growing isolates the 
Sensititire RAPMYCO panel was used according to the instructions of the manufacturer
(described in Cavusoglu et al. 2012), with the exception of the use of cation adjusted Mueller 
Hinton broth (CAMHB, Teknova M5887) without TES buffer as recommended in the CLSI
M24-A guidelines (CLSI 2011). The inoculated RAPMYCO panel was incubated for three days 
at 28-30°C. Slow-growing isolates were tested using the Sensititre SLOMYCO panel following 
the CLSI 24-A (CLSI 2011) and the manufacturer’s guidelines. An inoculum was prepared by 
sweeping a confluent portion of growth from the MB 7H10 agar plate and emulsifying it in 5 ml 
of sterile water. The inoculum density was adjusted to 0.5 McFarland standard using a 
nephelometer (Sensititre). Fifty μL of the inoculum was diluted in 11 mL CAMHB 
supplemented with 5% volume of OADC enrichment. The inoculated broth suspension was 
vortexed and then 100 μL was added to each well of the SLOMYCO MIC panel. The inoculated 
panel was incubated for seven days at 28-30°C. Additional positive control plates were prepared 
by inoculating MB 7H10 agar plates with 1μL of the positive control well contents. Serial 
dilutions of the inoculated CAMHB were prepared to verify density of 1.0x105-1.0x106 colony 
forming units (CFU)/ml for the panel inoculum. 
Following incubation, the panels were scored daily for three consecutive days to ensure 
consistent scoring. Growth was scored following the CLSI M24-A guidelines for interpretation 
of broth microdilution MIC end points (CLSI 2011). The MIC for each antibiotic agent tested 
was determined based on these scores; in the scenario of growth cessation at different antibiotic 
concentrations between daily readings, the highest MIC was chosen. MIC panels were run in 
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triplicate for each species of Mycobacterium included in this study. There are no published 
breakpoints for MIC values for zebrafish mycobacteria; however, values are available for clinical 
isolates from humans. These available breakpoints were used to classify MICs as susceptible, 
intermediate, or resistant.
4.4 Results
All species grew successfully in the broth medium and growth endpoints were easily 
determined. Growth was observed in the positive control well of all panels, as well as on the 
positive control agar plates. Growth counts of the serial dilution plates confirmed an inoculating 
density of 1.0 x 105-1.0 x 106 CFU/ml.
Rapidly growing Mycobacterium spp.
A summary of MIC results for five rapid-growing species of Mycobacterium spp. tested 
with 15 different antibiotic treatments is given in Table 2. Species and strain differences in 
antibiotic susceptibility are observed as well as variation in the effectiveness of different 
treatments. Using the CLSI M24-A MIC break-points for rapidly growing Mycobacterium spp., 
strains were categorized as susceptible, intermediate, or resistant to treatment. Species in the M.
fortuitum group (M. fortuitum and M. peregrinum) and M. salmoniphilum (ATCC13758) are 
susceptible to amikacin treatment; however M. abscessus and M. chelonae strains exhibited 
intermediate susceptibility. Mycobacterium chelonae strains and M. salmoniphilum show 
resistance to cefoxitin. Mycobacterium abscessus and M. fortuitum show intermediate cefoxitin 
susceptibility while M. peregrinum displays susceptibility. Ciprofloxacin results show resistance 
or intermediate susceptibility in all strains except the M. fortuitum group species which are 
susceptible to treatment. Susceptibility to clarithromycin is observed in M. chelonae species, M. 
salmoniphilum and M. peregrinum, but M. abscessus and M. fortuitum are resistant. Resistance 
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to doxycycline is observed in all strains tested with the exception of one M. chelonae strain 
(ESF35) that was susceptible to treatment. Interestingly, this same strain of M. chelonae
independently susceptible to doxycycline is the only strain that exhibits resistance to imipenem, 
while the other strains tested showed intermediate to complete susceptibility. Tobramycin was 
effective against growth as results show intermediate to full susceptibility among all strains 
tested. Based on breakpoints listed for sulfamethoxazole all strains tested are resistant to the 
trimethoprim/sulfamethoxazole treatment. 
Of the antibiotic treatments tested without CLSI breakpoints listed, no MIC was observed 
for treatment with cefepime or ceftriaxone. Amoxicillin/clauvulanic acid treatment resulted in no 
MIC for M. chelonae and M. abscessus strains and a MIC of 8/4 μg/mL and 16/8 μg/mL for M.
fortuitum and M. peregrinum respectively. No MIC was observed for minocycline treatment 
except for the previously observed unique M. chelonae strain. Moxifloxacin and linezolid 
treatment resulted in high or no MIC for all strains except M. fortuitum and M. peregrinum.
Tigecycline was effective at inhibiting growth for all species with a MIC range of 0.12-2.0
μg/mL.
Slow growing Mycobacterium spp.
A summary of MIC results for six slow-growing species of M. marinum tested with 12
different antibiotic treatments is given in Table 3. Some strain differences in antibiotic 
susceptibility are observed as well as variation in the effectiveness of different treatments. Using 
the CLSI M24-A MIC breakpoint indicating resistance for M. marinum, strains were categorized 
as resistant to treatment. All strains of M. marinum tested were susceptible to amikacin and 
clarithromycin treatments. Resistance to trimethoprim/sulfamethoxazole treatment was observed 
for all strains tested. Variation in susceptibility between strains was observed for ciprofloxacin,
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doxycycline, ethambutol, moxifloxacin, rifabutin and rifampin treatments. No CLSI resistance 
breakpoints are available for ethionamide, isoniazid, linezolid or streptomycin. All strains show 
MICs for ethionamide at lower test concentrations. Variation in MICs for isoniazid and linezolid 
were observed across strains, and streptomycin MICs were at the high end of the range of 
concentrations tested. 
TABLE 4-3. MICs for slow growing M. marinum strains in the microdilution broth system. 
Each isolate culture was tested in triplicate; a single MIC is shown when all replicates resulted in 
the same MIC. Reference resistance (R) breakpoints for antibiotics are indicated. Bolded results 
indicate MICs indicating antibiotic susceptibility.
MIC (μg/ml) for SGM isolates
Antibiotic Agent (R) MA-1 AR103K OR932 ATCC927 TG19 OSU214
Amikacin (>32) <1, 2, 2 <1, 2, 2 2, 2, 4 2 2, 2, 4 2
Ciprofloxacin (>2) 1, 4, 4 4, 2, 8 4, 4, 8 4, 4, 8 8, 8, 8 2, 2, 4
Clarithromycin (>16) 2, 4, 4 2, 2, 4 4 2 2, 4, 4 2, 4, 4
Doxycycline (>4) 2, 4, 4 4, 4, >16 4, 4, 8 2 2, 4, 4 8
Ethambutol (>4) 1, 8, >16 4, 8, 16 4, 4, >16 2, 2, 4 4, >16, >16 8
Ethionamidea <0.3 <0.3 0.6, 0.6, 1.2
0.6, 0.6, 
2.5 0.6 0.6, 0.6, 1.2
Isoniazid (>16) 0.5, 2, 1 1 1, 2, 2 4, 4, >8 4 8
Linezolida 1, 8, 1 8, 8, 32 <1, <1, <1 <1, <1, 2 8, 8, 8 <1, <1, <2
Moxifloxacin (>2) 1, 4,  >8 1, 1, >8 2, 4, >8 4, 2, 2 2, >8, >8 4, 2, 2
Rifabutin (>2) 2, 4, 4 4, 8, >8 4, 8, 8 4, 4, 8 8 4, 4, 8
Rifampin (>1) 1, >8, >8 2, >8, >8 2, 4, >8 4, >8, >8 2, >8, >8 4
Streptomycina 8, 16, 16 8 16 16, 16, 8 16 8
Trimethoprim/ 
sulfamethoxazole (>2/38)
0.5/9.5, 
>8/152, 
>8/152
8/152, 
8/152, 
>8/152
8/152, 
8/152, 
>8/152
>8/152
8/152, 
>8/152, 
>8/152
>8/152
a No breakpoints indicating resistance to antibiotic agent available for this antibiotic in the CSLI M24-A2 standard 
(CSLI, 2011)
4.5 Discussion
Overall, the results from this study indicate that there are differences in the effectiveness 
of each antibiotic tested and that variable antibiotic susceptibilities are observed across different 
species and strains of mycobacteria. Due to these differences, the type of Mycobacterium spp.
causing infection should be identified before considering a particular antibiotic treatment. 
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Antibiotic susceptibilities of different Mycobacterium spp. 
Rapid growers. – Infection of M. chelonae and M. abscessus is common in zebrafish,
and infections often present as subclinical with little to no external signs of infection (Watral and 
Kent 2007; Whipps et al. 2007a; Whipps et al. 2007b; Whipps et al. 2012). These subclinical 
infections are extremely concerning as they can be a source of uncontrolled experimental 
variance (Kent et al. 2004; Whipps et al. 2012). For human clinical M. chelonae infections 
tobramycin is the first recommended treatment, followed by clarithromycin and linezolid as 
second choices (Cavusoglu et al. 2012; Griffith et al. 2007). Our results show that M. chelonae
isolates from zebrafish are similarly susceptible to tobramycin and clarithromycin, as well as 
tigecycline. We also observed resistance to cefoxitin in addition to amoxicillin/clauvulanic acid, 
ciprofloxacin, doxycycline, minocycline, and trimethoprim/sulfamethoxazole. Interestingly, of
the M. chelonae strains tested, one strain (ESF35) was uniquely susceptible to doxycycline and 
resistant to imipenem treatments indicating that there is some variability in drug susceptibility 
testing amongst different strains of M. chelonae.
Results from human clinical research indicate that M. abscessus is uniformly resistant to 
standard antituberculosis agents, and drug-susceptibility testing is highly recommended prior to 
treatment (Griffith et al. 2007). Recommended antibiotic treatments include clarithromycin, 
amikacin and cefoxitin; however, clinical strains of M. abscessus have been shown to have 
acquired mutational resistance to clarithromycin and amikacin (Cavusoglu et al. 2012; Griffith et 
al. 2007). We showed that zebrafish M. abscessus is: susceptible to tigecycline; shows 
intermediate susceptibility to amikacin, cefoxitin and imipenen; and was resistant to all other 
antibiotic tested. Drug susceptibilities are very similar when comparing M. chelonae and M. 
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abscessus isolates, which is not surprising as they phylogenetically group within the M. chelonae 
complex (Kent et al. 2004). 
Mycobacterium salmoniphilum is a M. chelonae–like bacterium isolated from salmon 
(Ross, 1960; Whipps et al. 2007a). Phylogenetically, it is nested within the M. chelonae complex 
(M. chelonae and M. abscessus) (Whipps et al. 2007a). Thus, similarities in antibiotic 
susceptibility to M. chelonae are not surprising. One difference is that M. salmoniphilum is also 
susceptible to amikacin whereas M. chelonae is not. This pathogen has never been isolated from 
zebrafish, but has been reported in salmonids, and knowledge of the antibiotic susceptibility of 
this species might be of interest to that industry. 
Infection with M. fortuitum and M. peregrinum, both members of the M. fortuitum
complex, are less frequently observed in zebrafish; however, M. fortuitum is ubiquitous in water 
(Galassi et al. 2003). Zoonotic transmission to humans from fish has also been previously 
reported for M. fortuitum (Astrofsky et al., 2000). Clinical research indicates that M. fortuitum
and M. peregrinum are susceptible to many antibiotic treatments, and doxycylcine, minocycline, 
clarithromycin, linezolid and sulfonamides are recommended for treatment in humans
(Cavusoglu et al. 2012; Griffith et al. 2007). It should be noted that M. fortuitum has previously 
displayed macrolide (i.e., clarithromycin) resistance. Interestingly, our results show different 
susceptibilities compared to human isolates; we observed susceptibilities to amikacin, 
ciprofloxacin, imipenem and tigecycline. In that study, M. peregrinum infections in zebrafish 
have been reported as low-severe (Kent et al. 2004). In this study, M. peregrinum shows similar 
antibiotic susceptibilities as what we observe for M. fortuitum with the addition of cefoxitin and 
clarithromycin susceptibilities. 
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Slow growing M. marinum. – Out of all the Mycobacterium spp. included in this study, 
zebrafish M. marinum infections are the most severe (Watral and Kent 2007; Whipps et al. 
2007a; Whipps et al. 2007b; Whipps et al. 2012). Also, zoonotic transmission of M. marinum
(i.e., fish handlers’ disease) is a major concern as treatment is lengthy and could require 
debridement (Wu et al. 2012). Clinical recommendations for treatment in humans include 
multiple antibiotics which are commonly used in combination and include: rifampin, rifabutin, 
ethambutol, clarithromycin, sulfanomides, trimethoprim/sulfamethoxazole, doxycycline and 
minocycline (Griffith et al. 2007). In addition, clinical testing has shown resistance to isoniazid 
(Griffith et al. 2007). Previous studies in yellowtail fish infected with M. marinum show 
rifampin, streptomycin and erythromycin to be effective antibiotic treatments; however, a
Mycobacterium sp. was re-isolated from surviving fish following treatment in this study
suggesting complete elimination of infection was not successful (Kawakami and Kusuda 1990). 
Our results show that all six strains of M. marinum tested were susceptible to amikacin, 
clarithromycin, and rifampin. Variation in susceptibilities is observed for the other antibiotics 
tested, and some strains of M. marinum are more susceptible to treatment.
Additional considerations for antibiotic treatment of Mycobacterium spp.
Although Mycobacterium spp. isolated from zebrafish responded similarly in vitro to 
different antibiotic treatments compared to human clinical isolates, further in vivo testing is 
required in order to confirm susceptibilities due to the following considerations. First, species of 
Mycobacterium have been reported to have different antibiotic susceptibilities depending on their 
environment. This difference is thought to be due to differences in gene regulation when 
mycobacteria are in stationary metabolic phases within biofilms or active phases within a host 
(reviewed in van Ingen et al., 2012). For example, M. abscessus has smooth and rough colony 
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types due to differences in the expression of cell wall glycolipid content (regulated by mtrAB 
expression) that confers natural resistance to antibiotics through glycolipid-rich cell walls in 
rough colonies (Cangelosi et al. 1999; Cangelosi et al. 2006). In addition to this, the route of 
drug administrations should be taken into account. Common antibiotic administration techniques 
used for fish are medicated feed, bath, and injection (Toutain et al. 2010; Yanong 2013). Of 
these, medicated feed is the most common. When antibiotics are administered through feed they 
are absorbed into the gut epithelium and enter systemic circulation following a hepatic first-pass 
(Toutain et al. 2010). Loss of drug commonly occurs during this first-pass and depends on the 
amount of catabolism occurring in the liver. Although this metabolic pathway is similar to 
humans, drug bioavailability has been reported lower in fish compared to humans (Martinsen and 
Horseberg 1995). Similar concerns arise with bath treatments, where drugs enter through the 
gills and undergo a renal-pass (Toutain et al. 2010). Water-quality issues also arise for topical 
bath treatments (Yanong 2013). Treatment dose and duration also require further investigation as 
details regarding pharmacokinetics remain to be elucidated in fish (Yanong 2013). Additionally, 
zebrafish susceptibility to antibiotic treatment may be strain specific and different genetic lines 
of fish may respond differently to antibiotic treatment, as variation in strain susceptibility to 
mycobacterial infections has been previously observed (Whipps et al. 2012).
Results from this study also indicate that zebrafish mycobacteria are less resistant to 
antibiotics compared to clinical isolates. This is likely due to less frequent exposure of these 
zebrafish isolates to antibiotics and therefore weaker selection for resistance. However, antibiotic 
resistance is common in bacteria (including mycobacteria) isolated from ornamental fish, an 
industry where antibiotic use is common (Rose et al. 2013). These ornamental fish bacteria have 
been shown to possess plasmids that may carry resistance genes and acquisition of antibiotic 
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resistance has been shown in to be transferable in fish isolates of Pseudomonas spp. and 
Aeromonas spp. between resistant and susceptible strains (Rose et al. 2013). Thus, high potential 
for zebrafish mycobacteria to acquire additional antibacterial resistance exists and diligence
should surround the usage of antibiotics in laboratory zebrafish. Additionally, because some 
species of zebrafish mycobacteria are zoonotic and treatment of these infections in humans can 
be long in duration and require multiple antibiotics (Wu et al. 2012) the potential consequence of 
antibiotic resistance for fish handlers is of great concern. Considering these risks, it is important 
to emphasize that antibiotic use in zebrafish be used judiciously. A specific example would be to 
treat a valuable or rare line of brood fish prior to breeding. We emphasize that infection would 
need to be diagnosed and the Mycobacterium species identified so that the appropriate antibiotic 
could be used. It would not likely be practical or wise to treat large groups of fish. 
In conclusion, Mycobacterium spp. isolated from laboratory zebrafish do exhibit 
susceptibility to some, but not all antibiotics tested. Antibiotic susceptibilities show variation that 
coincides with phylogenetic groupings of Mycobacterium spp. highlighting the importance of 
species identification to determine the most effective antibiotic treatment for inhibiting 
mycobacterial growth. Similarities in drug susceptibilities are observed between zebrafish and 
human isolates; however, zebrafish isolates were resistant to fewer antibiotics, most likely due to 
the low usage of antibiotics currently in zebrafish compared to humans. More research is 
required in order to test antibiotic susceptibility of these isolates in vivo due to environmentally 
regulated changes in bacterial gene expression as well as the influence pharmacokinetics has on 
antibiotic availability. 
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5.1 Abstract 
 Zebrafish (Danio rerio) are a popular model organism used in a growing number of 
research fields. Maintaining healthy, disease-free laboratory fish is important for the integrity of 
many of these studies. Mycobacteriosis is a chronic bacterial infection caused by several 
Mycobacterium spp. and is the second most common disease found in laboratory zebrafish. 
Current mycobacteriosis control measures recommend the removal of infected fish and in severe 
outbreaks, depopulation. These measures can be effective, but less disruptive measures should be 
assessed for controlling mycobacteriosis, particularly when valuable and rare lines of fish are 
affected. Here, the in vivo efficacy two drug candidates, tigecycline (1 ȝg/g) and clarithromycin 
(4 ȝg/g), was tested in adult zebrafish experimentally infected with Mycobacterium chelonae. 
We assessed both short (14 day) and long-term (30 day) treatments and evaluated fecundity and 
pathological endpoints. Fecundity and histology results show that zebrafish tolerated antibiotics. 
Antibiotic treatments did not significantly impact the prevalence of acid-fast granulomas; 
however, the severity of infections (acid fast granuloma intensity) was significantly decreased 
following treatments. 
Keywords: zebrafish, mycobacteriosis, antibiotic treatment, clarithromycin, tigecycline, 
Mycobacterium chelonae. 
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5.2 Introduction 
 The Zebrafish (Danio rerio) is a popular vertebrate model organism used in a wide range 
of research fields (Dahm & Geisler 2006; Phillips & Westerfield 2014). Zebrafish are currently 
considered rising stars of model-organism research with almost a 60% increase in National 
Institutes of Health R01 awards from 2008-2015 (Gaind 2016). Zebrafish are used in an ever-
increasing range of disciplines including, but not limited to, toxicology (Truong, Harper & 
Tanguay 2011), aging (Gerhard 2003), oncology (Feitsma & Cuppen 2008), and behavior 
(Wong, Elegante, Bartels, Elkhayat, Tien, Roy, Goodspeed, Suciu, Tan, Grimes, Chung, 
Rosenberg, Gaikwad, Denmark, Jackson, Kadri, Chung, Stewart, Gilder, Beeson, Zapolsky, Wu, 
Cachat & Kalueff 2010). Mycobacteriosis is the second most common disease in laboratory 
zebrafish (Kent, Spitsbergen, Matthews, Fournie, Murray & Westerfield 2012), caused by 
several Mycobacterium spp. (Astrofsky, Schrenzel, Bullis, Smolowitz & Fox 2000; Kent, 
Whipps, Matthews, Florio, Watral, Bishop-Stewart, Poort & Bermudez 2004; Kent 2012; 
Whipps, Lieggi & Wagner 2012). Several species and strains of Mycobacterium have been 
implicated in zebrafish mycobacteriosis including both rapid-growing species (e.g. 
Mycobacterium chelonae, Mycobacterium abscessus, Mycobacterium peregrinum, 
Mycobacterium fortuitum) and slow-growing species (e.g. Mycobacterium marinum and 
Mycobacterium haemophilum) (Astrofsky et al. 2000; Kent et al. 2004; Whipps, Matthews & 
Kent 2008). The severity of mycobacteriosis in zebrafish varies among species and can range 
between high levels of mortality with M. marinum and M. haemophilum to little observed 
mortality with M. abscessus and M. chelonae (Watral & Kent 2007; Whipps, Dougan & Kent 
2007; Whipps et al. 2012). Infection related morbidity is also variable and includes external signs 
such as skin lesions, emaciation, raised scales, swollen abdomen, and irregular/lethargic 
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swimming behavior, as well as internal signs like granulomas, especially on haematopoeitic 
organs (Astrofsky et al. 2000; Kent 2012; Whipps et al. 2012). Additionally, signs of disease 
may not be present in the case of subclinical infections (Kent et al. 2004; Whipps et al. 2012). 
Mycobacterial infections in zebrafish are detrimental to research both when severe outbreaks 
result in high levels of mortality and also when subclinical infections persist undetected in 
populations as a source uncontrolled experimental variance (Kent et al. 2004; Whipps et al. 
2012). 
 Control recommendations for zebrafish mycobacteriosis focus on disease prevention 
through quarantine, disinfection, UV disinfection, and sentinel programs for health monitoring 
(Kent, Feist, Harper, Hoogstraten-Miller, Mac Law, Sanchez-Morgado, Tanguay, Sanders, 
Spitsbergen and Whipps 2009; Whipps et al. 2012; Chang, Colicino, DiPaola, Al-Hasnawi & 
Whipps 2015). Mycobacteria are facultative pathogens and persist environmentally in surface 
biofilms (Falkinham 2009; Falkinham, Norton & LeChevallier 2001). Thus, established 
mycobacterial infections in zebrafish facilities substantially complicate disease control and 
management and involve invasive management steps such as depopulation, facility sterilization, 
and rederivation of zebrafish populations (Whipps et al. 2012). These measures have been 
demonstrated to be effective at controlling zebrafish mycobacteriosis outbreaks, but such 
extreme measures may not always be feasible for research facilities (Whipps et al. 2012). For 
example, if an outbreak occurs in during an ongoing experiment or in a valuable mutant line 
depopulation and rederivation may not be an option (Whipps et al. 2012). This challenge is also 
true in the case of mycobacteriosis infections in other fish species such as valuable zoo 
collections (Strike, Feltrer, Flach, Macgregor & Guillaume 2016). There is a need to explore 
alternative methods for disease management, such as antibiotic treatment. 
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 The treatment of non-tuberculosis mycobacteriosis in humans is routine (Griffith, 
Aksamit, Brown-Elliott, Catanzaro, Dalet, Gordin, Holland, Horsburgh, Huitt, Iademarco, 
Iseman, Olivier, Ruossvon,  Reyn, Wallace Jr & Winthrop 2007; Wu, Chiu, Yang, Leu, Huang, 
Chen, Wu, Chang, Su, Kuo, Chia, Lu & Lai 2012), but similar treatments in fish have yet to be 
thoroughly investigated (Chang & Whipps 2015). We previously evaluated the in vitro 
susceptibility of several rapid- and slow-growing strains of Mycobacterium spp. isolated from 
infected zebrafish from different facilities in the United States (Chang & Whipps 2015). We 
observed differential susceptibility to the antibiotic treatments across species and drugs that 
coincided to phylogenetic groupings of Mycobacterium spp. and were also similar to those 
observed in human isolates (Chang & Whipps 2015). We were able to highlight key antibiotic 
candidates that demonstrated in vitro effectiveness against Mycobacterium species that 
commonly cause disease in zebrafish, as well as determine the minimum inhibitory concentration 
(MIC) for these antibiotics (Chang & Whipps 2015). Two candidates identified in this study 
were tigecycline and clarithromycin, which were effective at very low concentrations against 
several species of Mycobacterium (Chang & Whipps 2015).  
 In this study we evaluate the in vivo efficacy of tigecycline and clarithromycin treatments 
of M. chelonae infection in adult zebrafish, the most common Mycobacterium species found in 
laboratory zebrafish. We evaluate treatment using these drugs at the MIC determined in our 
previous study (Chang & Whipps 2015), which also corresponds to the dosages recommended 
for treatment of NTM infections in humans (Muralidharan, Micalizzi, Speth, Raible & Troy 
2005; Kim, Chi, Oh, Kim, Kim, Lim, Kim & Kwon 2011). Both 14-day and 30-day treatments 
will be evaluated for both drugs. Our first study goal is to evaluate the safety of these treatments 
and evaluate effects on fish health and fecundity. We hypothesize that because treatments are at a 
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dose similar to what is currently used for human treatments, there will be no effects on 
morbidity, mortality or fecundity for both tigecycline and clarithromycin treatments. Our second 
study goal was to evaluate the effectiveness of these treatments in eliminating M. chelonae from 
infected zebrafish. We hypothesize that these treatments will result in a significant decrease in 
mycobacteria, with longer-term (30-d) treatments being more effective than short-term (14-d) 
treatments. 
5.3 Methods 
Fish
 All fish used in this study were bred and maintained in the zebrafish facility at the 
SUNY-ESF Center for Integrated Teaching and Research in Aquatic Science. Adult AB wild 
type line zebrafish (n=576; 288 male and 288 female; age = 6 months), originally obtained from 
the SARL at Oregon State University (Corvallis, OR) and bred for two generations at SUNY-
ESF, were utilized in this study. Animals were housed at a density of 6-10 fish/liter in either 1.8 
L (tolerance experiment) or 2.6 L (efficacy study) tanks on a timed, flow-through housing system 
(Aquaneering, San Diego, CA). The housing system included ultraviolet disinfection of 
dechlorinated (carbon filter) municipal tap water maintained to pH 7.6, a conductivity of 600-
700 us/cm2, and a temperature of 28.5°C, and ammonia levels ranging from 0-0.25 ppm. The 
zebrafish facility maintained a 14:10 light:dark photoperiod. Fish were fed a commercial feed for 
zebrafish (Gemma, Skretting) twice daily on weekdays and once daily on weekends during 
periods they were not being fed a treatment gelatin feed. Prior to the experiment, routine 
cleaning of all equipment (e.g. tanks, lids, baffles, nets, and tubing) consisted of bi-weekly 
washing and scrubbing in warm water with a new soft sponge and bleaching in 1000 ppm 
chlorine bleach for 30 minutes, followed by rinsing three times in dechlorinated water and 
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drying. All tanks, lids, and baffles were also autoclaved using a program specified by the tank 
manufacturer that reaches a temperature of 105-110°C for 15 minutes. During experiments this 
tank cleaning procedure occurred when the placement of fish in a new tank is mentioned in the 
methods below. All animal work was approved by the SUNY-ESF Institutional Animal Care and 
Use Committee, protocol #151001. 
Medicated Feed Preparation 
 Antibiotics were delivered orally through a commercially developed gelatin feed (Gelly 
Belly, Florida Aqua Farms). This gelatin feed has previously been previously shown to be 
comparable to other zebrafish diets (Sciarra, Tyler & Kolb 2014). Prior to preparing medicated 
feeds, concentrated stock solutions of each antibiotic were prepared as followed. Tigecycline 
(Sigma Aldrich) was initially dissolved in DMSO to reach a concentration of 3 mg/mL as per 
manufacturer’s recommendation. This dilution was then further diluted further to 1.5 mg/mL in 
Hanks Buffered Salt Solution as recommended in (Adekambi & Drancourt 2004) and stored at -
20°C to minimize drug loss through storage. Clarithromycin (Sigma Aldrich) was dissolved in 
DMSO to reach a final concentration of 1 mg/ml as per manufacturer recommendations, and 
stored at -20°C. Medicated Gelly Belly feed was prepared with the addition of clam juice as in 
(Sciarra, et al. 2014). Medicated Gelly Belly was weighed and minced following this method as 
well. Food aliquots for each tank were stored in sterile culture tubes at -20°C until immediately 
prior to feeding. Tigecycline feed was prepared so that fish would receive a target dosage of 1 
g/g of body weight in each feeding. Clarithromycin feed was prepared so fish received a target 
of 4 g/g of body weight in each feeding. The average body weight was 600 mg/fish. Control 
feeds were prepared with the addition of no antibiotics; sterile water was used in the place of any 
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medication. Once medicated and control feeds were prepared they were re-labelled A, B, or C by 
a third party so that further observations were blinded.  
Tolerance Study Design 
 Experimental groups (n=36/group) were organized as follow into feed treatment: 
untreated 14-d (no antibiotic feed), untreated 30-d (no antibiotic feed), treated tigecycline 
treatment 14-d (1 g/g tigecycline/day), treated tigecycline treatment 30-d (1 g/g 
tigecycline/day), treated clarithromycin treatment 14-d (4 g/g clarithromycin/day), treated 
clarithromycin treatment 30-d (4 Ɋg/g clarithromycin/day). For each experimental group fish 
were divided evenly into12 fish/tank replicated three times. Each tank had an equal number of 
male and female fish. 
 Fish were measured prior to the start of the study so that average growth could be 
evaluated. For measurements, fish fasted for 12-h were anaesthetized in a bath treatment of 0.15 
g/L MS222 buffered to a pH of 7.5. Once anesthetized, the sex and the standard length (snout to 
the end of the caudal peduncle) of each fish were measured to the nearest millimeter. Once 
measured, fish recovered in fresh zebrafish system water and were returned to the appropriate 
study tank. This measurement procedure was also carried out for all groups post-treatment (14-d 
and 30-d) as well as 11-weeks post 14-d or 30-d treatment. 
 Two weeks prior to the start of treatment feeding, background breeding was conducted 
weekly to determine a baseline for fecundity values. Each tank was bred overnight in its own 
breeding chamber (Aquaneering). The following morning fish were given 3 hours to breed 
following the beginning on the light photoperiod. Following breeding, fish were returned to new 
clean (autoclaved) tanks. The number of embryos collected as well as the 24-hour embryo 
mortality for each tank was determined. Following 24-hour mortality data collection, all embryos 
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were euthanized in 0.3g/L MS222 buffered to a pH of 7.5. Following euthanasia, all embryo 
waste was bleached at an estimated concentration of 1000 ppm prior to disposal. This same 
breeding procedure was repeated weekly from 2-11 weeks post-treatment. 
 Antibiotic feed treatments were administered daily from 9:30-10:30 am for either 14 days 
or 30 days. Prior to feeding all tanks were cleaned to remove any feces and/or detritus from 
tanks. At feeding, pre-prepared (described above) gelatin-based food was distributed to each 
tank. Fish were allowed 20 minutes of eating time, following that excess food was removed by 
siphoning. Observations (changes in skin color, irregular swimming, lethargy, mortality) of fish 
in all tanks were made at 5 min, 30 min, 1 hour, and 2 hours post-feeding. Following tigecycline, 
clarithromycin, and control treatments (14-d and 30-d) standard length measurements were 
collected again using the method described above. There were no timed water exchanges during 
the pre-feeding cleaning and feeding periods. Following the removal of excess food after the 
feeding period, a timed water exchange was carried out replacing approximately 20 percent of 
the tank water.  
 At 11 weeks post-treatment all fish were measured as described above and euthanized in 
0.3 g/L MS222 buffered to a pH of 7.5. Euthanized fish were fixed in Davidson’s solution for 
48h, decalcified in 0.5M EDTA for 5 days, rinsed, and dehydrated to 70% EtOH for histology 
through a dehydration series (25% EtOH for 30 min, 50% EtOH for 30 min, 70% EtOH to store). 
Three representative fish from each replicate tank were sectioned and stained with hematoxylin 
and eosin (H&E).  
Statistics - Tolerance 
 The analysis described below was used to compare differences between treated 
tigecycline, treated clarithromycin, and untreated treatments for the same duration (14-d or 30-d) 
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and also to compare differences between durations (14-d and 30-d) for the same treatment 
(tigecycline, clarithromycin, or untreated controls). The same statistical method was used for all 
analyses and was carried out in R 3.1.0 (R Core Team 2013) and R Studio (R Studio 2012). 
Length data, embryo count data, and 24-hour embryo mortality data were organized in a 
spreadsheet. Growth was calculated for each replicate tank by subtracting average standard 
length measured before treatment, from post-treatment and 11 weeks post-treatment  length (e.g. 
Growth=average standard length at 11 weeks post-treatment – average standard length at pre-
treatment). Percent embryo survival was calculated as follows {Percent Survival = [1 - (24-hour 
embryo mortality/Total Number of Embryos Collected)]*100}. Data were sorted into separate 
spreadsheets by time-point and treatment and saved as individual text files for analyses. Prior to 
each statistical analysis, data were checked for normality and equal variances using the “stats” 
package (R Core Team 2013) and “car” package (Fox and Weisberg 2011) respectively. 
Residuals were also plotted using the “stats” package to further evaluate data normality. If data 
had a normal distribution (p>0.05) and equal variances (p>0.05), parametric ANOVA test was 
performed using the “stats” package (R Core Team 2013). Post-hoc analyses pair-wise analyses 
were conducted using t-tests using the “foreign” and “car” packages. Non-normally distributed 
data and data with unequal variances (p<0.05) were evaluated with the Kruskal-Wallis rank sum 
test using the “stats” package (R Core Team 2013). Post-hoc testing used the Nemenyi-tests for 
multiple comparisons of rank sums using the “PMCMR” package (Pohlert 2015). Descriptive 
statistics were determined using the “psych” package. Results were organized into bar plots 
using the “sciplot” package.  
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Efficacy Study Design 
 Experimental groups (N=60) were organized as follows: untreated (no antibiotic feed) 
sham injected, untreated (no antibiotic feed) M. chelonae injected, treated tigecycline (1 g/g) 
sham injected, treated tigecycline (1 g/g) M. chelonae injected, treated clarithromycin (4 g /g) 
sham injected, treated clarithromycin (4 g /g) M. chelonae injected. For each experimental 
group, fish were divided evenly into two tanks of 30 fish. Each tank had an equal number of 
male and female fish.  
 Prior to the set-up of experimental groups, mycobacterial infections or sham injections 
were established in the fish. Mycobacterium chelonae injected fish (N=180 fish) were injected 
intraperitonally (IP) with Mycobacterium chelonae (H1E2), and sham injected fish (N=180) 
injected with sterile saline, following the method described in Watral et al. (2007). The 
concentration of the bacterial inoculum was determined using a nephelometer (Sensititre) and 
confirmed with colony counts following culture on Middlebrook 7H10 agar plates. After IP 
injection, fish were placed in new tanks and maintained on the flow-through system for 8 weeks 
in order to allow for the development of infections in bacterium-injected fish. During this 8 week 
period fish were fed a commercial feed (Gemma, Skretting) twice daily on weekdays and once 
daily on weekends. Tanks were siphoned daily following feeding during this period. 
 Following the 8-week incubation period, fish were arranged in their respective 
experimental group in new tanks. Mycobacterium chelonae injected fish (N=180) were randomly 
divided into six tanks of N=30 (15 males, 15 females). Sham injected fish (N=180) were also 
divided into six tanks of N=30 (15 males, 15 females). At this point, each tank was fed either 
untreated Gelly Belly feed (prepared as described previously) or treated tigecycline or 
clarithromycin feed (prepared as described previously). Prepared tubes of thawed and minced 
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gelatin feed were emptied into each tank using the same method described above for the 
tolerance study. Timed water exchanges were carried out similar to the tolerance study above. 
Fish were fed daily for 14 days. On the 15th day, following a 12-h fasting period, half of the fish 
from each tank were euthanized in 0.3g/L MS222 buffered to a pH of 7.5. Once euthanized, fish 
were prepared for histology as described above. The remaining fish in each tank continued 
experimental feeds daily up until day 30. Following the 30th feed, fish were fasted overnight for 
12-h, then euthanized, fixed, decalcified and prepared for histology as described above. Sections 
from each specimen were stained with both hematoxylin and eosin (H&E) or Kinyoun’s acid fast 
stain.  
 Following staining, slides were examined, recording the number and location of 
granulomas in H&E sections. For acid fast-stained sections, the presence of granulomas 
containing acid fast bacilli (AFB) was recorded. The number and location of granulomas 
containing AFB was recorded, and the location of AFB not contained in granulomas was also 
recorded. AFB not within granulomas were considered to be internally located if they were 
located inside the epithelial boundary (e.g. not in the gut lumen or on the outside of the 
skin/scales). The prevalence of granulomas, granulomas containing AFB, and free AFB was 
calculated. The intensity of granulomas containing AFB was also calculated (Intensity = number 
of granulomas containing AFB/number of fish with the presence of granulomas containing 
AFB).  
Statistics - Efficacy 
 For each experimental group, a Chi-squared analysis with a Monte Carlo simulation 
method using 20,000 replications was used to compare replicate tanks to determine whether data 
from different tanks can be pooled for further group comparisons. Results from this test showed 
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no significant differences between replicate groups. Replicate data for each experimental group 
was pooled. Wilson’s 95% confidence intervals and prevalence values were determined using the 
“epitools” package (Aragon, Fay & Wollschlaeger 2012). There was no occurrence of acid-fast 
granulomas in sham injection fish and subsequent statistical analyses excluded these sham 
groups. Fisher’s exact test for count data was used to compare prevalence between treatment 
groups using the “stats” package (R Core Team 2013). Data was analyses comparing 
experimental groups for both sexes, with males or females only, and between sexes for each 
group. Results were organized into bar plots using the “sciplot” package (Morales 2012).  
5.4 Results 
Tolerance Study - Behavior 
 The prepared gelatin-based feed was eaten by all the fish without hesitation and as noted 
in Sciarra et al. (2014), a feeding frenzy occurred. The fish generally consumed most of their 
food within the 20-minute period; however, any remaining food was removed as it deteriorated 
water quality quickly. Observations at 5 min, 30 min, 1 hour and 2 hours post-feeding included 
no changes in skin color, no irregular swimming, no lethargy or mortality. The only observation 
noted, is that female fish would become very full and sometimes have a distended belly from 
consuming the gelatin feed. There was no resulting morbidity or mortality.  
Tolerance Study - Embryos 
 Generally, all experimental groups spawned on every breeding occasion throughout this 
study and 24-hour embryo mortality ranged from 0-42%. When embryo counts and 24-hour 
embryo mortality were compared (Table 5-1), there were only two instances of significant 
differences between groups. First, for average embryo count, there was a significantly higher 
average embryo count for both 14- and 30-d tigecycline treatments at 4 weeks post-treatment 
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compared to 14-d clarithromycin, untreated, and 30-d clarithromycin treatment [F(5)=7.627, 
p=0.002] (Table 1). Second, there was significantly higher percent mortality at both 2 and 3 
weeks post-treatment for the 14-d tigecycline treatment group compared to 30-d tigecycline and 
both 14- and 30-d untreated groups [week 2: F(5)=4.162, p=0.02; week 3: F(5)=4.509, p=0.0152] 
(Table 5-1). When comparisons were made for the same experimental group over time, there was 
only one instance where embryo count differed significantly between weeks. For the 14-d 
tigecycline treatment, the average embryo count at 7-weeks post-treatment (61) was significantly 
lower than counts at weeks two and three (226) [F(1)=5.37, p=0.03] (Table 5-1).  
Tolerance Study - Growth 
 When post-treatment growth between experimental groups was compared immediately 
following treatment, there was no significant difference between treated and untreated groups 
(Ȥ2(5)=6.05, p=0.30)(Figure 5-1). However; when comparing growth 11 weeks post treatment, 
there was a significant difference between groups (Ȥ2 (5)=13.17, p=0.02)(Figure 5-1). For this 
time-point, the 30-d clarithromycin and untreated groups resulted in significantly less growth 
than the other groups. 
Treatment Efficacy – H&E Granuloma Prevalence 
 Granulomas were mainly located in the reproductive tissues of both male and female fish. 
For the sham injected groups, granulomas were restricted to the ovaries, testes, and swim 
bladder. For the M. chelonae-injected tigecycline and clarithromycin treated groups the 
granulomas were located in additional types of tissues in addition to the ovaries, testes, and swim 
bladder, including: intestine, liver, pancreas, and adipose. The M. chelonae injected untreated 
group had granulomas in more tissue types (ovaries, testes, swim bladder, intestine, liver, 
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pancreas, adipose, and kidney). compared to the M. chelonae injected tigecycline and 
clarithromycin treated groups.  
 The prevalence of granulomas in H&E stained slides varied between experimental groups 
and sex (Appendix Table 1). Sham-injected groups displayed prevalence ranging from 0-0.13 
(Figure 5-2). Mycobacterium chelonae-injected groups display a granuloma prevalence ranging 
from 0.38-0.56 (Figure 5-2). There was no significant difference between the prevalence of H&E 
stained granulomas between experimental groups when comparing groups including both sexes, 
only males, and only females (Figure 5-2). However, when granuloma prevalence for males and 
females were compared for each group the M. chelonae injected 14-d tigecycline treated females 
had a significantly higher prevalence compared to males (p=0.01718) (Figure 5-2).   
 
Figure 5-1. Tolerance Study Growth Results. Growth (mm) in standard length (SL) immediately 
following 14-d and 30-d antibiotic treatment with tigecycline (1 g/g), clarithromycin (4 g/g), 
or control feed (white bars) and at 11-weeks post-treatment (grey bars). Significant differences 
are indicated by an asterisk (*).
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Figure 5-2. Barplot displaying prevalence of H&E granulomas for both sexes (white bars), 
males only (grey bars), and females only (black bars) for both sham-injected and M. chelonae–
injected zebrafish treated with 14-d or 30-d tigecycline (1 g/g), clarithromycin (4 g/g), or 
control feeds.  A significantly higher prevalence is observed for females compared to males for 
the 14-d tigecycline treatment (*).   
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Figure 5-3. Barplots displaying the (A) prevalence and (B) intensity for both sexes (white bars), 
males only (grey bars), and females only (black bars) of acid fast positive granulomas for M.
chelonae–injected zebrafish treated with 14-d or 30-d tigecycline (1 g/g), clarithromycin (4 
g/g), or control feeds. Significant differences in prevalences are indicated by asterisks (*). 
 
  For males only a significantly higher prevalence of AFG is observed for 30-d tigecycline 
and clarithromycin treatments compared to 14-d clarithromycin treatment. Higher prevalence 
was observed for females compared to males from the same treatment for 14-d tigecycline an
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30-clarithromycin treatments. A significant difference between intensity (B) for treatment groups 
of both sexes was also observed with control groups having the highest intensities.  
Treatment Efficacy - AF Granuloma Prevalence 
 When comparing the prevalence of acid-fast granulomas to granulomas observed in H&E 
stained sections, there was generally a lower prevalence of acid-fast positive granulomas 
compared to H&E stained counts. Two exceptions to this were observed for female granuloma 
prevalence of the M. chelonae tigecycline 14-d treated group and the M. chelonae 30-d 
clarithromycin treated group where a higher prevalence for granulomas in the ovaries were 
observed in acid-fast stained sections compared to H&E (Compare Figure 5-2 to Figure 5-3A).  
 The prevalence of acid-fast positive granulomas (Appendix Table 1). differed between 
experimental groups and sexes (Figure 5-3A). There were no acid-fast positive granulomas in 
sham-injected groups. When comparing the prevalence of acid-fast positive granulomas between 
M. chelonae injected experimental groups, there was no significant difference between 
treatments when considering groups including both sexes. However, significant differences were 
observed when single-sex groups were compared. A significantly higher prevalence was 
observed for males in the 14-d clarithromycin treated group compared to both the 30-d 
tigecycline and 30-d clarithromycin treated groups (p=0.04634) (Figure 5-3A). Males had a 
significantly lower acid-fast granuloma prevalence compared to females for the 14-d tigecycline 
treated group (p=0.004577) as well as 30-d clarithromycin treated group (p=0.06413) (Figure 5-
3A).  
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Treatment Efficacy - AF Granuloma Intensity 
 For individual fish with acid-fast positive granulomas, the intensity of acid-fast positive 
granulomas was determined and varied between experimental groups and sexes (Figure 5-3B). 
When intensity was compared between experimental groups there was significant difference 
(p<0.1) between groups [F(5)=3.631, p=0.0739], with the untreated groups having a significantly 
higher number of granulomas (*) (Figure 5-3B). 
 
Figure 5-4. Barplot displaying prevalence of acid fast positive bacilli (AFB) for both sexes 
(white bars), males only (grey bars), and females only (black bars) for both sham-injected and M.
chelonae–injected zebrafish treated with 14-d or 30-d tigecycline (1 g/g), clarithromycin (4 
g/g), or control feeds. A significantly higher prevalence is observed (*) for 14-d control females 
compared to 14-d tigecycline and clarithromycin treated females. Significantly higher AFB 
prevalence is also observed for 30-d control females compared to 30-d clarithromycin females 
(*). 
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Treatment Efficacy - AFB Prevalence 
 The prevalence of acid-fast bacilli (Supplemental Table 1). varied between experimental 
groups and sexes (Figure 5-4). The prevalence of internally-located acid-fast bacilli was also 
compared between experimental groups. For females, there was a significant difference in the 
prevalence of AFB (p=0.0536). Tigecycline and clarithromycin treated groups for 14-d, resulted 
in significantly lower prevalence compared to the 14-d untreated group (*). AFB in the 14-d 
clarithromycin treated group was also significantly lower than 30-d untreated females (+) (Figure 
5-4).  
 
Figure 5-5. Representative images of acid fast stained granulomas with acid fast positive bacilli 
(enclosed in dashed line trace) for (A) 14-d clarithromycin treatment located in the ovaries, (B) 
30-d clarithromycin treatment located ventral to the liver in a male fish , (C) 14-d tigecycline 
treatment located in the ovaries, and (D) 30-d control treatment located in the ovaries. 
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Treatment Efficacy - Granuloma Descriptive 
 Through visual observations of acid-fast positive granulomas there was a general trend in 
the amount of AFB located within positive granulomas of untreated and treated groups. This is 
most clear in representative images of AFB positive granulomas from tigecycline, clarithromycin 
and untreated fish (Figure 5-5). Untreated M. chelonae injected fish had granulomas containing 
visually more acid-fast bacilli relative to tigecycline and clarithromycin treated fish.  
5.5 Discussion 
Treatment Tolerance 
 In the tolerance study there were no differences in behavioral observations, morbidity or 
mortality between zebrafish experimental groups. This suggests that the tigecycline and 
clarithromycin treatments were tolerated well by the zebrafish and that there is potential for 
higher dosages to be further considered. To our knowledge there are no previous reports of 
treatment of zebrafish with these two particular drugs; however, fish have been treated with 
antibiotics for mycobacterial infections at much higher dosages than those used in this study 
(Bernut, Le Moigne, Lesne, Lutfalla, Herrmann & Kremer 2014; Strike et al. 2016). The dosages 
we used were in the ranges used for the treatment of human mycobacterial infections 
(Muralidharan et al. 2005; Kim et al. 2011) which suggests this might be safe for other 
vertebrates.  It should be noted that these dosages were targeted and may not equal the exact 
amount of antibiotic available to the fish as oral delivery is subject to loss of drug during 
digestion (discussed in Chang et al., 2015). There were no observed detrimental effects on 
zebrafish growth as there was no significant difference in growth post-treatment or 11 weeks 
post-treatment that differed significantly from untreated groups. Regarding effects on fecundity, 
there was no breeding cessation; however, treatment with tigecycline did significantly increase
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average embryo count and increase 24-hour percent morality compared to other treatment 
groups. Altogether, all experimental groups were able to reproduce following treatment allowing 
for the potential for treated fish population to be re-derived from embryos in the case of an 
outbreak in a zebrafish facility. Although this difference did not result in severely low embryo 
counts or percent mortality, impacts of tigecycline treatment on fecundity may be more severe 
over a longer treatment period or higher dosage. 
Treatment Efficacy 
 Observation of H&E stained fish revealed that granulomas were predominately located 
within the reproductive tissues and the swim bladder which is consistent with observations from 
other studies using the intraperitoneal injection mode of infection (Watral et al. 2007). 
 The highest prevalence of granulomas was observed in untreated M. chelonae–injected 
groups followed by M. chelonae-injected fish treated with clarithromycin, M. chelonae-injected 
fish treated with tigecycline, and lastly sham injected fish. No difference between experimental 
groups was observed when sexes were pooled; however, when groups of single sex were 
analysed separately a significant difference is observed between sexes for the 14-d tigecycline 
treatment. This finding indicated that further analyses should look at differences between sexes. 
Further analyses using acid fast staining techniques to identify AFB in granulomas was 
necessary in order to differentiate naturally occurring granulomas [e.g. in the case of egg 
degeneration (Kent et al., 2004)].  
 The locations of acid fast positive granulomas were similar to that observed for the H&E 
stained granulomas. None of the sham injected fish were observed to have any acid fast positive 
granulomas, which was expected as these fish were not exposed to M. chelonae. Generally the 
prevalence of acid fast positive granulomas was lower than H&E identified granulomas with the 
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exception of two female fish where acid fast staining allowed for the detection of a positive 
granuloma in the ovaries where previous H&E stained fish could not be differentiated from the 
appearance of a degenerating egg. This difference provides further support of using acid fast 
staining to correctly diagnose a mycobacterial infection (Noga, 2010). When groups of pooled 
sexes were analysed there was no significant differences between experimental groups. Further 
analyses of single sex groups indicate that for males, 14-d clarithromycin treatment resulted in a 
higher prevalence of acid fast positive granulomas than 14-d tigecycline, 30-d tigecycline or 30-d 
clarithromycin treatments. Treatments with either 14-d tigecycline or 30-d clarithromycin were 
less effective for female fish compared to males as females in these groups had a higher 
prevalence of acid fast positive granulomas for these treatments.  
 Importantly, we also evaluated the intensity of acid fast positive granulomas in order to 
better understand the severity of infections following different antibiotic treatments. There was a 
significant difference in acid fast positive granuloma intensity between the different 
experimental groups with the untreated groups having the highest intensity, followed by the 14-d 
clarithromycin treated group, then the 30-d tigecycline treated group, then the 30-d 
clarithromycin treated group, and the lowest intensity was observed for the 14-d tigecycline 
treated group. This trend is also observed for females. Males had a similar trend as well, however 
the 14- and 30-d tigecycline and the 30-d clarithromycin treated groups shared an intensity of 
zero. Increased infection severity in untreated fish compared to tigecycline and clarithromycin 
treated fish was also observed visually in the amount of AFB seen within granulomas. It appears 
as though the antibiotic treatments help to reduce the amount of observed acid fast bacteria 
present within granulomas; however, there are still some remaining bacilli that have not been 
eradicated. Thus, while tigecycline and clarithromycin treatments may not have resulted in a 
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reduction in the prevalence of acid fast positive granulomas, these treatments were effective at 
decreasing infection severity.  
Conclusions and Recommendations 
 This study used a conservative dosage of tigecycline and clarithromycin based on in vitro 
minimum inhibitory concentration (MIC) values for the strain of M. chelonae used in this study 
and commonly found in zebrafish. Because there were only minimal effects on fecundity and no 
morbidity or mortality, alternative doses are likely to be tolerated by zebrafish. Also, because a 
complete eradication of AFB and granulomas was not observed following treatment, higher 
dosages and/or longer treatment durations should be investigated to determine if the effect on 
infection correlates positively with these factors. If a higher dose or longer treatment duration is 
observed to be effective eliminating the infection, additional effects on growth and fecundity 
should be examined as we did observe some effect on embryo count and 24-hour mortality 
following treatment with tigecycline. Further differentiation of these two treatments 
effectiveness could then be evaluated following these additional studies. Additionally, evaluation 
of a combined tigecycline/clarithromycin treatment should be examined. Future studies should 
also investigate the effect of these treatments on zebrafish infected with more severe M. marinum 
or M. haemophilum infections in order to evaluate if these treatments are effective at decreasing 
the severity of these infections. 
 We found that tigecycline and clarithromycin treatments of 14- and 30-d are effective at 
decreasing the severity of infections but not eliminating infections. Generally, we do not 
advocate for treatment of whole colonies of zebrafish, and treatment should only be reserved for 
preserving valuable fish lines. As latency and reinfection could occur, treated fish should be used 
to re-derive valuable lines using surface disinfected embryos (Whipps et al., 2012). We 
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recommend treated fish not be placed back on a main system as they may still be an infection 
risk factor for other fish. Also, treatment alone in order to control an outbreak is not enough, 
system disinfection is also required or else reinfection can occur from mycobacteria in surface 
biofilms (Whipps et al. 2012). Disease prevention and detection should still be primary 
mechanisms for controlling mycobacteriosis in zebrafish populations. 
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6.1 Abstract
The zebrafish (Danio rerio) is a popular aquatic animal model used in many research 
fields. Zebrafish health is a primary research concern because it is prudent to conduct research on 
disease-free fish or fish with known disease status. Mycobacteriosis is a common bacterial 
disease in wild and captive fishes, including zebrafish. Despite its prevalence, the dynamics of 
transmission and potential sources of mycobacterial infections in zebrafish are only partially 
understood. One suspected natural infection source are surface biofilms on tanks and other 
system components. This study investigates the role that tank biofilms play in mycobacteriosis in 
laboratory zebrafish by evaluating the establishment of biofilms from bacteria shed from fish, 
and conversely the acquisition of infections in fish from surface biofilms. We found that 
zebrafish infected with Mycobacterium chelonae shed bacteria through feces and bacteria are 
transmitted to tank biofilms from one to 16 weeks post-infection. We also found that zebrafish 
acquire M. chelonae infections as soon as 2 weeks when introduced to tanks with establish M. 
chelonae biofilms. The results from this study highlight the role that tank biofilms play as both a 
reservoir and source of mycobacterial infections in zebrafish. Results support the inclusion of 
biofilm surveillance and prevention as part of a disease control program in zebrafish research 
facilities. 
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6.2 Introduction
The zebrafish (Danio rerio) is a popular aquatic model organism that has been 
recognized as a “rising star” among aquatic animal models of human disease (Gaind 2016). With 
increased popularity and investment from the research community, increased value is placed on 
the maintenance of health stocks of both mutant and wild-type lines. The health of laboratory 
zebrafish is a primary concern, as it is prudent to maintain and conduct research on healthy 
organisms. Ideally, research would be conducted on animals free of background infections, and if 
this is not possible, the disease status of the research subjects should be reported. The impacts of 
such infections is sometimes obvious when resulting in mortality or declines in reproductive 
fitness, but equally concerning are subclinical infections that can be a source of uncontrolled 
experimental variance (Kent 2012). Due to these concerns, measures to prevent and monitor
disease in laboratory zebrafish should be taken.
One common infection in laboratory zebrafish is mycobacteriosis. Mycobacteriosis 
affects approximately 40% of zebrafish facilities submitting cases to the Zebrafish International 
Resource Center’s (ZIRC) Diagnostic Services (Zebrafish International Resource Center (ZIRC) 
Health Services 2017). There is no single etiological agent of mycobacteriosis, as it is caused by 
several species and strains of Mycobacterium (Astrofsky, Schrenzel et al. 2000, Kent, Whipps et 
al. 2004, Whipps, Matthews et al. 2008). The severity of mycobacterial infections in zebrafish is 
variable and species specific, ranging from high mortality with Mycobacterium marinum and 
Mycobacterium haemophilum to few or no mortality with Mycobacterium abscesses and 
Mycobacterium chelonae (Watral and Kent 2007, Whipps, Butler et al. 2007, Whipps, Dougan et 
al. 2007, Whipps 2012). Similarly, morbidity is also variable and includes non-pathognomic 
signs including: skin lesions, emaciation, raised scales, swollen abdomen, and behavior that is 
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irregular or lethargic (Astrofsky, Schrenzel et al. 2000, Kent 2012). Internal signs include 
granulomas, particularly on hematopoietic organs (Astrofsky, Schrenzel et al. 2000, Kent, 
Whipps et al. 2004). Subclinical infections lack any observable signs and may go unnoticed
(Kent, Whipps et al. 2004, Whipps 2012).
Control and management measures for mycobacteriosis in zebrafish facilities highlight 
the importance of prevention, as established infections are difficult to eliminate (Whipps 2012, 
Mason, Snell et al. 2016). Current preventative measures include quarantine of imported fish and 
those that appear morbid, disinfection of embryos and fomites, ultraviolet sterilization of water, 
and sentinel programs (Kent, Feist et al. 2009, Whipps 2012). While these measures have, and 
continue, to effectively prevent the establishment of mycobacterial infections in zebrafish 
facilities more insight is needed into additional factors contributing this disease. One factor that 
has been speculated to be involved in the mycobacterial disease cycle in zebrafish facilities is 
surface biofilms. 
Non-tuberculosis mycobacteria (NTM) normally inhabit a variety of habitats that are 
shared with both humans and animals including water distribution systems (Falkinham, Norton 
et al. 2001). Piscine mycobacteria species are able to persist in surface biofilms that form in 
aquaria (Beran, Matlova et al. 2006, Whipps, Matthews et al. 2008). The hydrophobic and 
oligotrophic characters of mycobacteria allow for survival in environments with low levels of 
dissolved carbon while readily adhering to surfaces (Falkinham, Norton et al. 2001, Falkinham 
2009). Thus, mycobacteria are well adapted to survive in “clean” water systems such as aquaria 
(Whipps 2012). Many different species of mycobacteria can be found in biofilms (Schulze-
Robbecke, Janning et al. 1992), with several species isolated specifically from aquaria (Beran, 
Matlova et al. 2006, Whipps, Dougan et al. 2007, Whipps 2012). In zebrafish facilities, there 
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have been reports of detection of the same species of mycobacteria in both biofilms and fish, but 
many more species are only found in the biofilms (Whipps, Dougan et al. 2007, Whipps, 
Matthews et al. 2008). In addition to bacterial communities within aquatic biofilms, protozoans 
are an important component of biofilms (Arndt, Schmidt-Denter et al. 2003). Protozoans rapidly 
colonize aquatic biofilms, occurring in high abundances (Arndt, Schmidt-Denter et al. 2003).
These biofilm-dwelling protozoans may support bacterial survival and virulence as the 
protozoan/bacteria interaction allows for survival, replication, and distribution of pathogenic 
bacteria (Barker and Brown 1994).
Genetic comparisons between Mycobacterium isolates identify identical strains in both 
fish and biofilms of M. chelonae in zebrafish (Whipps, Matthews et al. 2008) and M. marinum in 
pompano Trachinotus carolinus (Yanong, Pouder et al. 2010). These results demonstrate a link 
between fish and biofilms, but not the direction of transmission; i.e., whether the fish are the 
source for biofilms, biofilms the source for the fish, or that both are possible. 
Biofilms can be found on all surfaces in the aquatic environment, and it is thought that these 
biofilms and detritus at the bottom of tanks are the source of mycobacterial infections in 
zebrafish (Whipps, Lieggi et al. 2012). In a study where zebrafish found in the sump tank were 
examined, they were found to be infected with mycobacteria (Whipps, Lieggi et al. 2012). The 
only source of food for these fish was the surface biofilms and tank detritus. This is consistent 
with what is known about the feeding habits of zebrafish, as they feed in the water column and 
on tank surfaces and substrates (Spence, Gerlach et al. 2008) as generalist consumers (Lawrence 
2007). Sentinel zebrafish residing in system sumps have also been observed to hunt for benthic 
organism and slow zooplankton along the biofilm scaffold (Whipps, Lieggi et al. 2012). Larvae 
(8-10 mm SL) are very active as hunters and grazers, which may result in the incidental 
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consumption of mycobacteria (Whipps 2012). A previous study found that zebrafish in larger 
tanks had a higher prevalence of M. chelonae infections compared to fish in smaller tanks 
(Murray, Bauer et al. 2011). This difference in prevalence was attributed to the different tank 
cleaning methods used for removing biofilms for the two tank sizes. The zebrafish in the larger 
tanks remained in the tanks during cleaning compared to zebrafish in the smaller tanks, which 
were swapped into new tanks before tanks were cleaned. The fish in the larger tanks were likely 
feeding on the tank debris that were suspended in the water column during the cleaning while the 
fish in smaller tanks were not exposed to this. Additionally, the oral route of infection has been 
demonstrated as a natural mode of mycobacterial transmission in zebrafish (Harriff, Bermudez et 
al. 2007). Conversely, support for biofilms as the sink for mycobacteria includes the natural 
shedding of bacteria from infected fish (Noga 2010, Whipps 2012) which contributes to biofilms. 
However, mycobacterial shedding and subsequent uptake into tank biofilms from zebrafish has 
not yet been studied. 
The goal of this current study is to investigate the route of transmission of mycobacteria 
between zebrafish and biofilms and elucidation of the role of biofilms as source or sink in these 
infections. We first investigate the transmission of mycobacteria from zebrafish with established 
M. chelonae infections (both through experimental IP injection infection and also experimental 
natural oral infection) to feces and tank biofilms over a 16 week period. We then investigate the 
transmission of M. chelonae GFP mutant from established tank biofilms to casper (nacre -/- roy 
-/-) zebrafish over a 16 week period using bi-weekly live fluorescent imaging of zebrafish. We 
hypothesize that biofilms play both roles and simultaneously are a source of infection at the same 
time as being a sink for mycobacteria shed from infected zebrafish. Results from this study will 
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contribute towards our understanding of zebrafish mycobacteriosis and contribute to disease 
control and management improving the overall health of laboratory zebrafish. 
6.3 Methods
Fish
All fish used in this study were bred and maintained in the zebrafish facility at the 
SUNY-ESF Center for Integrated Teaching and Research in Aquatic Science. Adult AB wild 
type zebrafish (n=144; 72 male and 72 female; age = 6 months) and casper (nacrew2/w2;roya9/a9)
zebrafish (n=30; 15 male and 15 female; age = 6 months) lines, originally obtained from the 
SARL at Oregon State University (Corvallis, OR) and bred for two generations at SUNY-ESF, 
were utilized in this study. Animals were housed at a density of 6-10 fish/liter in 1.8 L tanks on a 
timed, flow-through housing system (Aquaneering, San Diego, CA). The housing system 
included ultraviolet disinfection of dechlorinated (carbon filter) municipal tap water as the 
source, which was maintained at pH 7.6,  conductivity of 600-700 us/cm2,  a temperature of 
28.5°C, and ammonia levels ranging from 0-0.25 ppm. The zebrafish facility maintained a 14:10 
light:dark photoperiod. Fish were fed a commercial feed for zebrafish (Gemma, Skretting) twice 
daily on weekdays and once daily on weekends during periods where they were not being fed a 
treatment gelatin feed. Prior to the experiment, routine cleaning of all equipment (e.g. tanks, lids, 
baffles, nets, and tubing) consisted of bi-weekly washing and scrubbing in warm water with a 
new soft sponge and bleaching in 1000 ppm chlorine bleach for 30 minutes, followed by rinsing 
three times in dechlorinated water and drying. All tanks, lids, and baffles were also autoclaved 
using a program specified by the tank manufacturer that reaches a temperature of 105-110°C for 
15 minutes. During experiments this tank cleaning procedure occurred when the placement of 
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fish in a new tank is mentioned in the methods below. All animal work was approved by the 
SUNY-ESF Institutional Animal Care and Use Committee, protocol #151001.
Transmission to Biofilms
Experimental Infections
Prior to the set-up of experimental groups, mycobacterial infections or sham injections 
were established in the fish.
IP Injection: Mycobacterium chelonae injected wild type zebrafish (N=36 fish) were 
injected intraperitonally (IP) with 5.0 x 104 cfu/fish of Mycobacterium chelonae (H1E2) mutant 
expressing green fluorescence protein (GFP) provided by M.L. Kent, and sham injected fish 
(N=36) injected with sterile saline, following the method described in Watral et al. (2007). The 
concentration of the bacterial inoculum was determined using a nephelometer (Sensititre) and 
confirmed with colony counts following culture on Middlebrook 7H10 agar plates. After IP 
injection, fish from each injection type (M. chelonae or sham) were randomly divided equally 
into three new tanks (12 fish/tank) and maintained on the flow-through system for 1 week prior 
to the beginning of the experimental sampling. During this week period fish were fed a 
commercial feed (Gemma, Skretting) twice daily on weekdays and once daily on weekends. 
Oral Ingestion Infection: Mycobacterium chelonae ingestion wild type zebrafish (N=36) 
were experimentally infected through the ingestion of a gelatin feed containing Mycobacterium 
chelonae (H1E2) mutant expressing green fluoresce protein (GFP) through five consecutive 
daily feeds containing 1.0x104 cfu/feed/fish to reach a total ingestion of 5.0x104 cfu/fish. Gelatin 
feed (Gelly Belly, Florida Aqua Farms) was prepared as described in a previous study (Sciarra, 
Tyler et al. 2014). Once gelatin feed was set overnight at 4°C, a flame-sterilized metal spreader 
was used to spread a known concentration of M. chelonae culture diluted in sterile water to make 
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a final volume of 1 ml. The inoculated gelatin plate was then dried for approximately 24h at 
28.5°C in an incubator. Following this a flame sterilized razor blade was used to mince the 
gelatin and aliquots for each treatment tank were measured out by mass and stored at -20 °C until 
feeding. At feeding, aliquots were emptied into treatment tanks. Sham ingestion wild type 
zebrafish (N=36) were fed a gelatin feed containing sterile saline for five consecutive daily 
feeds. After ingestion infection, fish from each ingestion type (M. chelonae or sham) were 
randomly divided equally into three new tanks (12 fish/tank) and maintained on the flow-through 
system for 1 week prior to the beginning of the experimental sampling. During this week period 
fish were fed a commercial feed (Gemma, Skretting) twice daily on weekdays and once daily on 
weekends. Tanks were siphoned daily following feeding during this period.
Sample Collection and Processing
Sample collection started on the second week post-infection. Sampling was repeated 
weekly for 16-weeks total. For each sampling event, zebrafish from each treatment tank were 
transferred to a new tank and incubated overnight in the new tank on the bench top (static water). 
The old tank was also kept on the bench top. Following overnight incubation, a biofilm swab 
sample was taken for each old tank as previously described (Whipps, Dougan et al. 2007) and 
stored in 1% cetyl pyridinium chloride (CPC) (Kent and Kubica, 1985) in a sterile 2.0 ml 
screwcap tube. Collection of feces/detritus from the overnight incubation tank was also collected 
using a sterile disposable pipette and stored in 1% (CPC) in a sterile 2.0 ml screwcap tube. 
Biofilm and fecal samples were stored in the 1% CPC tubes for 2 hours at room temperature 
prior to sample processing. Following sample collection, fish were returned to their old tank and 
placed back on the zebrafish system racks unless otherwise noted below. 
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Processing of the biofilm swab samples consisted of swab samples stored in 2.0 ml screw 
cap tubes containing 200 μl 1% CPC being vortexed vigorously for 10 seconds. Next, flame-
sterilized forceps were used to remove the swab, which was disposed of in 95% EtOH. To the 
remaining solution in the screw cap tube, 900 μl of autoclaved dH2O was added, followed by 
vortexing. The vortexed tubes were then centrifuged for 10 minutes at 8000 x g in order to form 
a pellet. The supernatant was removed from the screw cap tubes, and 100 μl of autoclaved dH2O
was added, followed by vortexing. Next, 10 μl of this solution was streaked onto a Middlebrook 
(MC) 7H10 agar plate, which was sealed with Parafilm and incubated at 28°C for 5-7 days. 
Following incubation, resulting colonies were observed under fluorescence in order to identify 
those colonies expressing GFP. The number of tank biofilm swabs resulting in the growth of 
GFP positive colonies was recorded. In the case that two or more out of three replicate tanks for 
each treatment were recorded as positive, then fish incubated overnight for sample collection 
were placed back on system racks in the new tank instead of returning to their old tank so that 
future observation of transmission of bacteria to tank biofilms could be detected.
Processing of the fecal/detritus samples consisted of fecal samples stored in 1.5 ml tubes 
containing 200 μl 1% CPC being homogenized using a sterile plastic tissue pestle. Next, 900 μl
of autoclaved dH2O was added, followed by vortexing. The vortexed tubes were pelleted and 
subsequently cultured on MB agar plates as the biofilm samples were described previously. The 
number of tank fecal samples resulting in the growth of GFP positive colonies was recorded. 
End Analyses
After the 16th week of sampling all fish were euthanized by submersion in 0.3 g/L MS222 
buffered to a pH of 7.5 for a minimum of 10 minutes following the loss of opercular movement.
Once euthanized, fish were dissected to create an approximately 5 mm by 5 mm window on the 
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lateral side of so that internal organs could be observed under FITC fluorescence for signs of 
GFP expression. Images were taken when GFP expression was observed. Liver and spleen 
samples were also taken and stored for 1 hour in 1% CPC followed by the same homogenization, 
pellet, and culture procedure described above. Following imaging, euthanized fish were fixed in 
Davidson’s solution for 48h and then dehydrated to 70% EtOH for histology. Each fish was 
sectioned and stained with hematoxylin and eosin (H&E) and Kinyoun’s acid fast stain.  
Following staining, slides were examined for granulomas in H&E sections. For acid fast-stained 
sections, the presence of granulomas containing acid fast bacilli (AFB) was recorded. The 
location of granulomas containing AFB was recorded, and the location of AFB not contained in 
granulomas was also recorded. AFB not within granulomas were considered to be internally 
located if they were located inside the epithelial boundary (e.g. not in the gut lumen or on the 
outside of the skin/scales). The prevalence of granulomas, granulomas containing AFB, and free 
AFB was calculated. 
Statistics 
There was detection of bacteria in sham infection fish (both IP injection and oral feed) 
and these groups were excluded from further analyses and figures. For each set of three replicate 
tanks for each infection type (M. chelonae IP injection, M. chelonae gelatin feed), a Chi-squared 
analysis with a Monte Carlo simulation method using 20,000 replications was used to compare 
replicate tanks in order to determine whether data from replicate tanks can be pooled for further
comparisons. No significant differences between replicate groups were identified, and replicate 
data for each infection type group was pooled. Fisher’s exact test for count data was used to 
compare prevalence between infection types using the “stats” package (R Core Team 2013).
Comparisons of prevalence were made between diagnostic methods (in vivo GFP expression, 
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liver/spleen culture, and histology) as well as between sexes. The results were organized into bar 
plots using the “sciplot” package (Morales, with code developed by the R Development Core 
Team et al. 2012).
Transmission from Biofilms
Experimental Biofilm Set-Up
An experimental biofilm was created in three 1.8L tanks (Aquaneering). Cleaned and 
autoclaved tanks were filled with zebrafish system water and inoculated with Mycobacterium 
chelonae (H1E2) mutant expressing green fluoresce protein (GFP) that was diluted to 2.7 x 108
cfu/ml verified by a nephelometer (Sensititre). Following dilution, 3 ml of the diluted bacteria 
was inoculated into each tank and tank water was stirred using a sterile 25 ml graduated pipette. 
Tanks were incubated on the benchtop for 4 weeks at room temperature and topped off with 
zebrafish system water to maintain the water level. Each week, a biofilm swab was taken and 
processed as previously described. Following two consecutive weeks of isolation of GFP 
colonies from all three tanks, the tanks were emptied, rinsed, filled with fresh zebrafish system 
water, and placed on the flow-through zebrafish system. Tanks were then checked weekly to 
confirm the isolation of GFP colonies from the biofilm of all three tanks throughout the 
experiment.
Tagging Zebrafish with Individual Markers
Adult AB casper (nacrew2/w2;roya9/a9) zebrafish (n=30; 15 male and 15 female; age = 6 
months) were individually tagged so that fish could be individually tracked over the course of the 
study. Each of the three tanks received ten casper zebrafish (5 male, 5 female) with the following 
tag designations: male, no tag; male, right-side pink tag; male, right-side orange tag; male, left-
side pink tag; male, left-side orange tag; female, no tag; female, right-side pink tag; female, 
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right-side orange tag; female, left-side pink tag; female, left-side orange tag. Prior to tagging, 
fish were anaesthetized in 0.15 g/ml MS222 buffered to a pH of 7.5. Following anaesthesia, fish 
were placed in an autoclaved sponge soaked in the 0.15 g/L MS222 with a slit cut into middle of 
the sponge to stabilize the fish with its dorsal side exposed. For tagging, a manual injection kit 
for visible implant elastomer (VIE) tags was used (Northwest Marine technology, Inc., Shaw 
Island, WA, USA, http://www.nmt.us). Elastomer was prepared according to the manufacturer 
instructions (Northwest Marine Technology, Inc., 2011, ‘Manual elastomer injection systems. 
Instructions for 10:1 visible implant elastomer’, http://www.nmt.us/products/
vie/manual_vie_instructions.pdf). Tags were injected following the procedure described by 
(Hohn and Petrie-Hanson 2013) with the syringe needle inserted 2 mm further than the desired 
tag location, followed by elastomer expression and needle retraction until approximately 1 mm 
before the injection site. Tags were placed below the dorsal fin base, as (Hohn and Petrie-Hanson 
2013) found this site to be optimal for tag retention and visibility. Following tag insertion, fish 
were put into a recovery tank filled with zebrafish water. Following recovery, fish were placed in 
system tanks and observed for tag retention and tag-related morbidity for two weeks prior to 
placement in biofilm tanks.
Bi-Weekly Live-Imaging
Live-imaging occurred immediately prior to placing fish in the biofilm tanks, and bi-
weekly thereafter. For live-imaging, fish were anaesthetized in 0.15 g/L MS222. Following 
anaesthetization, tag location and color were noted and fish were imaged under FITC 
fluorescence in order to detect GFP expression. If GFP expression was detected, an image was 
taken and the location of the GFP expression was noted. Following imaging, fish were placed in 
a recovery tank containing fresh zebrafish system water. Once, recovered, fish were placed back 
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in their respective biofilm treatment tank. In the case that a fish appeared moribund, it was 
euthanized in 0.3 g/L MS222 and fixed and stored as previously described. 
End Analyses
After the 16th week of sampling all fish were euthanized as above. Once euthanized, four 
representative fish from each tank (2 male, 2 female) were dissected to create an approximately 5 
mm by 5 mm window on the lateral side of so that internal organs could be observed under 
fluorescence for signs of GFP expression. Images were taken when GFP expression was 
observed. Liver and spleen samples were also taken and stored in 200 μl sterile dH2O followed 
by the same homogenization, pellet, and culture procedure described above. DNA extraction 
from the liver/spleen homogenate was performed using the MO BIO Laboratories, Inc. 
UltraClean® Microbial DNA Isolation Kit following manufacturer protocol. Next, a M.
chelonae-specific PCR as in (Meritet, Mulrooney et al. 2017) was performed followed by gel 
electrophoresis on a 1% agarose gel. All euthanized fish were fixed in Davidson’s solution for 
48h and then transferred to 70% EtOH for storage.
Statistics
A Chi-squared analysis with a Monte Carlo simulation method using 20,000 replications 
was used to compare replicate tanks in order to determine whether prevalence data from these 
tanks could be pooled for further comparisons. There was no significant difference between 
replicate groups and prevalence data was pooled. Fisher’s exact test for count data was used to 
compare prevalence between infection types using the “stats” package (R Core Team 2013).
Comparisons of prevalence were made between diagnostic methods (in vivo GFP expression, in 
vivo GFP expression with dissection, liver/spleen culture, and liver/spleen PCR) as well as 
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between sexes. The results were organized into bar plots using the “sciplot” package (Morales, 
with code developed by the R Development Core Team et al. 2012).
6.4 Results
Transmission to Biofilms
The detection of GFP positive colonies in tanks over time shows variable detection in 
feces and biofilm samples over time between IP injected and oral feed infection modes (Table 6-
1). Detection for the feces and biofilm samples for all M. chelonae IP injection replicate tanks 
occurred as soon as the first week of sampling (Table 6-1) and continued to be consistently 
detected for the first 9 weeks of sampling in both the feces and biofilm with the exception of 
week 5. By week 10, detection of GFP positive colonies became more intermittent; however,
persisted through the 16 weeks of sampling. For fish infected with M. chelonae through oral 
feed, detection in colonies only occurred in the biofilm of one M. chelonae oral feed infection 
tank for week one. By week three GFP colonies started to be detected intermittently in two or 
more of the three replicate tanks for the oral feed infection fish. GFP colonies were detected in 
feces in two or more tanks starting in week two and were detected intermittently through week 
16. GFP colonies were not detected in any sham infection tanks with the exception of weeks 7 
and 8 where colonies were detected in biofilm samples for  oral feed sham infection tanks, for 
one and two weeks respectively.
We were able to use three different methods in order to evaluate prevalence of M. 
chelonae infections: in vivo GFP screening (Figure 6-2A and D), culture of liver and spleen 
samples, and histology (Figure 6-2G-I). There was no detection of bacteria in sham infection 
fish.
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When comparing the prevalence of M. chelonae infections between the two modes of 
infection (IP injection vs. oral feed), differences depended on the diagnostic method used (Figure 
6-1, plus sign). Prevalence determination through dissection and in vivo GFP screening (grey 
bars) resulted in no difference between the two different modes of infection when comparing 
groups of both sexes, only males, and only females (p=0.57). When using culture of liver and 
spleen samples in order to isolate GFP colonies (black bars), IP injected groups of both sexes and 
males had a significantly higher prevalence compared to oral feed infected groups of both sexes 
and males (p=8.15 x 10-3). Histology (white bars) resulted in a significantly higher prevalence in 
all IP injected compared to all oral feed infected groups (p<2.2 x 10-16).
When comparing the prevalence based on each method within group of the same 
infection mode and sex (Figure 6-1, asterisk), liver culture resulted in a significantly lower 
prevalence compared to histology and in vivo GFP screening for IP injection infected groups of 
both sexes (p=6.02 x 10-8), males (p=8.46 x 10-4), and females (p=5.94 x 10-5). For oral feed
infection, in vivo GFP screening resulted in significantly higher prevalences for groups of all
sexes (p=3.39 x 10-14), males (p=2.57 x 10-9), and females (p=2.57 x 10-9). 
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Figure 6-1. Prevalence of M. chelonae infections for the two modes of infection [oral Gelly 
Belly (GB) infection vs. IP injection infection]. Different diagnostic methods include histology 
(white bars), in vivo GFP screening (grey bars, and liver/spleen culture (black bars).Statistically 
significant differences between diagnostic methods used are indicated (+), as well as those 
between sexes are also indicated (*)
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Figure 6-2. Examples of the different diagnostic methods used in this study. Comparative 
brightfield and FITC screening were used to identify areas of GFP expression (compare A, D, G
to B, E, H). For the transmission from fish to biofilms study histology was also used to identify 
acid-fast bacteria in granulomas (encircled in C, F, I). SB=swim bladder. 
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Transmission to Fish
The VIE tags were retained for the entirety of the study and we were able to differentiate 
individual fish from each tank. We also were able to observe GFP expression in vivo through the 
skin/scales of the casper mutant fish (Figure 6-2B and C, 6-2E and F). The number of fish with 
detectable GFP expression increased over the 16 weeks of this study (Table 6-2). When the fish 
were first placed in the biofilm tanks, no in vivo GFP expression was observed. Beginning on 
week 2, GFP expression was observed in one female fish in Tank 2. At week 6, GFP expression 
was observed in two female fish in both Tank 2 and Tank 3. The number of fish with GFP 
expression gradually increased at each sampling time-point, with a higher proportion of females 
expressing GFP (observed in the ovaries). By the last sampling time point the tank prevalence of 
GFP expression ranged from 60-100%. Through the dissection of a subset of fish from each tank, 
additional GFP expression was detected increasing the prevalence (Table 6-2, X) in Tank 2 and 3 
to 70%. 
Similar to the previous results for the transmission to biofilm, the prevalence of M. 
chelonae infections depended on the method used (Figure 6-3, plus sign). In vivo GFP expression 
and in vivo GFP expression post-mortem after subset dissection resulted in a significantly higher 
prevalence compared to liver and spleen culture or PCR for both sexes (p=1.48 x 10-4), females
only (p=6.90 x 10-4). There was no difference in prevalence values for males between diagnostic 
methods (p=0.19). There was also no significant difference (p>0.05) between in prevalence 
between groups when considering each diagnostic method.
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TABLE 6-2. Transmission of Mycobacterium chelonae to zebrafish from tank biofilms over a 
period of 16 weeks based on detection of GFP expression in zebrafish during live-imaging. The 
presence (X) or absence (-) of GFP expression are indicated for each bi-weekly sampling event. 
The presence of GFP expression only observed following dissection is also indicated (X).
Week
Tank Number Sex 0 2 4 6 8 10 12 14 16
1 Fish 1 M - - - - - - - - X
Fish 2 M - - - - - - - X X
Fish 3 M - - - - - - - X X
Fish 4 M - - - - X X X X X
Fish 5 M - - - - - - - X X
Fish 6 F - - - - X X X X X
Fish 7 F - - - - X X X X X
Fish 8 F - - - - - - X X X
Fish 9 F - - - - X X X X X
Fish 10 F - - - - X X X X X
2 Fish 1 M - - - - - - - - X
Fish 2 M - - - - - - - - -
Fish 3 M - - - - - - - - -
Fish 4 M - - - - - - - - -
Fish 5 M - - - - - - - - X
Fish 6 F - - - - X X X X X
Fish 7 F - - - X X X X X X
Fish 8 F - - - - - X X X X
Fish 9 F - X X X X X X X X
Fish 10 F - - - - - X X X X
3 Fish 1 F* - - - - X X X X X
Fish 2 M - - - - - - - - -
Fish 3 M - - - - - - - - -
Fish 4 M - - - - - - - - X
Fish 5 M - - - - - - - - X
Fish 6 F - - - - X X X X X
Fish 7 F - - - - - X X X X
Fish 8 F - - - - - - - - -
Fish 9 F - - - X X X X X X
Fish 10 F - - - X X X X X X
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Figure 6-3. Prevalence of M. chelonae infections following incubation in M. chelonae biofilm 
tanks based on four diagnostic methods: in vivo GFP screening with and without subset 
dissection, subset liver/spleen culture, and subset liver/spleen PCR. Statistically significant 
differences between diagnostic methods used are indicated (+).
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6.5 Discussion
Measures to prevent and monitor mycobacteriosis in laboratory zebrafish should be taken 
in order to minimize or eliminate the impact the disease. In this study, transmission of M. 
chelonae between zebrafish and tank surface biofilms was demonstrated. Transmission from
infected zebrafish to biofilms occurred within one week post-infection for IP injected fish and for 
fish exposed orally. Observation of GFP M. chelonae in feces occurred in week 1 for IP injected 
fish, and by week 2 for orally infected fish. Detection of M. chelonae in feces and tank biofilms 
persisted through the end of the study period for both groups; however, as the study progressed,
detection became intermittent. This observation of initial consistent transmission of M. chelonae 
to tank biofilms and feces followed by more sporadic transmission is likely due to the amount of 
bacteria shed by fish during the phases of infection, with a greater amount of shedding following 
initial infection. There were also two weeks where GFP positive colonies were detected in sham 
oral infection tanks, which we believe to be due to contamination during sample processing as
mycobacteria were never detected in any other sham samples. We expect that the observations 
from the oral ingestion infection fish simulate what would naturally be observed in zebrafish 
colonies. It is likely that mycobacteria are shed for an extended period time as we observed 
shedding and transmission to tank biofilms up to the endpoint of this study (16 weeks). Many 
studies investigating zebrafish mycobacteriosis end at 8 weeks post-infection, and little is known 
about infections past these experimental endpoints. It is likely that some natural infections are 
eventually cleared while some shedding occurs (Harriff, Bermudez et al. 2007); although a 
stressful event could exasperate the situation and result in an outbreak.  
We also observed transmission of M. chelonae from tank biofilms to uninfected zebrafish 
demonstrating that biofilms can be a natural source of infection in zebrafish colonies. Although 
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we cannot entirely determine whether infection occurred through ingestion from zebrafish 
feeding on biofilms or through immersion in the case that planktonic mycobacteria detached
from biofilms, the originating source of M. chelonae in this study was a tank biofilm. This result 
is significant as biofilms are a common reservoir for Mycobacterium spp. in aquatic systems and 
form readily.
There is still a dearth of clear demonstrations of natural transmission routes of 
mycobacteria in laboratory zebrafish. Transmission through oral ingestion has historically been 
suspected as the major source of infection, as major outbreaks in hatchery salmon in the 1950s 
and 1960s were correlated with unpasteurized fish feed (Ross 1970, Belas, Faloon et al. 1995). In 
zebrafish, Harriff et al. (2007) demonstrated mycobacterial infections through ingestion 
highlighting the intestinal tract as a route of entry. Infection by oral ingestion has previously 
been shown to be more infective than by culture alone demonstrated to be a more infective 
source of infection compared to culture alone. Mosquito larvae infected with Mycobacterium
marinum were more infective to Japanese medaka (Oryzias latipes) compared to immersion 
challenge at a high dosage (Mutoji 2011). In zebrafish, ingestion of the ciliated protozoan 
Paramecium caudatum containing M. marinum and M. chelonae resulted in a higher prevalence 
of infection compared to ingestion of culture alone (Peterson, Ferguson et al. 2013). These 
results follow previous studies describing an increase in virulence in mycobacteria in tissues (e.g. 
granulomas) compared to culture (Volkman, Clay et al. 2004).Infection through immersion has 
also been demonstrated in zebrafish embryos (Davis, Clay et al. 2002). Biofilms as a source of 
infection in laboratory zebrafish has been suspected (Whipps 2012), but had not yet been 
experimentally addressed until this study. 
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The identification of tank biofilms as both a source and reservoir for M. chelonae in this 
study can inform prevention and control of mycobacteriosis in zebrafish colonies. In terms of 
prevention, biofilm sampling can be used for environmental monitoring in conjunction with 
testing animals as part of a disease surveillance program (Collymore, Crim et al. 2016); however 
the intermittent nature of bacterial shedding and detection in the biofilm should be considered 
when interpreting environmental sampling results. Additionally, regular tank cleaning and 
removal of biofilms from tanks and other equipment in zebrafish systems should be carried out 
to minimize potential sources of infection. Removal of biofilms within systems can be labor 
intensive as pieces of equipment need to be scrubbed and disinfected but has previously been 
successful in controlling established outbreaks (Whipps 2012). Also, adjustment to tank cleaning 
measures have previously been demonstrated to be effective for management asymptomatic M. 
chelonae infections in zebrafish stock (Murray, Bauer et al. 2011). These husbandry 
considerations include tank size, population density, and changes in biofilm cleaning methods 
(Murray, Bauer et al. 2011). As demonstrated our study, mycobacterial transmission between 
tank biofilms and zebrafish occur rapidly, emphasizing the need for zebrafish facilities to 
incorporate these adjustments in husbandry measures. The control of mycobacterial biofilms has 
already been identified as major challenge in the medical setting, as nosocomial infections due to 
mycobacterial biofilms have been identified to contaminate water systems and medical 
equipment reviewed in (Phillips and von Reyn 2001). Also, environmental monitoring including 
sampling of biofilms, feces, and detritus can be useful for surveillance of Mycobacterium spp. 
pathogenic to zebrafish (Collymore, Crim et al. 2016), as not all infections result in observable 
signs of disease (Watral and Kent 2007). Recently, real-time PCR analysis of environmental 
samples were found to be more sensitive than those of antemorem zebrafish samples for 
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detecting the presence of mycobacteria in zebrafish facilities (Crim, Lawrence et al. 2017). Sub-
clinical infections with Mycobacterium spp. such as M. chelonae can go unnoticed and be a 
potential source of non-protocol experimental variation. Biofilm monitoring can assist in 
detecting Mycobacterium spp. in systems before morbid fish are observed and allow for 
identification and control of potential risk factors. It is also important to note that several species 
of Mycobacterium are ubiquitous in water systems and have not been observed to be pathogenic 
to zebrafish.
In terms of observable morbidity, the fish in this study showed a range of signs of 
morbidity and different diagnostic methods allowed for a higher degree of detection of M. 
chelonae infections. First, there were no observed mortalities due to any of the experimental M. 
chelonae infections in this study. This result is not surprising as M. chelonae has previously been 
reported to result in more chronic, low-level infections showing few clinical signs of infection
(Watral and Kent 2007). In vivo screening for GFP expression resulted in no difference in 
prevalence between IP injected fish and orally infected fish; however, IP injected fish resulted in 
a higher prevalence detected through both liver/spleen culture and histology. This is likely due to 
IP infections being more severe, as this is not a natural mode of infection and allowing bacteria 
to surpass natural barriers (e.g., epithelium of the intestinal tract). The difference in prevalence 
between diagnostic methods follows with oral ingestion infection resulting in fewer detected 
infections in the liver sample or through the observed histological sections. Results from the fish 
infected from tank biofilms were similar, as in vivo screening resulted in the highest prevalence 
value compared to liver/spleen culture and PCR when looking at groups of both sexes or only 
females, this difference did not occur when only comparing males. This difference between 
males and females could be related to the ovaries as an important location of granuloma 
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formation. All the female fish infected through tank biofilms had granulomas observed in their 
ovaries, while males were observed to have GFP expression in their hematopoietic organs, which
would influence detection of bacteria in liver/spleen samples.
This study was the first usage of the in vivo GFP whole-fish screening used by our group. 
Differences in detection were observed between this new method compared to histological and 
liver/spleen culture and PCR methods already established for studies investigating mycobacterial 
infections in zebrafish. In terms of the sensitivity, the ability to correctly detect positives the in 
vivo GFP screening had a high sensitivity compared to histology. This method was much less 
specific than histology, because detection was higher in in vivo GFP screening fish than 
histology, and we have no secondary method of diagnostic validation. This could be attributed to 
additional potential sources of auto-fluorescence within the zebrafish (e.g. gall bladder and 
degenerating eggs) that may result in false positives, requiring further analyses of bacterial 
smears or culture. It is important to note that the evaluation of histological sections may not be 
optimal for detecting a true negative, as only select midline sections were observed and not the 
entire fish. Future comparison of this new in vivo GFP screening method for detecting 
mycobacterial infections should be carried out and compared with real-time qPCR detection 
values to gain a better understanding of the specificity of this method. Importantly, it should be 
emphasized that his method was useful for the purpose of demonstrating the transmission of M.
chelonae between tank biofilms and zebrafish, which was confirmed by all diagnostic methods 
(GFP observation, PCR, and histology).
In this study, we have demonstrated that M. chelonae can be shed in feces and 
transmitted to tank biofilms from infected zebrafish, and that zebrafish can naturally acquire M. 
chelonae infections from tank biofilms. Additionally, the demonstration of this mode of 
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mycobacterial transmission emphasizes other important disease control measures that reduce risk 
of biofilms forming in zebrafish facilities (e.g. quarantine and “eggs only” policies for fish from 
an outside facility, quarantine of moribund fish, regular tank cleaning). This transmission of M. 
chelonae between biofilms and zebrafish is also likely true to additional species of 
Mycobacterium as well as other fishes. This study has implications for the control and 
management of mycobacteriosis in laboratory zebrafish, as well as other fishes. 
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Investigating transmission of Mycobacterium spp. in laboratory zebrafish 
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7.1 Abstract
The zebrafish (Danio rerio) is a popular vertebrate model organism used in a wide range 
of research fields. Mycobacteriosis, caused by Mycobacterium species is particularly concerning 
because it is a common disease and is associated with chronic infections and zebrafish mortality
and introduces experimental variability which may impact research results. Food sources have 
been highlighted as a risk factor as live feeds for zebrafish are common and include paramecia 
(Paramecium caudatum), brine shrimp (Artemia franciscana), and rotifers (Branchionus spp.). 
Although nutritionally beneficial, live feeds pose a biosecurity risk. In this study we investigate
transmission of Mycobacterium chelonae and Mycobacterium marinum through consumption of 
live food vectors. We show that mycobacterial infections are transmitted through all three feed 
vectors. This observation emphasizes the need for live feed vectors to be considered as a 
source of biosecurity risk. This study is of importance to other beyond the zebrafish 
community, including those of additional aquatic models. 
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7.2 Introduction
Currently, mycobacteriosis are an important infectious disease in zebrafish research 
occurring in approximately 40% of facilities (Kent, Spitsbergen et al. 2012). Disease 
management recommendations highlight the importance of prevention, as eradication, although 
effective, is intensive and requires re-derivation of fish strains and complete facility disinfection
(Whipps, Lieggi et al. 2012) . Despite mycobacteriosis being commonly reported in zebrafish, 
much remains to be understood regarding the modes of transmission. 
The natural route of transmission of mycobacteria in zebrafish is thought to be
predominantly through ingestion. This is due to inference from transmission in salmonids, where 
outbreaks in the 1950s and 1960s were correlated to unpasteurized fish feed (Ross 1970, Belas, 
Faloon et al. 1995). Mutoji (2011) showed significantly increased infection of Mycobacterium 
marinum in Japanese medaka by infection through feeding mosquito larvae with M. marinum in 
the gastrointestinal tract than feeding cultured mycobacteria alone. Transmission through 
ingestion has been demonstrated in zebrafish and the intestinal tract was identified as a route of 
mycobacterial entry (Harriff, Bermudez et al. 2007). Ingestion as a source of natural 
mycobacterial transmission in zebrafish highlights feed as a potential risk factor. 
Live feeds for zebrafish are both common and recommended and include the ciliated 
protozoan Paramecium caudatum, brine shrimp Artemia fransicana as well as rotifers 
Branchionus spp. Despite nutritional benefits gained from the usage of these live feeds, live fish 
feeds have previously been shown to be risk factors for pathogen transmission. In aquaculture, 
brine shrimp and rotifers are common feeds for larval fish and crustaceans. However, bacteria 
present in these feeds have been shown to be transmitted to larvae and negatively affect survival 
and growth of fishes (Gatesoupe 1989). Artemia feeds have been shown to be contaminated with 
Mycobacterium spp. (Beran, Matlova et al. 2006), highlighting the risk to laboratory fish culture.
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Additionally when Mycobacterium spp. are transmitted through a live food vector 
experimentally, an increase in bacterial virulence has been observed. Mosquito larvae infected 
with Mycobacterium spp. were more infective to Japanese medaka (Oryzias latipes) than 
cultured mycobacteria (Mutoji 2011) and Mycobacterium spp. transmitted to zebrafish through 
the ciliated protozoan Paramecium caudatum resulted in a higher prevalence of infections than 
bacteria transmitted from culture plates alone (Peterson, Ferguson et al. 2013). Mycobacterium 
spp. infected Acanthamoeba castellanii were also more infective to zebrafish (Harriff, Bermudez 
et al. 2007) relative to control fed.
Free-living aquatic protozoans (e.g., Acanthamoeba and Dictyostelium) have evolved as 
phagocytic cells, actively preying on bacteria within the air water interface of biofilms (Barker 
and Brown 1994). These aquatic protozoans inhabit the same environmental niches as 
mycobacteria, and they digest mycobacteria in food vacuoles. However in some instances, 
mycobacteria persist. This mycobacterial persistence within free-living aquatic protozoan host 
has been examined in the amoebae host where an endosymbiotic relationship between the 
bacteria and the amoebae has been hypothesized (Winiecka-Krusnell and Linder 2001). More 
than 25 species of Mycobacterium shown to have some form of endosymbiotic relationship with 
free-living amoebae (Steinert, Birkness et al. 1998). Many bacterial traits co-evolved with 
amoebae in order to resist predation and digestion, including: bacterial encapsulation, toxin 
secretion, blockage of phagolysosomal fusion, intracellular replication within host (Cosson and 
Soldati 2008).
Amoebae are thought to act as surrogates for macrophages causing Mycobacterium spp.
to upregulate virulence genes in the intracellular environment (Harriff, Bermudez et al. 2007).
Similar mechanisms may be responsible for the increase in virulence observed in paramecium 
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and mosquito larvae (Mutoji 2011; Peterson, Ferguson et al. 2013). More work investigating the 
virulence of Mycobacterium spp. when transmitted through a live feed vector is required as live 
feeds used in zebrafish culture pose a risk factor for enhanced mycobacterial transmission.
The goal of this study is to investigate the virulence of Mycobacterium species that 
commonly infect laboratory zebrafish when they are transmitted through different live food 
vectors. First an experimental model for the transmission of Mycobacterium species to the 
zebrafish host through live feed vectors was developed, a more natural exposure route than the 
commonly used intraperitoneal (IP) injection or bath treatment. Next, this experimental model
was used to compare differences between the virulence of Mycobacterium chelonae (H1E2) and 
Mycobacterium marinum (OSU214) when transmitted to the zebrafish host through three 
different feed vectors: paramecia (Paramecium caudatum), brine shrimp (Artemia franciscana), 
rotifers (Branchionus plicatilis), and through ingestion without a vector. Insight from this study 
can be utilized by the zebrafish research community in order to make recommendations 
regarding pathogen risk factors associated with the usage of live feeds, directly impacting 
zebrafish health and welfare. 
7.3 Methods
Fish
The fish used for this study were bred and maintained in the zebrafish facility at the 
SUNY-ESF Center for Integrated Teaching and Research in Aquatic Science. Adult casper 
(nacrew2/w2;roya9/a9) zebrafish (n=396; 198 male and 198 female; age = 6 months) lines, 
originally obtained from the SARL at Oregon State University (Corvallis, OR) and bred for two 
generations at SUNY-ESF, were utilized in this study. Animals were housed at a density of 6-10
fish/liter in 1.8 L tanks on a timed, flow-through housing system (Aquaneering, San Diego, CA). 
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The housing system included ultraviolet disinfection of dechlorinated (carbon filter) municipal 
tap water maintained to pH 7.6, a conductivity of 600-700 us/cm2, and a temperature of 28.5°C, 
and ammonia levels ranging from 0-0.25 ppm. The zebrafish facility maintained a 14:10 
light:dark photoperiod. Fish were fed a commercial feed for zebrafish (Gemma, Skretting) twice 
daily on weekdays and once daily on weekends during periods where they were not being fed a 
treatment feed. Prior to the experiment, routine cleaning of all equipment (e.g. tanks, lids, 
baffles, nets, and tubing) consisted of bi-weekly washing and scrubbing in warm water with a 
new soft sponge and bleaching in 1000 ppm chlorine bleach for 30 minutes, followed by rinsing 
three times in dechlorinated water and drying. All tanks, lids, and baffles were also autoclaved 
using a program specified by the tank manufacturer that reaches a temperature of 105-110°C for 
15 minutes. During experiments this tank cleaning procedure occurred when the placement of 
fish in a new tank is mentioned in the methods below. All animal work was approved by the 
SUNY-ESF Institutional Animal Care and Use Committee, protocol #151001.
Fish were randomly divided into 33, 1.8L tanks (n=12, 6 male and 6 female). Three tanks 
per treatment were designated: sham artemia, M. chelonae artemia, M. marinum artemia, sham 
rotifers, M. chelonae rotifers, M. marinum rotifers, sham paramecium, M. chelonae paramecium, 
M. marinum paramecium, M. chelonae no vector, M. marinum no vector. 
Bacterial culture and growth media
For this study Mycobacterium chelonae (H1E2) mutant expressing green fluorescence 
protein (GFP) provided by M.L. Kent and Mycobacterium marinum (OSU214) were used. The 
M. chelonae was maintained at 28-30°C on solid-phase Middlebrook 7H10 agar supplemented 
with oleic albumin dextrose catalase (OADC) for 5 days. Mycobacterium marinum was cultured 
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at 28-30°C on solid-phase Middlebrook 7H10 agar supplemented with OADC and 60 μM hemin 
for 10-14 days.
Vector Culture and Dosage Determination
Artemia
For artemia experiments, Grade A Brine Shrimp Eggs were used (Brine Shrimp Direct). 
Manufacturer instructions were used for preparing artemia hatching water with a salinity of 25 
parts per thousand and a pH of 8.  Following preparation, the hatching water was autoclaved and 
cooled to room temperature. Prior to hatching, artemia cysts were disinfected and decapsulated 
by bleaching. For bleaching, cysts were placed in a mesh bottom container, nested within a glass 
beaker. The glass beaker was maintained in an ice bath. Cysts were bleached in a 1:1 ratio of 
Clorox® to hatching water under constant aeration. Bleaching was done until cysts were 
decapsulated and orange in color. Following bleaching, cysts were rinsed three times with 
hatching water. Next, rinsed cysts were placed in hatching cones containing hatching water 
(Aquaneering). Hatching cones were maintained on a bench top with constant overhead lighting 
at room temperature (25°C).
Initial bacterial incubations were conducted to gain insight into the uptake of Mycobacterium 
spp. by vectors. For initial bacterial incubations with artemia, artemia nauplii were collected and 
concentrated in a mesh-bottom filter at 24 h post hatching. Concentrated artemia were distributed 
into sterile petri dishes and incubated at a 3:1 ratio with M. chelonae diluted in autoclaved dH2O
to a concentration of 2.7 x 108 cfu/ml using a nephelometer where 1 ml of diluted M. chelonae 
per 3 ml of concentrated artemia (Sensititre). Incubations were done for 4 time-points: 10 
minutes, 30 minutes, 1 hour, and 24 hours. Control incubations with no bacteria were also 
170
 
conducted. Following incubation periods, artemia were filtered and rinsed using a mesh-bottom 
conical tube and resuspended in autoclaved hatching water. 
For imaging, artemia were immobilized using carbonated water (grocery store) and imaged 
using a Leica inverted compound microscope under both brightfield and fluorescence. 
Representative images of artmeia from each incubation time-point were taken. 
For qPCR, triplicate 200 μl samples from each time-point were taken from the concentrated 
and rinsed artemia. An additional 200 μl sample was taken and set aside so that the number of 
organisms in the sample could be counted. Artemia were homogenized using a sterile plastic 
tissue pestle. Homogenized samples were then used for DNA extraction using the MO BIO 
Laboratories, Inc. UltraClean® Microbial DNA Isolation Kit following manufacturer protocol.
Following DNA extraction, a real-time qPCR was performed with technical triplicates for each 
triplicate sample using primer, probes, and protocol previously published (Meritet, Mulrooney et 
al. 2017). Ct values of serial dilutions of either M. chelonae or M. marinum were used to create a 
standard curve and calculate the colony forming units for each sample (Excel 2010, Microsoft). 
Paramecium
Starter cultures of paramecia were obtained from Carolina Biological. Paramecia were 
cultured following previously described directions (ZFIN, 2014, https://wiki.zfin.org/
display/prot/Paramecium+Recipes+for+Large+and+Small+Facilities). Initial bacterial 
incubations with paramecia were performed similarly to those previously described above for 
artemia. With the amendment of paramecia being immobilized for imaging using 0.3 g/L MS222 
dropped into rotifer suspension using a sterile plastic pipette until movement of paramecia 
ceased, imaging was conducted similarly to artemia as well. The qPCR assay was also performed
the same as those previously described for the artemia.
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Rotifers
A starter culture of 1 million live marine L-type rotifers was obtained from Reed 
Mariculture Inc. along with a Compact Culture System (CCS) for benchtop-scale culture of the 
rotifers. Rotifers were cultured following directions from the manufacturer with a 20% daily 
harvest and feeding of RGComplete (Reed Mariculture, http://apbreed.com/
product_compact_culture_system.php). Initial bacterial incubations were performed as
previously described for the paramecium, with the amendment of rotifers being evaluated only 
by qPCR at the 24-h time-point.
Vector Feed Preparation
From the previous qPCR assays, it was determined that 24 hour incubation was optimal 
for highest bacterial dose. Vectors (artemia, paramecium, rotifers, and bacteria only) were 
incubated with either M. chelonae, M. marinum, or no bacteria for 24 hours as described above. 
Following incubations, vectors were filtered and rinse. Triplicate 200 μl samples were taken 
while the remaining concentrated vectors were stored at 4°C. From these samples a DNA 
extraction followed by qPCR assay was performed as described above to verify the amount of 
vector required to reach the desired infective dose. This inoculant dose was calculated to 
determine the amount of concentrated vector needed based on each fish receiving 1.0 x 104 cfu 
per feed each day for five days (resulting in a total dose of…) at a daily feeding amount of 5% 
body weight based on an average fish size of 0.4 g.
Gelatin feed (Gelly Belly, Florida Aqua Farms) was prepared as previously described 
(Sciarra, Tyler et al. 2014) with 10 g of Gelly Belly being dissolved in 20 ml (minus volume of 
inoculant) of clam juice (grocery store brand) warmed to approximately 50°C. Once the gelatin 
mix was mixed thoroughly using a flame sterilized metal spatula. The inoculant was then added 
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to the warmed mixture to and mixed well. Following mixing the entire mixture was spread on a 
sterile plastic petri dish and allowed to set at 4°C. After the gelatin mix had set, it was minced 
suing a flame-sterilized razor blade and aliquoted into the mass of feed needed for one tank’s 
(N=12) daily feed. Aliquots were stored at -20°C until feeding time. Treatment tanks were fed 
the treatment feeds for five consecutive days. Aliquoted treatment feeds were briefly thawed 
from storage in the freezer and then emptied into treatment tanks. Following 30 min of feeding 
tanks were observed for any excess food, none was noted.  Following the 5 treatment feeds, fish 
were returned to regular feeding and care as listed in the details above.
Live Imaging of M. chelonae infected zebrafish
For M. chelonae treatments (M. chelonae broth, M. chelonae artemia, M. chelonae 
paramecium, and M. chelonae rotifers) live imaging of fish was done at 4 weeks post-infection.
For live-imaging, fish were anaesthetized in 0.15 g/L MS222 and imaged under FITC 
fluorescence in order to detect GFP expression. If GFP expression was detected, an image was 
taken and the location of the GFP expression was noted. Following imaging, fish were placed in 
a recovery tank containing fresh zebrafish system water. Once, recovered, fish were placed in 
new clean 1.8L tanks and returned to the zebrafish system. 
End Analyses
After 8 weeks week of sampling all fish were euthanized by submersion in 0.3 g/L 
MS222 buffered to a pH of 7.5 for a minimum of 10 minutes following the cessation of opercular 
movement. For M. chelonae treatments (M. chelonae broth, M. chelonae artemia, M. chelonae 
paramecium, and M. chelonae rotifers) euthanized fish were imaged under both brightfield and 
fluorescence. In the case that no GFP expression was initially detected, a 5 mm by 5 mm window 
was made on the lateral side of the fish so that internal organs could be observed under FITC 
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fluorescence for signs of GFP expression. Images were taken when GFP expression was 
observed with corresponding brightfield images. Samples of any GFP expressing tissue along 
with liver, and spleen were also taken and stored in 200 μl sterile dH2O. These samples were 
further processed with homogenization using a sterile plastic tissue pestle. Next, 900 μl of 
autoclaved dH2O was added, followed by vortexing. The vortexed tubes were pelleted and 
subsequently cultured on MB agar plates. Resulting growth with GFP positive colonies was 
recorded. Finally, real-time qPCR of the homogenate was conducted using M. chelonae specific 
primers as previously described (Meritet, Mulrooney et al. 2017). Finally, euthanized fish were 
fixed in Davidson’s solution for 48h and then transferred to 70% EtOH for storage.  
For M. marinum treatments (M. marinum broth, M. marinum artemia, M. marinum
paramecium, and M. marinum rotifers) euthanized fish were imaged under both brightfield 
followed by a 5 mm by 5 mm window was made on the lateral side of the fish so that internal 
organs could be further observed for signs of granulomas. Images were taken for all fish. 
Samples of any granulomas, liver, and spleen were also taken and stored in 200 μl sterile dH2O. 
These samples were further processed as described for the M. chelonae treatment fish with the 
amendment of M. marinum specific primers (Meritet, Mulrooney et al. 2017) being used for 
qPCR. Finally, euthanized fish were fixed in Davidson’s solution for 48h and transferred to 70% 
EtOH for storage. This same process was repeated for control (no bacteria) artemia, paramecium, 
and rotifer treatment fish with Mycobacterium species-specific primers (Meritet, Mulrooney et 
al. 2017) being used for qPCR. 
End Analyses Vector
The quantity of Mycobacterium spp. that were taken up by each vector was compared 
following the collection of real-time qPCR data using R 3.1.0 (R Core Team, 2013) and R Studio 
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(R Studio, 2012). Prior to statistical analyses the resulting quantity of bacteria following qPCR 
was calculated by both sample (50 μl DNA extraction product) and also by organism based on 
counts of organisms in each sample. For each treatment descriptive statistics were obtained 
using the “psych” package (Revelle, 2014). Data were also checked for normality equal 
variances using the “stats” package (R Core Team, 2013) and “car” package (Fox and Weisberg, 
2011) respectively. Since all data sets were found to have non-normal distributions (p<0.05) and 
unequal variances (p<0.05) the non-parametric Kruskal-Wallis rank sum test was used to 
compare percent survival values using the “stats” package (R Core Team, 2013). In the case of a 
significant result, indicating differences between disinfection treatments, post-hoc tests for 
pairwise multiple comparisons of the ranked data were performed using the “PMCMR” package 
(Pohlert, 2015). Data were then visualized as a clustered bar graph using the “sciplot” package 
(Morales et al., 2012).
End Analyses Fish
For M. chelonae and sham infections, analyses of end prevalence values based on three 
diagnostic techniques (in vivo screen for GFP, dissection followed by in vivo screen for GFP, and 
real-time qPCR of liver/spleen samples) was carried out. Prior to statistical comparisons between 
treatment groups, replicate tanks for the same treatment were compared to see if results could be 
pooled using a Chi-squared analysis with a Monte Carlo simulation method using 20,000 
replications. There was no significant difference between replicate groups thus prevalence data 
was pooled for each treatment for further analyses. To compare the prevalence values obtained 
by each diagnostic method between treatments, Fisher’s exact test for count data was used to 
compare prevalence between infection types using the “stats” package (R Core Team 2013). This 
comparison was carried out separately between groups of both sexes, males only, and females 
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only. It should be noted that prevalence via qPCR was not available for sham infection 
treatments, so sham treatments were excluded from comparisons of this diagnostic method. 
Prevalence values and statistical results were organized into bar plots using the “sciplot” package 
(Morales, with code developed by the R Development Core Team et al. 2012).
For M. marinum treatment groups, where only qPCR prevalence data was available, 
treatment groups were compared. Similar to the analyses described above, replicate tank data 
was compared in order to see if replicate data could be pooled for each treatment group. There 
was statistical difference between replicate groups, so data was pooled for further analyses. To 
compare treatments, an ANOVA test was performed using the “stats” package (R Core Team 
2013). Tukey post-hoc analyses was conducted using the “agricolae” package (CITE).
Prevalence values and statistical results were organized into bar plots using the “sciplot” package 
(Morales, with code developed by the R Development Core Team et al. 2012).
7.4 Results
Vector Analyses
Both M. chelonae and M. marinum were taken up by all vectors, and when evaluated, the 
GFP expression was observed in both artemia and paramecia (Figure 7-1). In the artemia, the M. 
chelonae was observed to be collected in the organism’s gut. In the paramecia, the M. chelonae 
was observed to be taken up by the organism’s vacuoles. Based on real-time qPCR analysis, the 
amount of both M. chelonae and M. marinum taken up by each vector was quantified as 
followsFor M. chelonae, there were more bacteria detected in DNA extracts from paramecia, as 
compared to artemia, at both the 30 minute and 1 hour incubation time point [F(5)=21.55, p=1.3 
x 10-5] (Figure 7-2, asterisk). However; when corrected for the quantity of bacteria per organism, 
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there was no difference between vectors [F(5)=0.972, p=0.475]. When comparing incubation 
time points for each vector individually, artemia had the significantly highest quantity of M. 
chelonae at the 10-minute incubation point (Figure 7-2, plus sign) compared to longer 
incubations. Similarly, paramecium had the lowest quantity at the 24-hour incubation time point 
[F(5)=21.55, p=1.3 x 10-5].For M. marinum, the amount of M. marinum quantified from the 
DNA extraction did not differ significantly between vector organisms at the 24-hour incubation 
time-point [F(5)=0.972, p=0.475)].
Figure 7-1. Expression of M. chelonae GFP mutant in zebrafish feed vectors. (A) Artemia is 
shown in bright field and under (B) FITC fluorescence where GFP is observed in the gut of the 
artemia. (C) GFP expression is observed in the paramecium vacuoles. Scale = 100 μm.
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Figure 7-2. Quantity of M. chelonae in live feed vectors based on real-time qPCR analyses. 
Artemia (white bars), paramecium (grey bars), and rotifers (black bars) are shown. Significant 
differences between vectors at the same time-point is shown (*) and significant differences 
between time-points for the same vector is shown (+).
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Figure 7-3. Quantity of M. marinum in live feed vectors based on real-time qPCR analyses
following 24 hours of incubation. Artemia (white bars), paramecium (grey bars), and rotifers 
(black bars) are shown. No significant differences in bacterial uptake were observed.
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Figure 7-5. End real-time qPCR prevalence values for the detection of M. marinum in liver and 
spleen samples are shown for each treatment group. Differences between treatment groups 
consisting of both sexes only males and only females are shown (asterisk). Note sham controls 
were all negative and are not shown.
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End Prevalence Analyses
The feeding all three invertebrates to zebrafish, as well as the Gelly Belly diet, resulted in 
transmission of M. chelonae. Overall, there was no significant difference in resulting prevalence 
in fish fed the different invertebrate vectors based on real-time qPCR testing. When comparing 
treatment groups consisting of both sexes (Figure 7-4 A and D), differences were observed based 
on in vivo screening for GFP between treatment and sham groups. Rotifer and artemia sham 
infection prevalence was significantly less than all M. chelonae treatment groups (p=0.003). 
Similarly based on dissection followed by in vivo screening for GFP, all sham infection 
treatments had a significantly lower prevalence than M. chelonae treatments (p=3.56 x 10-7). No 
significant difference was observed between any of the treatments based on qPCR prevalence 
results. When comparing treatment groups consisting of males only (Figure 7-4 B and E) 
differences were observed based on in vivo screening for GFP between treatment and sham 
groups. The artemia M. chelonae treatment resulted in a significantly higher prevalence than the 
paramecium M. chelonae treatment and also the sham treatments (p=0.00014). Based on 
dissection followed by in vivo screening for GFP, all sham infection treatments had a 
significantly lower prevalence than M. chelonae treatments (p=0.249 x 10-7). No significant 
difference was observed between any of the treatments based on qPCR prevalence results. For 
groups consisting of only females (Figure 7-4 C and F) no significant differences were observed 
based on in vivo screening for GFP between treatment and sham groups. Based on dissection 
followed by in vivo screening for GFP, all sham infection treatments had a significantly lower 
prevalence than M. chelonae treatments (p=0.024). No significant difference was observed 
between any of the treatments based on qPCR prevalence results.
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Feeding all three invertebrates to zebrafish, as well as the Gelly Belly diet, resulted in 
transmission of M. marinum to fish except when rotifers were used as vectors. Overall, as no
transmission was detected via real-time qPCR analysis for rotifers, all other invertebrates and 
Gelly Belly feed resulted in significantly higher prevalence following transmission relative to
sham feeds. End prevalence values for M. marinum treatments are shown for real-time qPCR of 
liver and spleen samples (Figure 7-5). When comparing treatment groups consisting of both 
sexes, rotifer prevalence was significantly lower than paramecium and Gelly Belly treatments 
[F(3)= 9.461, p=0.005]. For females only, paramecium was significantly higher than other 
treatments [F(3)=15.27, p=0.00113]. Finally, for males only the Gelly Belly prevalence was 
significantly higher than the other treatments [F(3)=256, p=2.77 x 108].
7.5 Discussion
All vectors readily took up the mycobacteria, which was not surprising as the uptake of 
bacteria in live feed vectors has been demonstrated for other pathogens (Rombaut, Dhert et al. 
1999, Sahul Hameed and Balasubramanian 2000) and in previous studies looking at 
Mycobacterium spp. (Harriff, Bermudez et al. 2007, Peterson, Ferguson et al. 2013). No 
significant difference was observed between vectors in terms of the quantity of bacteria taken up. 
This study incubated feed vectors with a high dose of mycobacterial inoculant, and differential 
uptake of bacteria between vectors may occur with a lower dose of inoculant. We also only 
looked at uptake over a maximum period of 24 hours, and continued bacterial uptake or 
elimination cannot be ruled out. In terms of management insight, it is important to note that 
artemia do not take up bacteria until feeding by mouth begins at approximately 24 hours post-
hatch. Thus, the use of younger artemia may help prevent vector transmission of pathogens. 
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The observed virulence of mycobacterial infections through different methods resulted in 
variation in the prevalence of Mycobacterium spp. infections depending on the end point (e.g. in 
vivo screening for GFP vs. liver and spleen qPCR). We also observed some GFP expression in 
sham female fish that could be due to auto-fluorescence in the ovary due to degenerating eggs. 
However when smears were prepared from these tissues, no GFP rods were observed, and could 
be confidently categorized as uninfected. This study was the second usage of the in vivo GFP 
whole-fish screening used by our group. Similar to our previous study (unpublished), we found 
that the in vivo GFP screening was high in sensitivity, but low in specificity when compared to a 
gold standard like qPCR. This low specificity can be attributed to additional potential sources of 
auto-fluorescence within the zebrafish (e.g. gall bladder and degenerating eggs) that may cause
false positives. These can be examined further for the presence of GFP rods, to verify the 
presence or absence of bacteria. Despite the low specificity of the in vivo GFP screening method, 
it is important to emphasize that we detected transmission of mycobacteria from live feeds to 
zebrafish for all vectors examined using our most specific test, PCR.
Following end-analyses of M. chelonae treated fish, no significant differences were 
observed for any of the diagnostic methods when considering groups composed of both sexes or 
females. When only considering males, in vivo screening for GFP resulted in a significantly
higher prevalence in artemia M. chelonae treated fish. End real-time qPCR analyses of M. 
marinum treated fish resulted in rotifer M. marinum treated fish having the no prevalence for 
groups of both sexes, Gelly Belly M. marinum treatment resulting in the highest prevalence 
among males, and paramecium M. marinum treatment resulting in the highest prevalence among 
females. Thus no clear trend in virulence between vector feed treatment was observed. 
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Previous studies (Harriff, Bermudez et al. 2007, Peterson, Ferguson et al. 2013) have 
evaluated the influence of feed vectors separately, and this is the first study that compared 
virulence following treatment of multiple live-feed types. However, previous studies have found 
transmission through a live feed vector resulted in an increased virulence compared to treatment 
with culture (no live feed). We did not observe this increased virulence that could be due to 
several possible reasons. First with regard to dose, adult zebrafish in a previous study (Peterson, 
Ferguson et al. 2013) were fed an experimental dose of M. chelonae and M. marinum for 14 days 
compared the 5 days of feeding used in this study. A longer treatment period or higher dose may 
result in more severe infections and greater difference between feed vectors. Second in Peterson 
et al. (2013), end point analyses consisted of histological analyses, thus future histological 
analyses will help to further inform mycobacterial prevalence and infection severity in these fish. 
Third, we used exclusively adult casper (nacrew2/w2;roya9/a9) zebrafish. Differences may occur 
between wild-type and mutant fish, as well as zebrafish at different developmental time-
points.
Although no differences were observed between vector feeds used in this study, we did 
observe mycobacterial transmission through live feed vectors commonly used in zebrafish 
facilities. This observation emphasized the need for live feed vectors to be considered as a 
source of biosecurity risk. Future studies should be conducted to increase our understanding 
of the role live feeds play in mycobacterial transmission within zebrafish facilities, as live 
feeds have been shown to be a beneficial nutrition for zebrafish culture. These future studies, 
in addition to this one, will help not only zebrafish research facilities, but also those of additional 
aquatic models (i.e., Japanese medaka, swordtails, killifish, and Mexican cavefish). 
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Chapter 8: Conclusions
8.1 Overview
The general goal of this thesis was to investigate mycobacteriosis in laboratory zebrafish 
in order to increase our understanding of this disease with the intention of influencing control 
and management practices. As mycobacteriosis is the second most common pathogen affecting 
zebrafish, disease control is a priority within the zebrafish research community. This thesis has 
several aims that contribute towards improved disease management measures. 
First I aimed to investigate disease prevention through embryo disinfection. I evaluated 
the effectiveness of disinfectants commonly used for embryo disinfection in the aquaculture 
setting, but with unknown effectiveness against the species of Mycobacterium found in zebrafish.
Once I identified povidone-iodine as an effective disinfectant against Mycobacterium spp. in 
vitro, I evaluated the treatments effect on zebrafish embryo health by conducting a subsequent in 
vivo study.
Second, I aimed to examine the efficacy of antibiotic treatment against mycobacteriosis 
in zebrafish, as antibiotics are the established treatment in mycobacterial infections in other 
animals. I first was able to identify tigecycline and clarithromycin as key drug candidates as they 
were effective against preventing mycobacterial growth in vitro. I was then able to test both the 
tolerance and efficacy of these treatments in adult zebrafish, where treatments were well 
tolerated and resulted in a decreased severity in established mycobacterial infections. 
Finally, I aimed to examine natural modes of transmission of mycobacteria in zebrafish. I 
first examined transmission between tank biofilms and zebrafish and demonstrated the role 
mycobacterial biofilms play as both a reservoir for and source of Mycobacterium spp. in 
zebrafish tanks. Finally, I examined the role that live feeds play as vectors for mycobacterial 
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transmission to zebrafish. I demonstrated that common zebrafish feeds are able to transmit 
Mycobacterium spp. to zebrafish. Altogether, these studies contribute to our current knowledge 
of mycobacterial infections in laboratory zebrafish and help to inform disease management. 
These results are also of use to other fish species as well. 
8.2 Additional Considerations
Through these studies, three underlying considerations were identified and merit 
additional discussion. While these considerations were not directly tested in this thesis, they were 
noted, and along with results from recent literature contributions, should be considered in future 
research that investigates mycobacteriosis in laboratory zebrafish.
The first consideration is the importance of the reporting of standard conditions and 
reagent preparation. This was first identified in this thesis through the research aim investigating 
disinfection. As has previously been identified, many factors influence the effectiveness of 
disinfectants including: temperature, time of contact, pH, concentration as well as the presence of 
organic matter (Mainous and Smith, 2005). In the context of a zebrafish facility, environmental 
conditions (e.g., temperature, lighting) may impact the integrity of chemicals. Current long-term 
storage pracitices for disinfectants may not be appropriate and alternative measures are necessary 
(e.g., refrigeration). We identified that the preparation of working solutions of disinfectants
influences the effectiveness of treatment, as working solutions of povidone idone had the iodine 
concentration diminish over 24 hours. We found that some users of iodine disinfectants did not 
find their treatments as effective at preventing Mycobacterium spp. growth (Mason et al., 2016); 
however, details regarding the source, storage, and preparation of the working solutions were not 
reported and could have caused this discrepancy. In general within the zebrafish community, the 
importance of standardization and reporting in zebrafish studies in order to conduct repeatable 
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and comparable studies (Collymore, Crim et al. 2016, Goodwin, Karp et al. 2016, Watts, 
Lawrence et al. 2016) cannot be overemphasized. It is prudent that zebrafish research includes 
the reporting of the health status of fish so that implications of background infections can be 
taken into account. 
The second consideration is differences between mycobacterial infection prevalence and 
severity between male and female zebrafish. I had decided to conduct additional analyses 
comparing sexes, as sex as a biological variable (SABV) is a recent concern highlighted by the 
National Institutes of Health (NIH) (Tannenbaum, Schwarz et al. 2016). I also saw SABV as 
potentially informative for disease management in zebrafish. This initiative turned out to be 
important as during the in vivo antibiotic study (Chapter 5), I observed differences in 
mycobacterial prevalence and severity between male and female fish. I also subsequently 
observed similar differences in the biofilm transmisison study (Chapter 6) and the vector 
transmission project (Chapter 7). In all of these studies I observed that experimental 
mycobacterial infections were both more prevalent and severe in female zebrafish, with the 
majority of granulomas being observed in the ovaries. Mycobacteria infections have been 
previously discussed to target the ovaries (Kent, Whipps et al. 2004, Whipps, Matthews et al. 
2008) and mycobacteriosis is commonly found in zebrafish with widespread chronic 
inflammation. Previous studies discuss the association between mycobacterial infections and Egg 
Associated Inflammation and Fibroplasia (EAIF), a common condition in laboratory zebrafish 
(Kent, Whipps et al. 2004). As EAIF occurs commonly with no pathogen present, it is thought 
that EAIF provides a macrophage-rich environment within the ovaries for mycobacterial 
infections to be established (Kent, Whipps et al. 2004, Kent, Watral et al. 2016). Theses results 
support further investigation of SABV in zebrafish mycobacteriosis. Understanding SABV in 
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mycobacteriosis will benefit those interested in improving disease control and management 
within zebrafish but it will also help inform studies studying mycobacterial disease using the 
zebrafish model for biomedical research.
The final consideration, is the choice of diagnostic end-point for determining 
mycobacterial prevalence. In our studies we looked at a variety of  end-points including 
histology, in vivo GFP screening before and after dissection, liver and spleen culture, and liver 
and spleen real-time qPCR. These different end points resulted in variable prevalence values. 
This difference was more pronounced in fish infected through a more natural mode of infection 
compared to IP injected fish. For example, in the biofilm transmission study (Chapter 6), in vivo 
GFP screening resulted in a higher prevalence compared to histology for oral feed infected fish. 
Whereas this difference between diagnostic methods was not observed in IP injection fish. Both 
modes of infection still resulted in a lower prevalence through liver culture. Previous studies 
have found a high agreement in prevalence between culture and histology for diagnosing 
mycobacterial infections in zebrafish (Whipps, Matthews et al. 2008). Depending on the severity 
of mycobacterial infections, agreement between diagnostic methods may vary. More severe 
infections would result in a greater probability of detecting mycobacteria in the haematopeotic 
organs or through midline histological sections. Less severe infections, particularly those isolated 
in the ovaries, may not be detected by histology or haematopoetic organ culture/PCR, but may be 
observed through in vivo GFP screening. Additionally, the timing sampling in relation to the 
infection course may impact detection. The progression of granuloma pathology and growth of 
mycobacteria within the zebrafish is both time and dose dependent, as higher doses and/or longer 
incubations result in more severe infections with a more detectable mycobacteria (Swaim, 
Connolly et al. 2006). Also, little is known about the natural mycobacterial infection clearance in 
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zebrafish, which has been previously attributed to low bacterial counts in experinmentally 
infected fish (Swaim, Connolly et al. 2006). More research is needed to compare diagnostic
methods across modes of infection and timing of experimental end-points to better understand 
detection of mycobacteriosis in zebrafish. 
For Chapters 6 and 7, we started using the in vivo GFP screening method in order to 
detect mycobacterial prevalence in vivo. While we experienced issues with the specificity of this 
method, it was still useful for the purpose of our studies tracking transmission of mycobacteria 
infections to zebrafish as we were able to easily detect infections in zebrafish without needing to 
euthanize the fish or utilize more expensive or time consuming diagnostic methods. This in vivo 
GFP method work well for initially detecting transmission of mycobacteria; however, more 
specific methods (e.g., real-time qPCR) may be more appropriate in other situations where a 
more specific diagnosis is required. Further evaluation of this in vivo GFP method should be 
done to improve the specificicity of this method.
The need for further understanding of mycobacterial infections within laboratory 
zebrafish research facilities  contributed to the broad nature of the studies presented in this thesis. 
Results from these studies have contributed to what we understand about the prevention, 
treatment, and transmission of mycobacteriois in zebrafish. Protocols for embryo disinfection 
and antibiotic treatment of zebrafish were developed, as well as, natrual disease transmission 
models to further this understanding. Results from these studies help to inform the zebrafish 
community, emphasizing the importance of proper husbandry techniques, particularily disease 
control and management measures as a means to prevent or control mycobacteriosis in these 
faciltities. While it may not be possible to entirely eliminate mycobacteria from laboratory 
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zebrafish facilities, results from this dissertation demonstrate measures can be taken to control 
and minimize infection risks.
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